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Summary 
Risk Assessment for Osteoporotic Fractures among Men and Women from a 
Prospective Population Study: The EPIC-Norfolk Study 
PhD Thesis by Alireza Moayyeri  
 
Osteoporotic fractures are a major and increasing clinical and public health 
concern internationally. Identification of individuals at high risk for fragility 
fractures may enable us to target preventive interventions more effectively. In this 
thesis, I aimed to evaluate novel risk factors for osteoporosis and develop a 
fracture risk assessment model among the middle-aged and older people. I used 
data from the European Prospective Investigation into Cancer (EPIC)-Norfolk 
study, which is a large population-based prospective study started in 1993. About 
25,000 men and women were assessed at baseline and about 15,000 of them 
returned for a second examination 4 years later. All participants are followed up 
to the present for clinical events including fractures. My work is in two parts. For 
the first part, I examined the risk of fracture associated with some novel or less 
well studied risk factors. These risk factors included change in height over time, 
respiratory function, physical activity and body fat mass. We found that men and 
women with annual height loss >0.5 cm are at increased risk of hip and any 
fracture (relative risk=1.9 (95% CI 1.3-2.7) per cm/year height loss). One litre 
lower forced expiratory volume in 1 second (FEV1) was associated with a 2-fold 
risk of hip fracture in men and women. We also observed a non-linear 
association, independent of body mass index, between increasing body fat mass 
and lower fracture risk in women but not in men. I performed a systematic review 
and meta-analysis of studies evaluating the association between physical activity 
and hip fractures. Using a new validated questionnaire in EPIC-Norfolk, we 
observed varying relationships between physical activity in different domains of 
life and fracture risk in men and women. For the second part of the thesis, I 
ii 
 
developed a biostatistical model to calculate 10-year risk of developing a fracture 
among EPIC-Norfolk study participants. This model incorporates clinical and 
radiological assessments known to be associated with fractures and can be 
extended to other risk factors assessed in other prospective cohorts. This helps 
clinicians to achieve a better estimate of the prospective risk of fracture in their 
patients. I applied this model to compare the predictive value of two different 
clinical assessment methods for osteoporosis, namely dual-energy X-ray 
absorptiometry (DXA) and quantitative ultrasound (QUS). We found that that the 
predictive power of QUS is comparable to, and independent of, predictive power 
of DXA. In summary, my studies have added to our knowledge about some novel 
and easy-to-use risk factors of osteoporosis and proposed a practical method to 
merge and utilise data from different risk factors for estimation of fracture risk in 
individuals. 
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Thesis Structure  
The scope of this PhD thesis consisted of: 1) assessment of new risk factors for 
osteoporotic fractures given the data available in the EPIC-Norfolk study; and 2) 
development of a model for integrating established risk factors and estimation of 
10-year absolute risk of fracture in this population. The thesis structure follows 
this scope. Chapter 1 is a literature search and a general introduction to the 
problem from different epidemiological aspects. To minimise repetition of 
methods in different Chapters, I have written out the common methods of the 
study in Chapter 2. Therefore, the Methods sections in the following Chapters 
contain only methods related to the specific objective of the Chapter. The rest of 
the thesis is structured around chapters written as papers, which answer specific 
research questions related to the scope of this PhD project. Chapters 3, 4, 6, and 
7 are based on studies for search of novel or less-studied risk factors of fracture 
using EPIC-Norfolk data. Given the importance and complexity of physical 
activity as a risk factor, I carried out a systematic review of the literature and the 
results are presented in Chapter 5. In Chapter 8, I have reviewed the importance 
of absolute risk measures in epidemiology and potential applications of it in the 
field of bone research. Chapters 9, 10, and 11 are based on the model I 
developed for estimation of absolute fracture risk in EPIC-Norfolk. Each of these 
Chapters follows the same format: Abstract, Introduction, Methods, Results, and 
Discussion. Chapter 12 presents a general discussion placing the research 
findings in context and highlighting potential areas for further work. Most of the 
thesis is written in the first person plural to acknowledge co-authorship for the 
papers. However, I have been in charge for the entire projects of this thesis and I 
am fully responsible for the data, analyses, and results of this thesis.   
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Chapter 1: Introduction 
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In this Chapter, I firstly explain the current state of knowledge about the 
epidemiology and burden of osteoporosis and hip fractures in the world and the 
increasing need for development of preventive strategies in high-risk populations. 
A review of the established risk factors of osteoporotic fractures is presented 
alongside with a brief introduction of the risk factors evaluated in this thesis. 
Different methods for risk assessment of osteoporosis are described and discussed 
with an emphasis on the absolute risk estimation methods. I then explain the aims 
and objectives of different sections of this thesis. 
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1.1. Epidemiology and burden of osteoporosis  
Osteoporosis is defined as a “systemic skeletal disease characterised by low bone 
mass and micro-architectural deterioration of bone tissue leading to enhanced 
bone fragility and a consequent increase in fracture risk” [1]. Osteoporosis is a 
highly prevalent disease among the elderly. For the year 2000, there were an 
estimated 3.1 million new osteoporotic fractures in Europe [2]. The 2004 US 
Surgeon General’s report has estimated that about 10 million Americans over the 
age of 50 years have osteoporosis, and around 1.5 million fragility fractures occur 
in these patients each year [3]. The report estimates that approximately one in 
two women and one in five men over the age of 50 will have an osteoporosis-
related fracture in their remaining lifetime [3]. An analysis of the General Practice 
Research Database (GPRD, which includes 6% of the UK population) showed a 
similar figure in the UK [4]. The most common sites of fragility fractures are the 
hip, spine and distal forearm. 
Approximately 98% of hip fractures occur among people aged 35 years and over, 
and the incidence of hip fracture in most populations increases exponentially 
with age (Figure 1.1) [5]. In 1990, an estimated 1.66 million hip fractures 
occurred worldwide, of which 1.19 million were in women [6]. The GPRD study 
estimated that the lifetime risk of hip fracture for 50-year-olds in the UK is 11.4% 
and 3.1% for women and men, respectively [4]. However, these figures might be 
underestimated given the changes in expected mortality rates [7]. Many vertebral 
fractures are asymptomatic, and there is disagreement about the radiographic 
definition of such fractures. It is estimated that only one-third of radiographically-
diagnosed vertebral fractures come to medical attention [8]. The overall age-
standardised incidence of vertebral fracture in the European Prospective 
Osteoporosis Study (EPOS) was 10.7 per 1,000 person-years in women and 5.7 
per 1,000 person-years in men (Figure 1.1) [9]. It is estimated that 1.4 million 
clinical vertebral fractures and 1.6 wrist fractures occurred globally in 2000 [2]. 
Wrist fractures show a pattern of occurrence that differs from that of hip and 
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vertebral fractures. Most wrist fractures occur in women with 50% occurring in 
women aged over 65 years (Figure 1.1). Data from the GPRD study showed that 
the lifetime risk of wrist fracture in a 50-year-old British woman is 16.6%, falling 
to 10.4% by 70 years of age. The corresponding figures in men are 2.9% and 
1.4%, respectively [4].  
 
 
 
 
Figure 1.1: Age- and sex-specific 
incidence of hip, radiographic 
vertebral, and wrist fractures 
Data derived from the European 
Prospective Osteoporosis Study [9] and 
General Practice Research Database 
[4]. Figure is reproduced from reference 
[10].  
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It should be noted that, while hip and vertebral fractures are associated with 
substantial burden associated with osteoporosis, the incidence of fractures in 
other sites is much higher and they impose a considerable burden on 
populations. These fractures are important as they occur at an earlier age 
compared to hip fracture, and their incidence rate exceeds that of hip fracture 
even in men and women aged >80 years (Figure 1.2) [11]. In the year 2000, 4.3 
million out of 9 million osteoporotic fractures were at sites other than hip, spine 
and forearm [2]. 
 
 
 
 
Figure 1.2: Incidence rate of fractures in different sites among post-menopausal women 
Non-vertebral, non-hip fractures include fractures of the ribs, pelvis, humeral shaft, 
proximal humerus, clavicle, scapula, sternum, tibia, fibula, distal forearm, and femoral 
fractures other than hip. Figure is adopted from the Geelong Osteoporosis Study [12]. 
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Hip fractures are associated with a significant increase in mortality, even in the 
<65 years age group [13, 14]. An estimated 740,000 deaths per year are 
associated with hip fracture worldwide [15]. Mortality associated with hip 
fracture increases with age and is higher in men than women. In the UK, the 12-
month survival rate after hip fracture for men is 63.3% versus 90.0% expected 
and for women is 74.9% versus 91.1% expected [4]. In the US, about 8% of men 
and 3% of women aged over 50 years die while in hospital following their hip 
fracture [16]. Mortality rates after hip fracture continue to rise over the subsequent 
months and peak at 1 year, with a rate of 36% for men (higher for the very 
elderly) and 21% for women [16]. Data from 28.8 million person-years of follow-
up from the patient register of Sweden suggested that 17-32% of deaths after hip 
fracture are directly related to the event, and hip fracture accounted for more than 
1.5% of all deaths in the population aged ≥50 years [17]. The Dubbo 
Epidemiology Study suggested that elevated mortality persists for up to 10 years 
after hip fracture [18]. Excess mortality after vertebral fracture seems to persist for 
up to 5 years in both sexes [18, 19], with only 8% of deaths following vertebral 
fractures directly attributable to osteoporosis. In the UK GPRD study, the 
observed survival in women 5 years after vertebral fracture was 56.5% versus 
69.9% expected [4]. Wrist fractures are not associated with excess mortality (see 
Table 1.1). 
Consistent with their effect on mortality, hip fractures contribute most to 
osteoporosis-associated morbidity. Alongside with acute complications such as 
pressure sores, bronchopneumonia and urinary tract infections, long-term 
mobility may be severely impaired. It is estimated that only 50% of hip fracture 
patients regain their pre-fracture status as judged by the ability to walk and the 
need for aids at home [20]. In the USA, 25% of formerly independent patients 
became at least partially dependent following a hip fracture, and 50% of those 
who were dependent pre-fracture were admitted to residential care [21]. The 
major clinical consequences of vertebral fracture are back pain, kyphosis, and 
height loss. This may lead to decreased quality of life and psychological problems 
 7 
 
such as depression and social isolation [22]. Although only a minority of vertebral 
fractures come to clinical attention, symptomatic vertebral fractures account for 
52,000 hospital admissions in the USA and about 2,000 in England and Wales 
each year in patients aged ≥45 years (Table 1.1) [23]. Wrist fractures do not seem 
to be associated with increased long-term morbidity [4]. 
 
 
Table 1.1: Impact of osteoporosis-related fractures in the UK 
Impact Hip Spine Wrist 
Lifetime risk    
 Women 14 28 13 
 Men 3 6 2 
Patients per year 70,000 120,000 50,000 
Hospitalisation (%) 100 2-10 5 
Relative survival 0.83 0.82 1.00 
Costs for all sites combined are estimated at approximately £1.7 billion. Table is reproduced from 
Reference [23]. 
 
 
 
Bone fractures are responsible for substantial costs related to hospitalisations, 
surgery, outpatient care, long-term care and premature death [24]. Fragility 
fractures account for 0.83% of the burden of non-communicable disease 
worldwide and 1.75% in Europe [2]. In the year 2000, the projected annual cost 
of osteoporotic fractures in the European Union was estimated at €32 billion [25], 
which was more than the annual cost of type 2 diabetes [26]. The projected 
direct costs are expected to increase to €76.7 billion in 2050 based on the 
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expected changes in the demography of Europe [27]. When burden of 
osteoporosis is compared to other health problems, the importance of the disease 
becomes more evident (Figure 1.3). In Europe, osteoporotic fractures accounted 
for more disability adjusted life years (DALYs) lost than common cancers, with the 
exception of lung cancer, and diseases such as hypertension, migraine and 
asthma [2]. For chronic musculoskeletal disorders, the DALYs lost in Europe due 
to osteoporosis were less than for osteoarthritis but greater than for rheumatoid 
arthritis. 
 
 
Figure 1.3: The estimated burden of diseases in Europe in 2002 
Figure is reproduced from Reference [2]. 
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The prevalence of osteoporosis is continuing to escalate with the increasingly 
elderly population. The global life expectancy is increasing steadily and the 
number of elderly individuals is rising in every geographic region. In the United 
Kingdom, the population aged over 60 is projected to increase by 50% between 
2000 and 2030 [28]. By the year 2050, the global population of individuals aged 
≥65 years is expected to reach to more than 1.5 billion. Assuming a constant age-
specific risk of hip fracture, the projected number of osteoporotic hip fractures 
worldwide is estimated to increase from 1.66 million in 1990 to 6.26 million in 
2050 [29]. Although some recent studies from Switzerland and Finland suggest 
that the age-adjusted incidence of hip fracture has declined over the last decade 
[30, 31], studies on the secular changes for hip fracture over the last century in 
Europe have shown an upward trend in age-adjusted incidence to the present 
time [23]. It should be noted that the number of elderly individuals is increasing 
faster in the developing countries of Asia and Latin America. This together with 
the upward secular trend in age-adjusted hip fracture incidence in these areas is 
likely to shift the geographical distribution of hip fractures, with only an estimated 
one-quarter occurring in Europe and North America by 2050 [29]. This trend 
calls for urgent action regarding the prevention and management of the disease. 
Osteoporosis fulfils most of the eight criteria recommended by the World Health 
Organisation (WHO) for screening diseases [32]. Osteoporosis is a worldwide 
health problem [15], the natural history of the disease is well understood [33], the 
disease is detectable pre-clinically [34], effective treatments are available for pre-
symptomatic patients [35], several facilities for diagnosis of the disease in 
inpatient and outpatient clinics are in place [36], and tests for early diagnosis are 
fairly safe and acceptable to the population [37]. However, considering the 
expenditure of diagnostic tests and medications for prevention of fractures, 
screening programmes appear to be cost-effective only in the high risk population 
[38, 39]. The other unfulfilled criterion is finding a suitable test to detect high risk 
individuals.  
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In summary, osteoporosis is a highly prevalent disease and imposes a great 
burden on the health system of both developed and developing countries. Hip 
and vertebral fractures are associated with impaired quality of life and a 20% 
reduction in survival. Future projections are more alarming given the increasing 
trend of life expectancy throughout the World. Despite the introduction of several 
new treatments in the past two decades, the disease still affects more than 200 
million women throughout the world [40]. Targeting individuals at high risk of 
fracture using new case-finding strategies is a major clinical and public health 
challenge. 
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1.2. Risk factors for osteoporotic fractures   
A large number of risk factors for osteoporotic fractures have been identified. The 
main ones include bone mineral density (BMD), age, sex, and history of fracture. 
Other risk factors show relatively poor specificity and sensitivity in predicting 
either bone mineral density or fracture risk [41, 42]. For the purposes of risk 
assessment, interest lies in those factors that contribute significantly to fracture 
risk over and above that provided by BMD measurements or age [43]. Here I 
review the main risk factors for osteoporotic fractures and some of the novel 
clinical risk factors (CRFs) for fracture and explain the relationships between 
them. 
 
1.2.1. Bone mineral density  
Bone mineral density (BMD) as measured by dual-energy X-ray absorptiometry 
(DXA) is the main available marker of bone health and is commonly used to 
diagnose osteoporosis [44]. In 1996, a reference meta-analysis of prospective 
cohort studies showed that the risk for fracture increases by a factor of 1.5–3.0 for 
each standard deviation decrease in BMD (Table 1.2) [45]. A recent individual-
level data meta-analysis on about 40,000 men and women followed for 170,000 
person-years confirmed these results [46]. The ability of BMD to predict fracture 
is comparable to the use of blood pressure to predict stroke, and significantly 
better than serum cholesterol to predict myocardial infarction [45]. Table 1.2 
indicates that power of BMD for prediction of fractures is improved by site-
specific measurements. The highest gradient of risk (relative risk per standard 
deviation) is found at the hip to predict hip fracture where the gradient of risk is 
2.6. Thus, an individual with a T-score of -3 SD at the hip would have a 2.63 or 
greater than 15-fold higher risk than an individual with a T-score of 0 SD. By 
contrast, the same T-score at the spine would yield much lower risk estimate—
approximately 4-fold increase (1.63). This emphasises the importance of accuracy 
or gradient of risk in the categorisation of fracture risk. 
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Table 1.2: Relative risk of fracture (95% CI) in women for 1 SD decrease in BMD 
below age-adjusted mean 
 Site of measurement Forearm fracture Hip fracture Vertebral fracture All fractures 
Distal radius 1.7 (1.4–2.0) 1.8 (1.4–2.2) 1.7 (1.4–2.1) 1.4 (1.3–1.6) 
Femoral neck 1.4 (1.4–1.6) 2.6 (2.0–3.5) 1.8 (1.1–2.7) 1.6 (1.4–1.8) 
Lumbar spine 1.5 (1.3–1.8) 1.6 (1.2–2.2) 2.3 (1.9–2.8) 1.5 (1.4–1.7) 
Table is reproduced from Reference [45]. 
 
 
Despite these performance characteristics, it should be recognised that 
absorptiometric techniques have high specificity but low sensitivity. Just because 
BMD is normal, there is no guarantee that a fracture will not occur, but the risk is 
decreased. Conversely, if BMD is in the osteoporotic range, then fractures are 
more likely, but not inevitable. Figure 1.4 shows the data from the National 
Osteoporosis Risk Assessment (NORA) study on about 200,000 post-menopausal 
women without known osteoporosis [47]. 7.2% of the study population had 
osteoporosis (defined as a T-score ≤ -2.5). This Figure confirms that fracture rates 
are significantly higher for those with the lowest T-scores. However, the most 
interesting finding from the study was that, even though the risk of fracture is 
much higher in individuals with osteoporosis, the greatest absolute number of 
fractures occurred in individuals with low bone mass (T-scores between -1 and  
-2.5) since they are roughly five times more than individuals with osteoporosis 
[47]. At the age of 50 years, the proportion of women with osteoporosis who will 
fracture their hip, spine or forearm or proximal humerus in the next 10 years (i.e. 
positive predictive value) is approximately 45% [48]. The detection rate for these 
fractures (sensitivity) is, however, low and 96% of such fractures would occur in 
women without osteoporosis [48, 49]. The low sensitivity is one of the reasons 
why widespread population based screening is not widely recommended in 
women at the time of the menopause [5]. 
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Figure 1.4: Osteoporotic fracture rates, population BMD distribution and number of 
fractures in post-menopausal women 
Data is from the National Osteoporosis Risk Assessment (NORA) study. Figure is reproduced from 
Reference [50]. 
 
 
 
1.2.2. Age and sex 
Osteoporosis is more common among women and incidence of osteoporotic 
fractures increases with age. This is a highly consistent feature across all of the 
studies and brings that all incidence rates should be reported in relation to age 
and separately for men and women. Moreover, age and sex are independent of 
BMD and interact with it for fracture risk prediction. For any BMD, fracture risk is 
much higher in the elderly than in the young [51]. The same T-score with the 
same technique at any one site has a different significance at different ages. This 
is because age contributes to risk independently of BMD. The impact of age on 
hip fracture probability is shown in Figure 1.5. In addition, the performance 
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characteristics of BMD vary with age. For example, at the age of 50 years, hip 
fracture risk increased 3.7-fold per standard deviation decrease in femoral neck 
BMD whereas at the age of 80 years the gradient of risk is 2.3 [46]. Thus, the 
consideration of age and BMD together increases the range of risk that can be 
identified. 
 
 
Figure 1.5: The relationship between femoral neck BMD and hip fracture probability in 
women from Sweden according to age 
Figure is reproduced from Reference [51]. 
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1.2.3. Previous fractures  
A personal history of fragility fracture is a well established and important risk 
factor for further fractures [53, 54]. The risk for an osteoporotic fracture is 
approximately doubled in the presence of a prior fracture [55]. The risk is more 
marked for vertebral fractures where the presence of a prevalent vertebral 
deformity leads to a 7- to 10-fold increase in the risk of subsequent vertebral 
deformities [56]. In the case of hip fracture, there is an obvious interaction (effect 
modification) between age and history of fracture. The predictive value of a prior 
fracture is most marked at younger ages and attenuates with age (Figure 1.6) [53]. 
The risks are in part independent of BMD. Distal forearm fractures are also shown 
to be associated with 1.4-fold increase in the risk of subsequent hip fracture in 
women and a 2.7-fold increase in men [57].  
 
 
Figure 1.6: Relative risk for hip fracture comparing individuals with and without a prior 
fracture by age, with and without adjustment for BMD  
Figure is reproduced from Reference [53]. 
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Other characteristics of previous fractures may have additional value for risk 
predictions. Data from the European Prospective Osteoporosis Study (EPOS) 
demonstrated that prevalent vertebral deformity is a strong predictor of incident 
hip fracture (with a rate ratio of 2.8-4.5), and the risk of hip fracture increases 
with the number of previous vertebral deformities [58]. The number and 
morphometry of baseline vertebral deformities also predict the occurrence of 
incident vertebral fracture [59]. A recent study showed that the relative risk of 
subsequent fracture declines with time from the initial fracture [60]. The 
incidence of new vertebral fracture within one year of an incident vertebral 
fracture is 19.2% [61]. Finally, data from the Dubbo Osteoporosis Epidemiology 
Study (DOES) suggested that re-fracture rates in men and women were similar 
over a 10-year period [62]. 
 
 
1.2.4. Other bone characteristics  
Although bone mass is an important determinant of the risk of fracture, other 
abnormalities occur in the skeleton that contribute to fragility. The term “bone 
quality” points out to a constellation of properties of bone such as bone turnover, 
microarchitecture, mineralisation, microdamage, and bone matrix composition. 
These factors contribute to bone strength independently of bone mineral density 
[5]. Currently, studies on various aspects of bone quality comprise a large 
segment of the field of bone research [63]. These include but not limited to: 
studies on the role of collagen and minerals in composition of bones [64], bone 
morphology and microcracks [65], biomechanical analysis of shape and 
geometry of the bones [66], cellular mechanisms for modelling and remodelling 
of bone [67], role of cellular mechanosensors and osteocytes’ communicating 
networks [68], trabecular thinning and loss of connectivity [69], and cortical 
thinning and porosity [70]. Unfortunately, assessment of bone quality is 
hampered by the inaccessibility of bone for investigation and there is no single 
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measure to cover all aspects of bone quality. This limits the use of these bone 
characteristics for fracture risk assessment [71]. New imaging techniques for 
quantitative assessment of macrostructural characteristics (such as bone 
geometry) and microstructural features (such as relative trabecular volume, 
trabecular spacing, and connectivity) have been developed recently [72]. These 
modalities may increase our power for fracture risk prediction but need further 
studies [73]. Biochemical markers of bone turnover are also suggested to be 
associated with prospective risk of osteoporotic fractures in women and these 
associations are independent of BMD and previous history of fracture in several 
studies [74].  
There is a growing interest in the use of quantitative ultrasound (QUS) 
measurements for the non-invasive assessment of osteoporotic fracture risk in the 
management of osteoporosis. The attractiveness of QUS lies in the fact that 
indirect and in vitro experience has suggested that ultrasound may give 
information not only about BMD but also about architecture and elasticity [75, 
76]. QUS is inexpensive, transportable, ionizing radiation free, and proven to 
predict hip fractures and all osteoporotic fractures in elderly women as accurately 
as dual-energy X-ray absorptiometry (DXA) [77, 78]. QUS measures have been 
considered throughout this thesis and I have compared their performance with 
that of DXA for prediction of fractures (please see Chapter 11).  
 
 
1.2.5. Other clinical risk factors 
Many independent risk factors for osteoporotic fracture have been identified. 
These include but not limited to: family history of hip fracture, low body weight, 
cigarette smoking, excessive alcohol consumption, corticosteroids therapy, low 
dietary calcium intake, vitamin D deficiency, rheumatoid arthritis, premature 
menopause, primary or secondary amenorrhoea, primary and secondary 
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hypogonadism in men, Asian or Caucasian race, poor visual acuity, 
neuromuscular disorders, and prolonged immobilisation [43]. Some of these risk 
factors are related to non-skeletal factors such as the liability to fall or higher force 
of impact during a fall. Not all of these risk factors have been verified in different 
cohorts as showing risk independent of bone mineral density [79]. Moreover, 
several endocrine or metabolic diseases (e.g., hypogonadism, hyperthyroidism, 
and primary hyperparathyroidism), nutritional conditions, medications, disorders 
of collagen metabolism, and other conditions may induce bone loss for patients 
[80]. These are classified as “secondary osteoporosis” and their management and 
risk assessment needs consideration of the causal disorder [80]. 
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1.3. Risk assessment methods 
The assessment of bone mineral density (BMD) is the main aspect of bone health 
that can be readily measured in clinical practice and it forms the cornerstone for 
the general management of osteoporosis. In 1994, the World Health Organisation 
(WHO) published diagnostic criteria for osteoporosis in postmenopausal women, 
intended primarily for descriptive epidemiology [44, 81]. Osteoporosis was 
described as a value for BMD at the femoral neck of 2.5 SD or more below the 
young female adult mean (T-score ≤ -2.5). Severe osteoporosis (established 
osteoporosis) was described as a T-score of ≤ -2.5 for femoral neck BMD in the 
presence of one or more fragility fractures. The recommended reference range 
was the Third National Health and Nutrition Examination Survey (NHANES III) 
reference database for femoral neck measurements in White women aged 20–29 
years [82]. The criteria have recently been updated [83]. These diagnostic criteria 
have been widely accepted and are commonly used to provide intervention 
thresholds, treatment and inclusion criteria for drug trials, and a basis for health 
technology assessments. 
Although BMD measurements have high specificity for assessment of bone health 
and fracture risk, they have poor sensitivity and this limits their application in 
clinical practice. As shown in Figure 1.4, most of the fractures in women occur in 
population with BMD values not in the range of osteoporosis (T-score ≤ -2.5). 
Therefore, clinicians aiming to start preventive treatments for their patients need 
to consider other risk factors in order to target those who would benefit most from 
these treatments. Several scientific societies affiliated to the field of bone health 
(mostly European and North American) have tried to make recommendations for 
treatment initiation. Most of these recommendations are based on a combination 
of central DXA measurements and established risk factors of osteoporosis. Some 
of these recommendations are summarised in Table 1.3. 
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Table 1.3: Current recommendations for specific anti-fracture therapy initiation 
from different scientific organisations  
  Postmenopausal women  Men >60 yrs  Comments 
NOF 2003 
(USA) [84] 
& ACOG 
2003 (USA) 
[85] 
Prior vertebral  (VF) or hip fracture (HF) 
T‐score <‐2.0 with no risk factors 
T‐score <‐1.5 with ≥1 risk factors 
  Major clinical risk factors: 
low trauma peripheral fracture 
Fragility fracture  in a first 
degree relative 
weight < 127 lbs 
current smoking 
corticosteroids > 3 months 
AACE 2006 
(USA) [86] 
low‐trauma fractures 
T‐scores  ≤ −2.5  with no risk factors 
T‐score <‐1.5 with ≥1 risk factors 
Women in whom non pharmacologic 
preventive measures are ineffective 
(bone loss continues or low trauma 
fractures occur) 
 
   
SIGN 2003 
(UK) [87] 
 
≥2 VF 
T‐score <‐2.5 ± FF 
T‐score <‐2.5 ± FF   
NAMS 2006 
(USA) [88] 
Low trauma VF 
T‐score ≤‐2.5 
T‐score ≤‐2 with a risk factor 
 
   
DVO 2006 
(Germany) 
[89] 
VF & T‐score <‐2.0 
10YR for VF+HF > 30% & T‐score <‐2.0 
50‐60: T‐score ‐4.0 
60‐65: T‐score ‐3.5 
65‐70: T‐score ‐3.0 
70‐75: T‐score ‐2.5 
>75:   T‐score ‐2.0 
 
VF & T‐score <‐2.0 
10YR for VF+HF > 
30% & T‐score <‐2.0 
60‐70: T‐score ‐4.0 
70‐75: T‐score ‐3.5 
75‐80: T‐score ‐3.0 
80‐85: T‐score ‐2.5 
>85:   T‐score ‐2.0 
If clinical risk factor: +1 T‐
score 
HF in a parent 
low trauma peripheral 
fracture 
current smoking 
Multiple falls, immobility 
AFSSAPS 
2006 
(France) 
[90] 
T‐score ≤‐2.5 & FF 
T‐score <‐1.0 & VF or HF 
T‐score <‐1.0 & other FF & CRFs 
T‐score ≤‐2.5 & 60+ years 
(T‐score <‐1.0 & major CRFs) 
  Clinical risk factors: 
      corticosteroids 
      family hip fracture 
      low BMI 
      current smoking 
      increased risk of falls 
OP Ca 2006 
(Canada) 
[91] 
50: LR >‐2.3   MR: ‐2.3/‐3.9   HR: <‐3.9 
55: LR >‐1.9   MR: ‐1.9/‐3.4   HR: <‐3.4 
60: LR >‐1.4   MR: ‐1.4/‐3.0   HR: <‐3.0  
65: LR >‐1.0   MR: ‐1.0/‐2.6   HR: <‐2.6 
70: LR >‐0.8   MR: ‐0.8/‐2.2   HR: <‐2.2 
75: LR >‐0.7   MR: ‐0.7/‐2.1   HR: <‐2.1 
80: LR >‐0.6   MR: ‐0.6/‐2.0   HR: <‐2.0 
85: LR >‐0.7   MR: ‐0.7/‐2.2   HR: <‐2.2 
  If clinical risk factor: +1 category 
FF after 40 years 
Corticosteroids 
Abbreviations: PM: postmenopausal; VF: vertebral fracture; HF: hip fracture; FF: fragility fracture; 
CRFs: clinical risk factors; 10YR: 10 year risk; LR (<10%): low 10YR (hip, spine, forearm, proximal 
humerus); MR (10-20%): moderate 10YR; HR (>20%): high 10YR 
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Table 1.3 shows that different societies have emphasised on different sets of 
clinical risk factors (CRFs). Moreover, they have not included many of other 
established risk factors as consideration to the interplay between all of these 
factors is impractical in the clinical setting. The aim of these recommendations is 
to provide clinicians with simple and accurate (as much as possible) criteria for 
treatment initiation. Integration of BMD and CRFs is critical for improvement of 
these clinical criteria.  
In general, clinical risk factors for osteoporosis show relatively poor specificity 
and sensitivity in predicting either bone mineral density or fracture risk [41, 42, 
79, 92, 93]. Over the past few years, a series of meta-analyses has been 
undertaken to identify clinical risk factors that could be used in case finding 
strategies with or without the use of BMD [55]. These meta-analyses have shown 
remarkable international consistency for low body mass index [94], a prior 
history of fracture [53], a family history of hip fracture [95], use of systemic 
corticosteroids [96], current smoking [97], high intake of alcohol [98], and 
rheumatoid arthritis [96]. The results of these meta-analyses are summarised in 
Table 1.4.  
 
Table 1.4: Risk ratios for hip fracture associated with risk factors adjusted for age, 
with and without adjustment for BMD 
Risk indicator  
Without BMD With BMD 
RR 95% CI RR 95% CI 
Body mass index 
(20 vs. 25 kg/m2) 1.95 1.71–2.22 1.42 1.23–1.65 
(30 vs. 25 kg/m2)  0.83 0.69–0.99 1.00 0.82–1.21 
Prior fracture after 50 years  1.85 1.58–2.17 1.62 1.30–2.01 
Parental history of hip fracture  2.27 1.47–3.49 2.28 1.48–3.51 
Current smoking  1.84 1.52–2.22 1.60 1.27–2.02 
Ever use of systemic corticosteroids  2.31 1.67–3.20 2.25 1.60–3.15 
Alcohol intake >2 units daily  1.68 1.19–2.36 1.70 1.20–2.42 
Rheumatoid arthritis  1.95 1.11–3.42 1.73 0.94–3.20 
Table is reproduced from Reference [55]. 
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Simplicity and applicability of the risk factor assessment in the clinical settings is 
another important issue. Many studies indicate, for example, that low intake of 
calcium is a risk factor for hip fracture [99]; however, the quantification of 
calcium intake is not readily available in general practice. Part of the aims of this 
thesis was to find clinically applicable and easy-to-use measures for fracture risk 
assessment. I have studied the role of measured height loss and respiratory 
function as potential risk identifiers for osteoporotic fractures (Please see Chapter 
3 and 4). Moreover, the relationships between osteoporotic fracture risk and some 
of the important clinical characteristics of patients (namely, physical activity level 
and obesity) have not been studied well. Physical activity is known to be 
protective against osteoporotic fractures (reviewed in Chapter 5), but few is 
known about the detailed associations between physical activity in different 
domains of life (i.e., at home, at work, for transportation, and at leisure time) and 
prospective risk of fractures (please see Chapter 6). Also, the shape of association 
between body mass index and fracture risk is not following a linear trend (as seen 
in Table 1.4) [94] and the specific role of different components of obesity (fat 
mass and lean mass) in relation to fracture risk is not known. Chapter 7 deals with 
this problem.  
Concerning the integration of risk factors, the multiplicity of clinical risk factors 
and the interactions between them and BMD poses problems in the units of risk 
to be used. The T-score becomes of little value in that different T-score thresholds 
for treatment would be required for each combination of risk factors. Although 
the use of relative risks is feasible, the metric of risk best suited for clinicians is the 
absolute risk (or probability) of fracture [100].  
The absolute risk of fracture depends upon age and life expectancy as well as the 
current relative risks (for BMD values and different CRFs). In general, remaining 
lifetime risk of fracture decreases with age especially after the age of 70 years 
since the risk of death with age exceeds the increasing incidence of fracture with 
age. Estimates of lifetime risk are of value in considering the burden of 
osteoporosis in the community and the effects of intervention strategies [101]. 
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However, for several reasons they are less relevant for assessing risk of individuals 
in whom treatment might be considered [51]. Hence, the International 
Osteoporosis Foundation and the World Health Organization recommend that 
risk of fracture should be expressed as a short-term absolute risk, i.e. probability 
over a 10-year interval [100]. The period of 10 years covers the likely duration of 
treatment and the benefits that may continue once treatment is stopped. 
The major advantage of using absolute fracture probability is that it standardises 
the output from a variety of techniques and sites used for BMD assessment. 
Moreover, it also permits the presence or absence of clinical risk factors other 
than BMD to be incorporated as a single metric. This is important because there 
are many risk factors that give information over and above that provided by BMD 
and age (Table 1.4). Models for calculation of 10-year probabilities of fracture 
can also consider the interactions (effect modifications) between different CRFs 
and BMD. Estimation of absolute fracture risks has several other applications in 
research and clinical settings that I have discussed in Chapter 8. 
Recently, algorithms that integrate the weight of clinical risk factors for fracture 
risk, with or without information on BMD, have been developed by the WHO 
Collaborating Centre for Metabolic Bone Diseases at Sheffield, UK [24]. The 
FRAX® tool (www.shef.ac.uk/FRAX) computes the 10-year probability of hip 
fracture or a major osteoporotic fracture (Figure 1.7). A major osteoporotic fracture 
is a clinical spine, hip, forearm and humerus fracture. There is a marked variation 
in fracture probability in different regions of the world, particularly well 
documented for hip fracture [102]. There are also differences in mortality. This 
means that probability models need to be calibrated to the epidemiology of 
fracture and death of any particular region. FRAX® algorithms are now available 
for several countries (currently 30 countries in 5 continents), and several more are 
being developed. Where a country is not represented (because of the lack of 
epidemiological data) a surrogate may be chosen. 
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Figure 1.7: The online tool (FRAX®) for calculation of 10-year absolute risk of fracture  
The tool estimates risk for patients from different countries based on different clinical risk 
factors with or without femoral neck BMD. The risk is estimated for hip and major 
osteoporotic fractures. The website is designed by the WHO Collaborating Centre for 
Metabolic Bone Diseases at Sheffield, UK and accessed in December 2010. 
 
 
Figure 1.8 summarises the approach recommended by the WHO for assessment 
of fracture risk in clinical settings [24, 100]. Measurement of BMD is indicated in 
individuals who have a high fracture probability (as estimated, for instance, by 
FRAX®), provided that it will influence the management decision. In some 
instances, treatment will be justified without measurement of BMD, for example 
in patients with fragility fractures and other strong risk factors. In other instances, 
the low cost and absence of side effects justify the use of some agents without 
BMD measurements in specific populations (e.g. calcium and vitamin D in the 
institutionalised elderly). Conversely in some patients, the fracture probability 
may be so low that a management decision will not be changed by information 
on BMD. An example is a woman at the time of natural menopause without 
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symptoms and with none of the clinical risk factors [24]. The size of the 
‘intermediate’ group in Figure 1.8, in whom a BMD test would be recommended, 
will vary by region and country. In countries with very limited or no access to 
assessment with BMD, the size of this segment will be very small. In those 
countries where screening is recommended (e.g. in women at the age of 65 years 
or older) this segment will include the majority of women. The measurement of 
BMD provides the opportunity to reassess fracture probability in the light of the 
test result and the clinical risk factors (Figure 1.8). 
 
 
 
Figure 1.8: Algorithm for the assessment of fracture probability recommended by the WHO 
Figure is reproduced from Reference [24]. 
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Choice of thresholds for high- and low-risk probabilities is an important issue and 
these values should ideally come from country-specific health economics studies. 
A recent study has used FRAX® as a case-finding strategy for men and women in 
the UK and estimated fracture probabilities at which BMD testing or intervention 
should be recommended [103]. The results suggested that treatment with generic 
alendronate therapy (assuming a conservative cost of £95 per year of treatment) 
was cost-effective at the age of 50 years when the 10-year risk of a major fragility 
fracture was higher than 7.5%. This rose progressively with age to 30% at the age 
of 80 years. The thresholds chosen are clearly influenced by a variety of health-
economic assumptions, not least the costs of medication and fracture care, as 
well as the amount society is willing to pay for a given benefit [103]. Further work 
to validate the FRAX® algorithm as a case-selection tool in the UK is underway. 
The SCOOP study (Screening of Older Women for Prevention of Fracture) is a 
seven year trial which is being coordinated by the University of East Anglia and 
seeks to recruit 12,000 women between the age of 70 and 85 from areas across 
the UK (http://www.scoopstudy.ac.uk). Recent data from Australia have suggested 
that FRAX® is able to discriminate between female patients with fragility fracture 
and controls, although the results for men were less robust [104]. 
Part of my PhD thesis aimed at development of a model for estimation of absolute 
fracture risk using available clinical data from a population-based study. The 
detailed methods are described in Chapter 9. The current recommendations for 
diagnosis of osteoporosis and assessment of fracture risk centre on the 
measurement of bone mineral density at the femoral neck using DXA. However, 
other sites and validated techniques (such as heel QUS) may also be used for 
fracture prediction. QUS in particular is much more affordable in the clinical 
settings given its cost and compliance. I further utilised the estimates of fracture 
probabilities to compare hip DXA and heel QUS (Chapter 10). Finally, the 
performance of QUS as an independent ‘risk factor’ for fractures was evaluated 
using the fracture probabilities (Chapter 11). 
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1.4. Aims and objectives 
The aims of this thesis were based on filling the knowledge gaps on novel risk 
factors of osteoporotic fractures and developing an all-inclusive model for 
estimation of absolute risk of fracture among the elderly. EPIC-Norfolk study is a 
large population-based prospective cohort study with long follow-up that 
provides an excellent opportunity for unbiased evaluation of clinical risk factors 
for different outcomes including fractures. The specific objectives for the first part 
of this thesis were:  
• To evaluate measured height loss and respiratory function as potential risk 
indicators for fractures; 
• To assess the association between different aspects of physical activity and 
prospective risk of fractures among the elderly; 
• To evaluate the non-linear association between body fat mass and risk of 
fracture considering the effects of weight or body mass index. 
 
The specific objectives for the second part of this thesis were:  
• To integrate available established risk factors of fracture and develop a 
statistical model for estimation of 10-year absolute risk of fracture in EPIC-
Norfolk population; 
• To compare performance of two radiological bone assessment methods for 
prediction of prospective risk of fracture; 
• To assess the additive value of bone ultrasound measurement for 
improvement of fracture risk prediction models. 
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Chapter 2: Methods 
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2.1. Settings and population 
The European Prospective Investigation into Cancer and Nutrition (EPIC) project 
was started in 1989-1990 [105, 106]. It was designed to investigate the 
relationship between nutrition and cancer, with the potential for studying other 
major diseases as well. The EPIC is an ongoing multi-centre prospective cohort 
study with 23 collaborating centres in 10 European countries (France, Germany, 
Greece, Italy, The Netherlands, Spain, United Kingdom, Sweden, Denmark and 
Norway). The study has recruited 519,978 participants (366,521 women and 
153,457 men), mostly aged 35-70 years. Populations in the study are 
characterised by large variations in dietary habits and cancer risk. Information on 
health, diet and other lifestyle variables were obtained from participants at 
enrolment, which took place between 1992 and 2000 in different collaborating 
centres. During clinical examination, anthropometric measurements were 
performed and blood samples taken [106]. In the United Kingdom, the two 
centres are based in Norfolk and Oxford.  
The work in this thesis is based in the EPIC-Norfolk cohort of approximately 
25,000 men and women aged 45-74 years from the general population. The 
recruitment target number of 25,000 represents a balance between the need for 
large numbers to generate sufficient end points, and the need to include better 
defined and more discriminating instruments for assessing exposure, including 
biological assays [107]. The Norfolk region study area includes the city of 
Norwich and the surrounding small towns and rural areas. This area has little 
outward migration in this age group and is mainly served by one District General 
Hospital i.e. Norfolk and Norwich University Hospital. Recruitment began in 
March 1993 and was completed at the end of 1997. From the outset, the study 
aims were expanded to include end points other than cancer, including the main 
causes of disability and death in middle and late life, and exposures other than 
diet, such as physical activity and psychosocial variables. Ethical permission for 
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the EPIC-Norfolk study was obtained from the Norwich District Health Authority 
ethics committee [107]. 
2.1.1. Baseline health examination 
There are 35 local General Practices in the Norfolk County. All eligible 
individuals on the age-sex registers of these practices were invited to participate 
in the study. As virtually 100% of people in the UK are registered with their 
General Practitioners through the National Health Service (NHS), these provide 
the equivalent of a population-based age-sex register. All individuals who wished 
to participate completed and signed a consent form. They also completed a 
detailed health and lifestyle questionnaire and a dietary questionnaire. These 
participants were then sent an appointment for a health examination at a 
designated clinic. During the health check, trained nurses performed the health 
examinations according to standard protocols. During this visit, a non-fasting 
blood sample was drawn by venipuncture. Participants could choose to complete 
only selected stages of the study.  
A total of 77,630 invitations were sent out and 30,447 consents (39.2%) were 
obtained. Of those who consented, 25,639 (84%) attended a health examination. 
There were 1,018 participants outside the target age range of 45 to 74 years due 
to variation in the coding of birthdates between general practices and in the 
timing of health check visits. Thus the participants in this study fell into the age 
range of 40 to 79 years. Health examinations started in 1993 and continued up to 
early 1997. 
 
2.1.2. Second Health Examination  
Between 1998 and 2000, all people who had sent their consent to participate in 
the study, who may or may not have attended the first health check, were invited 
for a second health examination. In total, 15,786 individuals attended this visit, of 
whom 15,028 had attended the first health check. This translated to a response 
 31 
 
rate of 58% of those mailed, after excluding those who had moved from the area 
or died. All participants in this phase completed a detailed health and lifestyle 
questionnaire, which was similar to the questionnaire filled at baseline visit with 
some additional items. Besides all the health examinations done in the baseline 
visit, quantitative ultrasound measurements of the heel and bioelectrical 
impedance tests were obtained and the DNA bank of EPIC-Norfolk was 
established. Trained nurses performed the health examinations according to 
standard protocols. Participants in this health examination aged 42 to 82 years. 
 
2.1.3. Other health questionnaires/examinations 
Between 1998 and 2000, EPIC Physical Activity Questionnaire ver.2 (EPAQ2) 
was posted to all people who consented to participate in the study. The 
questionnaires were posted accompanying invitation letters for the second health 
examination. About 15,500 participants returned the questionnaires, most of 
whom attended the second health examination. Therefore, data related to this 
questionnaire is analysed with second health check data (see Chapter 6). The 
questionnaire has been sent again to the participants in 2007-2008 (not used in 
this thesis). 
EPIC-Norfolk study collaborated in the European Prospective Osteoporosis Study 
(EPOS) between 1993 and 2000 [108]. This was a large multi-centre prospective 
study on the determinants of vertebral and other osteoporotic fractures conducted 
in 28 centres across Europe. About 2,000 EPIC-Norfolk men and women aged 
≥65 years and without clinical diagnosis of osteoporosis were randomly selected 
to be invited to participate in this study about 18 months after the baseline visit. 
About 75% of the invited participants consented and attended the clinic and 
underwent measurements of hip dual-energy X-ray absorptiometry (DXA) and 
heel quantitative ultrasound (QUS). More details can be found in Chapter 9. 
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There are other postal questionnaires sent to EPIC-Norfolk participants (including 
a 7-day food diary sent in 1993-1998, health questionnaire sent in 1997-2000, 
follow-up questionnaire sent in 2002-2003, and health questionnaire sent in 
2007-2008) that has not been used in this thesis. The third health examination of 
EPIC-Norfolk was started in 2006 and about 7,500 participants have attended the 
clinic visit so far. This extends previous health examinations with more detailed 
assessments in 42 domains of life among the elderly. Data from this health check 
are not used in this thesis. The flow chart of EPIC-Norfolk study related to this 
thesis is shown in Figure 2.1.  
 
 
 
Figure 2.1: Timeline and number of participants in different stages of EPIC-Norfolk study 
 
1990-1992: 77,630 invitations sent to all 
eligible individuals in Norfolk
1990-1992: 30,447 individuals consented 
to participate and returned the posted 
health questionnaire 
1993-1997: 25,639 attended a health 
examination in EPIC clinic (1HC)
1998-2000: 15,786 attended a health 
examination in EPIC clinic (2HC) of 
whom 15,028 had attended 1HC
1997-2000: 15,678 
returned the posted EPIC 
Physical Activity 
Questionnaire 
1998-2000: 15,515 
attended 2HC
1995-1997: 2,065 
participants aged ≥65 
invited for a hip DXA study
1995-1998: 1,511 
participated in DXA study
1993-2008: all participants are being 
followed for different health outcomes 
including fractures 
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2.2. Measurements  
2.2.1. Health and lifestyle questionnaire 
The health and lifestyle questionnaires were posted to the participants for self-
completion and they either returned it by post or took that with themselves to the 
clinic visit (please see Appendix 1). The health and lifestyle questionnaire has a 
common format across the EPIC cohorts. Demographic data and information on 
health and lifestyle of participants were collected from the questionnaire. 
Questions included smoking, alcohol consumption, socio-economic status, social 
class, occupational history, past history of diseases, short family history of main 
disease endpoints and a short section on exercise. For women, questions 
included reproductive history such as menstrual history and use of hormone 
replacement therapy. Details of medication being taken were also indicated on 
the questionnaire. 
 
 
2.2.1.1. History of fracture  
Personal medical history was derived from the question: `Has the doctor ever told 
you that you have any of the following?’ A checklist of conditions was provided 
with a box to tick `yes’ and to indicate `age first diagnosed’. The conditions 
included osteoporosis, fracture of the hip, fracture of the wrist after age 20, and 
fracture of vertebrae. Information on drugs or medicines taken was also obtained 
from the questionnaire. These medications were later coded and checked against 
the British National Formulary. Participants were considered to have had a history 
of fracture if they answered `yes’ to any of the three questions about fractures.  
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2.2.1.2. Cigarette smoking status 
Participants’ smoking history was derived from responses to questions on past and 
present smoking habits. For this study, cigarette smoking status was classified into 
three categories: never, former and current smoker status. The main questions on 
cigarette smoking habits in the questionnaire included: `Have you ever smoked as 
much as one cigarette a day for as long as a year?’ and `Do you smoke cigarettes 
now?’ A `no’ response to both of the above questions would classify the 
participants as `never’ smokers. An affirmative response to the first question but 
not to the second question classified the participants as `former’ smokers. 
Participants were defined as `current’ smokers if an `affirmative’ response was 
given to the second question.    
 
 
2.2.1.3. Alcohol intake 
Participants were asked the question “Are you a non-drinker/teetotaller now?”  
Those who answered “yes” were coded as 0 units of alcohol.  No distinction was 
made between former drinkers and never drinkers of alcohol.  Those who 
answered “no” were asked further questions to quantify the amount of alcoholic 
drinks consumed each week. One unit of alcohol consumption was defined as 
follows for four types of alcoholic drink: half pint of beer, lager or cider; a glass of 
wine; a glass of spirits (whisky, gin, brandy, vodka, etc.); and a glass of sherry, 
port, vermouth or liqueurs. Participants were asked to tick each category based 
on their average alcohol consumption in the previous year. Average alcohol 
consumption in units/week was calculated and used for analysis. 
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2.2.1.4. Menopausal and Menstrual history  
For women, additional information such as age at menarche, menopausal status, 
use of hormone replacement therapy and use of contraceptives were obtained. 
For this thesis, the use of hormone replacement therapy was categorised into 
three groups: never, former and current. This was based on the responses to 
questions: `Have you ever received any hormone replacement therapy?’ and `Are 
you currently taking this treatment?’. 
 
 
 
2.2.2. Physical activity questionnaire  
Physical activity was assessed using the self-completed EPAQ2 questionnaire that 
collects data on past year’s physical activity behaviours in a disaggregated way. 
The information obtained by this questionnaire can be re-aggregated according to 
the dimension of physical activity of interest [109]. The questionnaire consists of 
four sections: activity in and around the home, during work, transportation to 
work, and recreational physical activity (please see Appendix 2). With work here 
we meant being in paid employment or doing regular, organised voluntary work. 
All transportation and some domestic questions were designed specifically for this 
study, whereas the questions on occupational activity were derived from the 
Modified Tecumseh Occupational Activity Questionnaire that has been validated 
elsewhere [110]. The recreational section of the EPAQ2 was derived from the 
Minnesota Leisure Time Activity Questionnaire [111], with 30 predetermined 
sports selected according to their frequency and duration in a UK population (The 
Sports Council and The Health Education Authority, 1992) and six non-sportive 
activities, such as mowing the lawn, watering the lawn, digging, weeding, DIY 
(Do It Yourself; e.g. carpentry, home or car maintenance), and playing music, 
which are considered as activities undertaken in or around the home. Time spent 
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participating in recreational activities was derived from responses to frequency 
and usual time per episode separately for each activity. The questionnaire can be 
accessed online (http://www.srl.cam.ac.uk/epic/questionnaires/epaq2/epaq2.pdf). 
The questionnaire was validated against an objective measure of energy 
expenditure (4-day heart-rate monitoring with individual calibration on four 
separate occasions over 1 year), and the repeatability of the questionnaire has 
also been demonstrated [109]. Intensity of physical activity in different domains 
was calculated by summing energy expenditure derived from applying published 
metabolic equivalent (MET) values to usual time spent in all activities and is 
expressed as MET-hours per week (MET.h/wk) [112].  
 
 
 
2.2.3. Clinical measurements 
Participants in both first and second health examinations were assessed by trained 
nurses and according to published protocols. All examinations from the first 
health check were repeated with the same devices and protocols in the second 
health check. Participants could choose to complete only selected examinations 
and there might be some errors in the performance and recording of the test 
results. Thus, the number of participants with complete data for different 
examinations might be different from the attended participants in the health 
check. Table 2.1: Number of participants with available data in two health 
examinations of EPIC-Norfolk study shows the number of participants with 
available data for analysis on different questionnaires and clinical tests in first and 
second health examinations. 
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Table 2.1: Number of participants with available data in two health examinations 
of EPIC-Norfolk study 
 First Health Check (1HC) Second Health Check 
  Attended 1HC Total 
Health & lifestyle questionnaire  25,639 15,028  15,786  
EPAQ2 questionnaire  - 14,785  15,515  
Anthropometry measures 25,043 15,000 15,758 
Spirometry 25,043  14,800 15,542 
Bioelectrical impedance - 14,800 15,548 
Quantitative ultrasound  - 14,912 15,668 
 
 
 
 
2.2.3.1. Anthropometry  
Height and weight were measured in light clothing without shoes. Height was 
measured to the nearest millimetre using a stadiometer (CMS Weighing 
Equipment Ltd., London, UK). Weight was measured to the nearest 100 grams 
using calibrated digital scales (Salter Industrial Measurement Ltd., West 
Bromwich, UK). The same devices and protocols were used in both first and 
second health examinations. Body mass index (BMI) was calculated as weight in 
kilograms divided by the square of the height in meters.  
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2.2.3.2. Spirometry  
Respiratory function was assessed by forced expiratory volume in 1 second, FEV1, 
using an electronic turbine spirometer (Micro Medical, Ltd., Rochester, UK). After 
a practice blow, two measurements were made with the subjects standing and 
looking forwards. The nurses made a subjective judgement of the participants' 
spirometry technique. The higher of the two values for FEV1 were used for 
analysis. Forced vital capacity (FVC) and peak expiratory flow (PEF) were also 
recorded for all participants but only FEV1 is reported in this thesis as the other 
measures did not add information beyond FEV1. The machine was chosen for 
portability and simplicity in operation. The reproducibility was about 2.2% for 
FEV1 and the device is assessed as having a comparable accuracy to the 
Vitalaograph spirometer [113]. Calibration was performed regularly in a weekly 
basis to ensure the accuracy and precision of both equipment and personnel. 
 
 
2.2.3.3. Bioelectrical impedance analysis 
In the second health examinations, body fat mass was estimated using a standard 
bio-impedance technique (Bodystat, Isle of Man, UK). This test measures the 
Resistance (Ω) to the flow of an externally applied electric current through the 
tissues. This method has previously been shown to be valid [114] and reliable 
[115]. Total body water and fat-free mass were calculated using the impedance 
index (height2/resistance), body weight and resistance according to published 
equations (see Table 5 of Ref [116]). Fat mass was calculated as body weight 
minus fat-free mass. Percentage body fat (%BF) used in this thesis was fat mass 
expressed as percentage of total weight. 
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2.2.3.4. Quantitative ultrasound of the calcaneus 
Quantitative ultrasound (QUS) provides information about the structure, elasticity, 
and strength of the bones [117, 118]. QUS devices measure broadband 
ultrasound attenuation (BUA; expressed in dB/MHz) and speed of sound (SOS; 
expressed in m/s). BUA is the rate of attenuation in the acoustic energy across a 
broad range of frequency and this attenuation is due to absorption and scattering 
of ultrasound in the bone and soft tissue. BUA is influenced by both density and 
structural parameters [119]. SOS is the ratio of propagation distance to the pulse 
transit time and is affected by bone density and elasticity. Most devices measure 
the calcaneus because of its accessibility. This is a trabecular skeletal site which 
has a generally higher metabolic turnover rate than cortical bone [120]. 
In the second health examination of EPIC-Norfolk, CUBA sonometers (McCue 
Ultrasonics, Winchester, UK) were used for all participants at least twice on each 
foot [77, 121]. The CUBA sonometer is a gel-coupled device. The mean of the 
measures (left and right foot) was used for analysis. Five machines were used, and 
each was calibrated daily with its physical phantom and monthly with a roving 
phantom and on one operator’s calcaneus. Room temperatures were measured 
and recorded daily. There was no evidence for the effect of ambient temperature, 
machine, or machine drift on BUA measures [121]. The short-term coefficient of 
variation (CV) was 3.5%. Both BUA and SOS in EPIC-Norfolk have been reported 
to be strong predictors of hip and total fracture risk in men and women 
independently of known covariates [77]. 
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2.3. Follow­up methods 
The EPIC-Norfolk cohort is followed up by an established continuing system for 
ascertaining health endpoints. The entire cohort has been flagged with the NHS 
Central Register for death and admission to hospitals. Individuals were flagged for 
death certification at the UK Office of National Statistics (ONS), with vital status 
ascertained for the whole cohort. All deaths were also coded for cause of death 
by trained nosologists using the International Classification of Disease (ICD) 
revisions 9 and 10. Participants who were admitted to hospital were identified 
using their unique NHS number by data linkage with ENCORE (East Norfolk 
health authority database), which identifies all hospital contacts throughout 
England and Wales for Norfolk residents. Hospital admissions are coded for 
different diagnoses using the ICD revisions 9 and 10. These diagnostic codes 
were used to ascertain fractures by site occurring (ICD codes – 9th: 805-829 
excluding 815, 816, 825, and 826; ICD codes – 10th: S12, S22, S32, S42, S52, 
S62, S72, S82, S92 excluding S62.2-S62.8 and S92.3-S92.9). Fractures of skull, 
face, metacarpals, metatarsals, and phalanges were excluded from the analyses. 
Records are updated annually via data linkage. In this thesis, available updated 
records are between March 2006 and March 2008 depending on the time of 
analysis for each Chapter.  
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2.4. Statistical methods 
Detailed analysis plans for each study are described in the Methods sections of 
each Chapter. In general, I have used survival analysis using Cox proportional-
hazards regression models to look at the association between different risk factors 
and prospective risk of fractures. Categorising different exposures based on 
quartiles or sensible clinical cut-offs has been used to improve the power for 
finding risk trends across the range of values. Given the potentially different 
nature of risk associations for osteoporotic fractures between men and women, 
and the power of our studies to detect such differences, I have used sex-specific 
analyses unless otherwise stated. All multivariable models are adjusted for 
established risk factors of osteoporosis available in our study, including age, 
previous history of fracture, body mass index, smoking status, and alcohol intake. 
Other risk factors have been tested and, if significantly contributed to the models, 
reported for different studies. Apart from the height loss study (Chapter 3), all the 
analyses were performed using Stata software, version 10.0. A value of P<0.05 
was used for statistical significance throughout the thesis. 
Multivariable fractional polynomial modelling has been used in Chapters 6 and 7 
to search for non-linear associations between risk factors and fracture outcomes. 
Fractional polynomial (FP) modelling is based on simple power transformations of 
covariates when non-linearity is suspected. Royston and Altman [122] formalised 
the simple power models and called them fractional polynomials of degree 1 
(FP1), and extended them to FPs of higher degree. An FP1 transformation of a 
covariate (x) in the regression model with power p is defined as xp, where p 
belongs to the set of powers S ൌ ሾ–2, –1, –0.5, 0, 0.5, 1, 2, and 3ሿ. x0 (i.e. with power 
p = 0) equals the natural log of x rather than 1. An FP1 function or model is 
defined as: 
φ1 ሺx, pሻ ൌ β0 ൅ β1 xp 
42 
 
For instance, for p = –2 the model is β0 ൅  β1  /  x2. A second-degree fractional 
polynomial (FP2) transformation of x with powers p  ൌ  ሺp1,  p2ሻ, or for p1  ൌ  p2 
(called ‘repeated powers’) (p1, p1), is the vector xp with: 
ݔ࢖ ൌ  ݔሺ௣ଵ,௣ଶሻ ൌ   ൜
ሺݔ௣ଵ, ݔ௣ଶሻ,                    ݌ଵ ്  ݌ଶ
ሺݔ௣ଵ, ݔ௣ଵ log ݔሻ,     ݌ଵ ൌ  ݌ଶ
 
 
An FP2 function or model with parameter vector β = (β1, β2) and powers p is: 
φ2 ሺx, pሻ ൌ β0 ൅ β xp ൌ β0 ൅ β1 xp1 ൅ β2 xp2 
 
For instance, for p1 ൌ 2 and p2 ൌ –1 the model is β0 ൅ β1 x2 ൅ β2 / x. Likewise, for 
p1 ൌ p2 ൌ 2 the model is ߚ଴ ൅ ߚଵ ݔଶ ൅ ߚଶ ݔଶ log x. The set S includes the straight 
line (i.e. no transformation, p = 1), and the reciprocal, logarithmic, square root, 
and square transformations. Even though the set is small, the powers offer a 
considerable flexibility. In practice, the families of eight FP1 and 36 FP2 functions 
provide a good fit to many biomedical datasets, and higher-order functions are 
rarely needed [123]. 
Typically, FP models are fitted by maximum likelihood. Since an FP model is 
linear in transformed x for any power(s) p, maximum likelihood estimation 
amounts to finding the β which maximizes the likelihood of models with linear 
predictors β0 + x
p β. For a given class (FP1 or FP2), this is done for each possible p 
with powers in S. The best fitting model is the one whose p gives the highest 
likelihood. For the FP1 class, eight models must be fit, whereas 36 models are 
examined for FP2. 
For hypothesis testing, all tests are based on χ2 statistics from deviance 
differences. Deviance, also known as the entropy of a model, is defined as minus 
twice the maximised log likelihood (–2 × log likelihood). The best FP1 model for 
x is that with the smallest deviance among the eight models with one power term. 
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Similarly, the best FP2 model is that with the lowest deviance among all 36 
possible pairs of powers from S. As all FP1 models are nested within a second-
degree one, the deviance of the latter is guaranteed to be smaller. The deviance 
difference between best-fitting FP2 model and best-fitting FP1 model as well as 
the deviance difference between best-fitting FP1 model and linear model is 
calculated and compared with the 95th percentile of χ2 distribution with relevant 
degrees of freedom. Ignoring the 1 degree of freedom (d.f.) for the intercept β0, an 
FP model of degree m is considered to have 2m d.f.: 1 d.f. for each β and 1 d.f. 
for each power. Hence, for comparison of FP2 and FP1 best-fitting models the χ2 
distribution with 2 d.f. will be considered and for comparison of best-fitting FP1 
and linear model 1 d.f. will be considered. Using this algorithm, if FP2 model is 
not significantly more predictive than FP1 model, the FP1 model will be preferred 
and compared to linear model. If the deviance difference between FP1 best-fitting 
model and linear model is also not significant, the linear model will be chosen as 
the best fitting model. 
This method has been extended to multivariable modelling and has been 
implemented in several statistical packages, including Stata version 9 and later. In 
Chapters 6 and 7, I have used this method using the ‘mfp’ command in Stata to 
look for the non-linear associations between physical activity as well as body fat 
mass and risk of fractures.  
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Chapter 3: Measured Height Loss 
 
 
 
 
 
 
 
 
 
 
The work presented in this Chapter has been published in: 
Moayyeri A, Luben RN, Bingham S, Welch A, Wareham NJ, Khaw KT. Measured height loss 
predicts fractures in middle aged and older men and women: the EPIC-Norfolk prospective 
population study. Journal of Bone and Mineral Research 2008 Mar;23(3):425-32  
Please see Appendix 3. 
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3.1. Abstract  
Height change can be easily measured and may contribute to fracture risk 
prediction. We assessed measured height loss and fracture incidence in the 
Norfolk cohort of the European Prospective Investigation into Cancer (EPIC-
Norfolk). In this prospective population study, height was measured in first health 
check (1993-1997) and repeated (1998-2000) with the same device and 
protocols. Incident fractures up to 2006 were ascertained by hospital record 
linkage. In 14,921 men and women aged 42-82 years, during a mean follow-up 
period of 7.1 years, there were 390 fractures, including 122 hip fractures. Prior 
annual height loss in those who had an incident fracture (1.8 ± 0.3 mm) was 
significantly greater than other participants (0.9 ± 0.2 mm; p<0.001). Participants 
with annual height loss >0.5 cm had an age and sex adjusted hazard ratio of any 
fracture of 1.76 (95%CI 1.16-2.67) and of hip fracture of 2.08 (95%CI 1.07-4.05) 
compared to those with no height loss. Each centimetre per year height loss was 
associated with a hazard ratio of 1.86 (95%CI 1.28-2.72) for all fractures and 
2.24 (95%CI 1.23-4.09) for hip fracture after adjustment for age, sex, past history 
of fracture, smoking, body mass index, alcohol intake, and heel ultrasound 
measures. Annual height loss of 1 cm was comparable to having a past history of 
fracture and equivalent to being about 14 years older in chronological age in 
terms of the magnitude of relationship with fracture risk. In conclusion, middle-
aged and older men and women with annual height loss >0.5 cm are at increased 
risk of hip and any fracture. Serial height measurements can contribute to fracture 
risk prediction. 
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3.2. Introduction 
Height loss is a frequent manifestation among the elderly and is simple to 
evaluate in the clinical settings. Several non-pathological mechanisms have been 
proposed for height loss associated with age such as changes in the vertebral 
body shape and height, loss of inter-vertebral disc height, and postural changes 
[124]. Previous studies have shown that, when compared to the recalled height at 
the third decade of life, historical height loss is a risk factor for osteoporotic 
fractures in the elderly [125-133]. Most of these studies showed the association 
between height loss and vertebral fractures [127, 129, 132, 133]. However, 
whether serial measurements of height in the shorter term can improve fracture 
risk prediction in middle-aged and older people has not been established 
prospectively. The relationship between height loss and fractures other than 
vertebral is also uncertain [125, 126, 128, 130]. In this study, we aimed to 
examine the association between recent height loss, as measured in two visits of 
EPIC-Norfolk study, and incident fractures.  
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3.3. Methods 
The detailed design and operation of the EPIC-Norfolk study have been described 
in Chapter 2. In this study, participants who attended both first and second health 
examinations were considered. In first and second visits, height was measured to 
the nearest 0.1 cm using the same stadiometer (CMS Weighing Equipment Ltd., 
London, UK). Weight was measured using Salter digital scales and body mass 
index (BMI) was calculated as weight (in kilograms) divided by height squared (in 
meters). Smoking status, weekly alcohol intake, and use of hormone replacement 
therapy (HRT) in women were derived from the health and lifestyle 
questionnaires in the second health check. Quantitative ultrasound of the 
calcaneus was measured in the second health examination. 
To assess the prospective impact of height loss on fractures, participants who had 
developed a fracture between two visits were excluded from the analysis. We 
used diagnostic codes to ascertain fractures by site occurring in the cohort up to 
the end of July 2006 for present analyses, a mean follow-up time from the second 
visit of 7.1 years (SD 0.7; range 5.8–8.5 years). 
Characteristics of those who had developed fracture after second visit were 
compared with other participants using student t-tests for continuous variables 
and chi-square test for categorical variables. Alcohol intake was not normally 
distributed and was compared between two groups using Mann-Whitney U test. 
We also compared the characteristics of the subset of individuals who had a hip 
fracture with other participants. Height loss and known risk factors of fracture 
were entered into a Cox proportional-hazards model to determine their 
independent contribution to the risk of fracture. Clinically applicable cut-offs 
were used to categorise patients based on their annual height loss and hazard 
ratios for these categories were calculated in comparison to the group with no 
height change. A value of P<0.05 was used for statistical significance. Values are 
expressed as mean ± SD unless otherwise stated. Sex-specific analyses were 
performed using SPSS for Windows Version 14 (SPSS Inc., Chicago, Illinois). 
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3.4. Results 
3.4.1. Characteristics of the study participants 
After exclusion of fracture sufferers between two visits, 14,921 participants were 
entered into the analysis. Table 3.1 summarises the characteristics of this 
population. There were significant differences between men and women for the 
descriptive variables and sex-specific analyses were used throughout this Chapter. 
The interval between two visits was 3.7 ± 0.7 years on average and participants 
were followed for 103,136 person-years after the second visit. 390 fractures of 
any type (122 hip fractures, 69 vertebral fractures, 99 wrist fractures, and 100 
other types including ribs, sternum, clavicle/scapula, humerus, pelvis, shaft/distal 
femur, patella, tibia/fibula, and ankle fractures) occurred in the study period. In 
women, the incidence of hip fracture and any fracture were 145.2 and 467.3 per 
100,000 person-years, respectively. The corresponding numbers for men were 
77.7 and 251.6 per 100,000 person-years, respectively. On average, fractures 
occurred 4.0 years (SD 2.1) after the second visit. 
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Table 3.1: Characteristics of 14,921 men and women aged 40-79 years at 
baseline and follow up visit and fracture rates 1998-2006  
  Women Men 
  n=8,381 n=6,540 
First visit 1993-1997  
 Age  (years) 57.9 (8.9) 59.3 (8.9) 
 Height (cm) 161.3 (6.1) 174.2 (6.5) 
 Weight (kg) 67.4 (11.3) 80.1 (10.9) 
 Body Mass Index (kg/m2) 25.9 (4.1) 26.4 (3.1) 
 Past history of any fracture 620 (7.4%) 373 (5.7%) 
 Smoking  (Current) 758 (9.0%) 608 (9.3%) 
  (Former) 2612 (31.2%) 3544 (54.2%) 
  (Never) 4939 (58.9%) 2340 (35.8%) 
 Alcohol intake (units/week) 4.6 (5.6) 10.2 (11.6) 
   
Second visit 1998-2000  
 Age (years) 61.6 (9.0) 62.9 (9.0) 
 Height (cm) 160.9 (6.2) 173.9 (6.6) 
 Weight (kg) 68.7 (11.8) 81.4 (11.5) 
 Body Mass Index (kg/m2) 26.5 (4.4) 26.9 (3.3) 
 Smoking  (Current) 672 (8.0%) 515 (7.9%) 
  (Former) 2725 (32.6%) 3651 (56.1%) 
  (Never) 4955 (59.3%) 2345 (36.0%) 
 Alcohol intake (units/week) 4.5 (5.7) 9.8 (11.4) 
   
Height change (mm) 5.2 (6.6) 4.6 (6.0) 
Height change per year (mm) 1.0 (2.4) 0.8 (2.3) 
BUA (dB/MHz) 72.2 (16.5) 90.1 (17.5) 
SOS (m/sec) 1624.8 (40.2) 1645.3 (39.9) 
   
Fracture (any type) 274 (3.3%) 116 (1.8%) 
Fracture (hip) 86 (1.0%) 36 (0.6%) 
Continuous variables are reported as mean (standard deviation in parenthesis) 
BUA: broadband ultrasound attenuation; SOS: speed of sound 
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3.4.2. Height loss and fractures  
When characteristics of participants with and without fracture were compared 
(Table 3.2), height loss was significantly higher in the group of fracture sufferers. 
Annual height loss was almost double in men and women with any fracture 
compared to those without fracture and differences were even greater for the 
subgroup of patients with hip fracture. Patients with fractures were significantly 
older and a higher proportion reported a past history of fracture. Hormone 
replacement therapy (both current and former) was associated with lower fracture 
risk in women. Ultrasound measures were significantly lower in men and women 
with any or hip fracture in comparison to other participants. While women with 
hip or any type of fracture had significantly lower consumption of alcohol, this 
pattern was not observed for men. Other variables (height, weight, BMI, and 
smoking) were not different between two groups (Table 3.2). 
Participants were categorised according to their annual height loss into three 
groups (no change, 0.1-0.5 cm annual height loss, and >0.5 cm annual height 
loss). Patients with higher height measurement in the second visit (2565 cases) 
were included in the no change group. Fracture incidence was higher in the 
group with >0.5 cm height loss per year with an age and sex adjusted hazard 
ratio of any fracture of 1.76 (95%CI 1.16-2.67) and of hip fracture of 2.08 (95%CI 
1.07-4.05) compared to those with no height loss. These differences were 
apparent in subgroups stratified by sex and age groups <60, 60-69, and ≥70 years 
(Figure 3.1). In women, the fracture incidence in those with no height loss 
compared to those with annual height loss of >0.5 cm were 222 and 499 per 
100,000 person-years, respectively, in those aged <60 years and 997 to 1291 per 
100,000 person-years, respectively, in those aged >70 years. A similar pattern 
was apparent in men with fracture incidence of 160 and 309 per 100,000 person-
years, respectively, in those <60 years and 260 and 737 per 100,000 person-
years, respectively, in those >70 years. While in Figure 3.1 there is a suggestion 
that the association between height loss and fractures may be modified by age 
group and sex, none of age-sex interactions were statistically significant.   
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Table 3.2: Comparison of baseline characteristics of those who subsequently had any incident or only hip fracture 
 No Fracture Any Fracture Hip Fracture  
  P value P value 
Women          
 N  8,107  274   86  
 Age (years)  57.7 (8.9)  63.9 (8.2) <0.001  67.0 (7.2) <0.001 
 Height (cm)  161.3 (6.1)  160.5 (5.9) 0.05  160.6 (5.9) 0.27 
 Weight (kg)  67.4 (11.3)  66.5 (10.6) 0.18  65.2 (10.2) 0.07 
 Body Mass Index (kg/m2)  25.9 (4.1)  25.8 (3.9) 0.63  25.2 (3.6) 0.14 
 Past history of any fracture  567 (7.0%)  53 (19.3%) <0.001  19 (22.1%) <0.001 
 Smoking  (Never) 4769 (59.3%)  170 (62.5%) 0.57  56 (65.1%) 0.53 
  (Current) 736 (9.2%)  22 (8.1%)   6 (7.0%)  
  (Former) 2532 (31.5%)  80 (29.4%)   24 (27.9%)  
 Alcohol intake (units/week)  2.5  1.5 0.003  1.3 0.008 
 HRT (Never) 5390 (66.5%)  206 (75.5%) 0.007  73 (84.9%) 0.001 
  (Current) 1742 (21.5%)  40 (14.7%)   6 (7.0%)  
  (Former) 968 (11.9%)  27 (9.9%)   7 (8.1%)  
 Height change (mm)  3.6 (8.3)  6.8 (9.5) <0.001  9.3 (10.4) <0.001 
 Height change per year (mm)  1.0 (2.4)  1.9 (2.7) <0.001  2.5 (2.9) <0.001 
 BUA (dB/MHz)  72.5 (16.4)  62.7 (16.1) <0.001  56.4 (16.1) <0.001 
 SOS (m/sec)  1625.6 (40.0)  1601.4 (39.2) <0.001  1589.3 (37.8) <0.001 
Men          
 N  6,424  116   36  
 Age (years)  59.3 (8.9)  61.8 (9.1) 0.003  67.3 (6.9) <0.001 
 Height (cm)  174.2 (6.5)  175.0 (6.7) 0.17  174.2 (6.5) 0.54 
 Weight (kg)  80.1 (10.9)  82.3 (10.9) 0.03  81.6 (12.2) 0.41 
 Body Mass Index (kg/m2)  26.4 (3.1)  26.9 (3.2) 0.09  27.1 (3.9) 0.16 
 Past history of any fracture  361 (5.6%)  12 (10.3%) 0.03  6 (16.7%) 0.004 
 Smoking  (Never) 2301 (36.1%)  39 (33.9%) 0.39  14 (38.9%) 0.84 
  (Current) 593 (9.3%)  15 (13.0%)   4 (11.1%)  
  (Former) 3483 (54.6%)  61 (53.0%)   18 (50.0%)  
 Alcohol intake (units/week)  6.5  7.7 0.58  5.7 0.69 
 Height change (mm)  3.0 (8.1)  5.5 (9.1) 0.001  7.5 (1.1) 0.001 
 Height change per year (mm)  0.8 (2.3)  1.5 (2.6) 0.001  2.0 (2.8) 0.003 
 BUA (dB/MHz)  90.2 (17.5)  83.1 (17.2) <0.001  80.0 (18.3) 0.001 
 SOS (m/sec)  1645.7 (39.7)  1622.7 (40.9) <0.001  1610.4 (46.6) <0.001 
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Figure 3.1: Incidence rate of any fracture among 8,381 women (A) and 6,540 men (B) 
according to the categories of age (years) and annual height loss (cm) 
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3.4.3. Height loss as a predictor of fractures  
For Cox proportional-hazards models, we further categorised participants with >1 
cm annual height loss to create four categories for height loss. Results of the 
analyses are summarised in Table 3.3. Compared to those who had not lost 
height, participants with height loss of >1 cm had a significantly higher risk of 
developing fractures and this risk remained significant after adjustment for other 
variables including age, sex, past history of fracture, smoking, BMI, alcohol 
intake, and heel ultrasound measures. Sex-specific analysis showed a similar 
pattern of risk in men and women. Models for hip fracture showed higher hazard 
ratios but with larger confidence intervals given the lower number of events 
(Table 3.3).  
When height loss was entered to the model as a continuous variable (Table 3.3, 
right column), it remained a significant risk factor of both any fracture and hip 
fracture in the multivariate model. The hazard ratios of annual height loss for 
vertebral (1.48; 95 CI 0.57-3.86) and wrist fractures (1.57; 95 CI 0.73-3.38) were 
in a similar direction but not statistically significant. Table 3.4 shows the Cox 
proportional-hazards model for any type of fracture in all male and female 
participants. Annual height loss (as a continuous variable), age, past history of 
fracture, and BUA were the significant predictors of any fracture in this model. 
The hazard ratio for any fracture was 1.86 (95% CI 1.27-2.71) for every 1 cm 
height loss per year. Table 4 shows that 1 cm height loss per year is comparable 
to past history of fracture and equivalent to being about 14 years older in 
chronological age in terms of magnitude of relationship with future fracture risk. 
The effect of 1 cm annual height loss on fracture risk was also equivalent to about 
30 dB/MHz decrease in BUA, which is nearly two times the standard deviation of 
BUA among our participants. The sex differential in future fracture risk was not 
apparent after inclusion of BUA into the model. Further analyses excluding the 
993 men and women who had a past history of fracture gave consistent results 
with a hazard ratio of 1.81 (95% CI 1.17-2.79) for any fracture per 1 cm annual 
height loss. 
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Table 3.3: Hazard ratios (95% CI in parentheses) of annual height loss for incident fractures in EPIC-Norfolk study, 1998-2006 
  Annual height loss (centimeters) 
   Categorical Continuous 
   0  0.1-0.5  0.6-1.0  >1.0  Per 1 cm  
            
All   N=5,313  n=8,991  n=557  n=60  n=14,921 
 
Any 
Fracture 
N (%) 104 (2.0%)  252 (2.8%)  27 (4.8%)  7 (11.7%)   
  Age & sex-adjusted HR 1  1.10 (0.87-1.39)  1.56 (1.01-2.40)  3.20 (1.48-6.95)  2.09 (1.44-3.02) 
  Multivariable-adjusted HR* 1  1.06 (0.84-1.34)  1.37 (0.89-2.12)  2.93 (1.34-6.39)  1.86 (1.28-2.72) 
            
 Hip Fracture N (%) 26 (0.5%)  80 (0.9%)  13 (2.3%)  3 (5%)   
  Age & sex-adjusted HR 1  1.13 (0.72-1.77)  2.05 (1.04-4.05)  3.38 (1.01-11.3)  2.64 (1.48-4.71) 
  Multivariable-adjusted HR* 1  1.05 (0.67-1.65)  1.66 (0.83-3.30)  2.95 (0.87-9.99)  2.24 (1.23-4.09) 
            
Women   N=2,895  n=5,101  n=345  n=40  n=8,381 
 
Any 
Fracture 
N (%) 70 (2.4%)  180 (3.5%)  19 (5.5%)  5 (12.5%)   
  Age-adjusted HR 1  1.05 (0.79-1.39)  1.25 (0.75-2.10)  2.29 (0.91-5.72)  1.86 (1.20-2.87) 
  Multivariable-adjusted HR* 1  0.99 (0.75-1.32)  1.08 (0.64-1.83)  2.15 (0.85-5.41)  1.64 (1.05-2.56) 
            
 Hip Fracture N (%) 17 (0.6%)  57 (1.1%)  10 (2.9%)  2 (5%)   
  Age-adjusted HR 1  1.15 (0.67-2.00)  2.00 (0.90-4.45)  2.55 (0.58-11.2)  2.52 (1.30-4.90) 
  Multivariable-adjusted HR* 1  1.02 (0.58-1.78)  1.52 (0.68-3.43)  2.11 (0.47-9.44)  2.03 (1.01-4.05) 
            
Men   N=2,418  n=3,890  n=212  n=20  N=6,540 
 
Any 
Fracture 
N (%) 34 (1.4%)  72 (1.9%)  8 (3.8%)  2 (10%)   
  Age-adjusted HR 1  1.20 (0.79-1.82)  2.26 (1.03-4.95)  6.25 (1.49-26.2)  2.69 (1.31-5.52) 
  Multivariable-adjusted HR* 1  1.16 (0.76-1.76)  2.05 (0.93-4.51)  4.59 (1.07-19.7)  2.16 (1.05-4.43) 
            
 Hip Fracture N (%) 9 (0.4%)  23 (0.6%)  3 (1.4%)  1 (5%)   
  Age-adjusted HR 1  1.09 (0.50-2.37)  1.96 (0.52-7.35)  6.63 (0.83-53.1)  2.66 (0.79-8.90) 
  Multivariable-adjusted HR* 1  1.05 (0.48-2.31)  1.59 (0.42-6.04)  5.67 (0.67-47.7)  2.24 (0.65-7.66) 
*Variables in the equation: age, body mass index, smoking habit, alcohol intake, past history of any fracture, broadband ultrasound attenuation (and history of 
hormone replacement therapy for women) 
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Table 3.4: Cox proportional-hazards model to predict any type of fracture among 
14,921 EPIC-Norfolk participants 
 Cox β coefficient Hazard Ratio 95% Confidence Interval  
    
Height change (cm/year) 0.623* 1.86 1.27-2.71 
Age (years) 0.045* 1.05 1.03-1.06 
Sex (male) -0.250 0.78 0.60-1.02 
Past history of any fracture (yes) 0.662* 1.94 1.47-2.55 
Body Mass Index (kg/m2) 0.008 1.01 0.98-1.03 
Smoking (current) -0.199 0.82 0.57-1.18 
Alcohol intake (units/week) 0.002 1.00 0.99-1.02 
BUA (per 15 dB/MHz) -0.309* 0.73 0.66-0.81 
* Statistically significant at level of p<0.05 
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3.5. Discussion 
Height change is an easily measured variable that can help identify those at 
increased risk of future fractures. Those with height loss greater than 1 cm/year 
compared to those with no height loss were at nearly three-fold increased risk of 
future fracture, after adjustment for age, sex, past history of fracture, body mass 
index, smoking, alcohol intake, and hormone replacement therapy use (in 
women). Intriguingly the relationship was also independent of bone 
characteristics as assessed by heel ultrasound and suggests that some mechanisms 
other than simply lower bone density may play a role here. This study indicates 
that middle aged and older men and women with a height loss of more than 2 cm 
in a 4 year period (i.e. 0.5 cm annual height loss) are at increased risk of fractures.  
Generally, stature decreases with age through several non-pathological 
mechanisms such as changes in vertebral body shape and height, loss of inter-
vertebral disc height, and postural changes [124]. The magnitude of this height 
loss is variable and unpredictable. All types of vertebral deformity (crush, wedge 
and biconcave deformities) are associated with height loss with crush deformity 
being the most hazardous one [134]. The pathophysiology of these deformities 
and their relation to osteoporosis are still uncertain. A potential explanation for 
the contribution of these deformities to the increased risk of non-spine fractures 
might be their relationship to the risk of falls among older people. Falling is the 
strongest known risk factor of non-spine fractures [135, 136] and its attributable 
risk for fracture is considered to be even more than established osteoporosis 
[137]. Kyphosis, inter-vertebral disc degeneration and other postural changes can 
be considered as general indicators of frailty among the elderly. Poor muscle 
strength, poor movement, and poor balance in frail individuals may lead to 
increased risk of falling and fractures. We could not, however, evaluate this 
hypothesis in our study as we have not measured the incidence of injurious or 
total falls in our population. 
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Height loss may also result from vertebral fractures that are highly related to 
osteoporosis [127, 129, 132, 133]. As trabecular bone in the spine becomes more 
porous, vertebral fractures occur and cause the vertebrae to collapse or curve 
forward resulting in a loss of height [134, 138]. However, only a small proportion 
of these fractures come to medical attention [139]. A weakness of the present 
study is that we had only access to clinically apparent vertebral fractures, which 
are likely to be a small fraction of the actual vertebral fractures in our population 
(considering the low number of these fractures comparing to hip fractures). As no 
spinal X-rays were performed at baseline or follow-up visits, we cannot be sure of 
how far non-clinically apparent vertebral fractures could account for the 
association between height loss and other clinical fractures. Nevertheless, people 
in the general population are not routinely screened by X-rays for vertebral 
fractures. Whatever the mechanism for the relationship, this study suggests that 
measured height loss may be a clinically useful early indicator of future clinically 
evident vertebral and non-vertebral fractures.  
Osteoporosis is defined as a systemic disease with two main characteristics: low 
bone density and low bone quality [1]. Currently there is no simple way to assess 
and quantify bone quality and our knowledge about osteoporosis comes mainly 
from bone density. Dual-energy X-ray absorptiometry (DXA) is the standard 
method of measurement of bone mineral density (BMD) and current diagnostic 
criteria for osteoporosis are mainly based on this measure. However, QUS is an 
emerging alternative method due to its affordability and comparable predictive 
power. The diagnostic sensitivity of ultrasound measurement of the calcaneus in 
the prediction of hip fracture has been shown to be similar to hip BMD measured 
with DXA and superior to spine BMD [140]. QUS provides comparable 
diagnostic sensitivity to spine BMD in vertebral fractures and there is a general 
consensus that both bone quality and bone density have effects on QUS measures 
[140]. People with lower BMD as assessed by DXA lose height substantially faster 
than those with higher BMD [141-143]. The current study, however, did not 
show such an association between height loss and BUA measures. The 
correlation coefficient was 0.11 among our participants. Since the hazard ratio of 
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annual height loss for any fracture remained significant after inclusion of BUA 
into models, our study suggests that height loss may provide some additional 
information predicting fracture risk that may improve predictive models for 
fracture risk assessment. 
Previous studies evaluating the role of height loss on fractures were mostly 
restricted to postmenopausal women [126, 129, 131-133, 144-147]. Although 
osteoporosis is more common in women, men are, with a time lag, also affected 
and morbidity and mortality after osteoporotic fractures appears to be more 
serious in men than in women [148]. However, there is a general paucity of 
prospective data on fracture risk in men. Moreover, retrospective assessment of 
height loss using self-reported maximum lifetime height, which is used in most of 
these studies [126, 129, 131-133, 146, 147, 149], is prone to recall bias. Relying 
on an older person’s memory to remember an exact number after more than 30 
years may not be practical and the choice of cut-off for clinical application based 
on these figures is highly inconsistent [144, 149]. 
Few prospective studies have evaluated the role of measured exact height loss in 
the elderly on incident vertebral fractures [144, 145, 150]. Some retrospective 
studies have found a significant relationship between stature loss and hip fracture 
and other fragility fractures [125, 128, 130]. The current study confirms the role 
of height loss as an independent risk factor for osteoporotic fractures. The pattern 
of this relationship seems to be very similar between men and women. Height 
loss is probably an indicator of vertebral bone loss and might therefore be 
expected to be most strongly predictive for future vertebral fractures. However, 
height loss was in fact predictive of fractures at all sites, and in particular hip 
fractures, representing that it is a good indicator of bone health in general. 
It might be argued that measurement of height loss in clinical settings is not an 
easy and straightforward task. Accurate and precise stadiometers might not be 
available in some clinics and clinicians need to consider other factors like general 
health status of the patients or the time of measurement of height (given the 
diurnal variations of height) [151]. However, availability and feasibility of height 
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measurement in the clinical setting is an unquestionable advantage over other 
modalities for assessment of bone health and clinicians can benefit considerably 
from useful information derived from simple height measurement for making 
more knowledgeable decisions for their patients. Moreover, when viewed in the 
context of family practice, detection of 2 cm height loss over a period of 4 years 
(rapid height losers with >0.5 cm per year) is quite achievable for all practices 
and even with less precise stadiometers. Therefore, height registration by the units 
of millimetres can be recommended for general practices.  
Possible limitations of this study include incomplete ascertainment of fractures as 
not all fractures are admitted to hospital. The distribution of fractures among our 
population seems to be skewed toward hip fracture in comparison to wrist and 
vertebral fractures. Nevertheless, hospital admissions are likely to reflect fractures 
which have the most clinical impact [2]. There are also likely to be some 
potential errors in height measurement including assessment in different times of 
the day by different measurers. However, these random errors are more likely to 
attenuate any associations between exposure and outcomes. We were able to 
measure height change in about 15,000 participants who attended the second 
visit out of about 25,000 baseline participants. Although these participants at the 
second visit are likely to be healthier than non-respondents, bias in selection of 
healthier population is unlikely to explain our results as the relationship between 
height loss and fractures is unlikely to be in the opposite direction among non-
respondents. Again, selection bias is more likely to attenuate findings in our 
study. 
Identifying individuals at increased risk of fracture for targeted interventions has 
moved from simple threshold definitions of osteoporosis based on bone density 
measures to attempts to quantify absolute fracture risk. There is a general trend 
towards appreciation of clinical risk factors as important contributors to the 
fracture risk instead of bone density measures [152, 153]. However, there is still a 
paucity of population-based data as to which clinical risk factors may contribute 
most to absolute fracture risk charts. In this general population of middle-aged 
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and older men and women, the magnitude of increased fracture risk associated 
with height loss of 1 cm per year was comparable to having a past history of 
fracture and equivalent to being 14 years older in chronological age after 
adjustment for other known risk factors. This study suggests that height change 
may be an important and easily-measurable factor to help identify those at 
increased risk of fracture for preventive interventions and should be considered in 
fracture risk assessment tools for middle-aged and older people. 
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Chapter 4: Respiratory Function 
 
 
 
 
 
 
 
 
 
 
 
The work presented in this Chapter has been published in: 
Moayyeri A, Bingham S, Luben RN, Wareham NJ, Khaw KT. Respiratory function as a marker of 
bone health and fracture risk in an older population: the European Prospective Investigation into 
Cancer-Norfolk Study. Journal of Bone and Mineral Research 2009 May;24(5):956-63 
Please see Appendix 4. 
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4.1. Abstract 
Identification of those at high risk of osteoporosis and fractures using clinically 
available tests beyond bone density measures is a major clinical challenge. We 
examined forced expiratory volume in 1 second (FEV1), an easily obtainable 
measure of respiratory function, as a clinical measure for fracture prediction. In 
this EPIC-Norfolk study analysis, 8,304 women and 6,496 men aged 42-81 years 
underwent a health check including spirometry and heel quantitative 
ultrasonography between 1998 and 2000 and were followed up for incident hip 
fractures until 2007. The Main Outcome Measures were broadband ultrasound 
attenuation (BUA) of the heel (cross-sectional analysis) and hip fracture risk 
(prospective analysis). In multivariate regression models, 1 litre increase in FEV1 
was associated with a statistically significant 2.2 dB/MHz increase in BUA 
independent of age, smoking, height, body mass index, history of fracture and use 
of corticosteroids. Mean FEV1 was significantly lower among 84 women and 36 
men with hip fracture compared to other participants. In multivariate 
proportional-hazards regression models, the hazard ratio (HR) of hip fracture 
associated with 1 litre increase in FEV1 was 0.5 (95% confidence interval, 0.3–
0.9, P<0.001) for both men and women. HR of hip fracture for 1 SD increase in 
FEV1 was approximately equivalent to 0.5 SD increase in BUA among women (1 
SD among men) and about 5 years decrease in age among both men and women. 
In conclusion, middle-aged and older people with low respiratory function are at 
increased risk of osteoporosis and hip fracture. FEV1, an easy, low cost and 
feasible clinical measure, may help improve the identification of high-risk groups. 
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4.2. Introduction 
Projections suggest that, in the next few decades, numbers of fractures worldwide 
are likely to increase substantially [29]. Therefore, early identification of groups at 
high risk of fracture who may benefit most from preventive interventions is a 
major challenge [154]. Though low bone mineral density (BMD) is an established 
predictor of increased fracture risk, the majority of fractures occur in patients with 
BMD above the thresholds commonly used to diagnosis osteoporosis. 
Identification of other factors that independently predict fracture risk may not 
only help improve identification of high-risk groups, but also help understanding 
of the pathophysiology of the disease. A number of previous studies have 
suggested a link between respiratory function and BMD [155-157]. Some 
pathophysiologic mechanisms also plausibly support an association between 
pulmonary function and bone health. Apart from demographic and 
anthropometric factors like age, sex, and height, this association can be mediated 
via modifiable behavioural risk factors, namely physical activity and smoking [97, 
158-160]. In this study, we investigated whether pulmonary function testing is 
associated with bone characteristics (as assessed by quantitative ultrasound 
measurement) and prospective risk of hip fracture. 
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4.3. Methods 
This study is based on data from participants in the second health examination of 
EPIC-Norfolk study. Details of the recruitment and assessment procedures are 
described in Chapter 2. Briefly, in the second health examination in 1998-2000, 
15,028 participants returned for a health visit and completed a self-administered 
health and lifestyle questionnaire. Respiratory function was assessed by forced 
expiratory volume in 1 second, FEV1, using an electronic turbine spirometer 
(Micro Medical, Ltd., Rochester, UK). The higher of the two values for FEV1 
measurements were used for analysis. Forced vital capacity (FVC) and peak 
expiratory flow (PEF) were also recorded for all participants but only FEV1 is 
reported here as the other measures did not add information beyond FEV1. The 
reproducibility of the test was about 2.2% for FEV1 and calibration was performed 
regularly in a weekly basis to ensure the accuracy and precision of both 
equipment and personnel [107]. 
Height and weight were measured during the health examination and body mass 
index (BMI) was calculated as the weight in kilograms divided by the square of 
the height in meters. Smoking status, weekly alcohol intake, current or ever use of 
corticosteroid drugs, bronchodilators, and hormone replacement therapy (HRT) as 
well as history of respiratory diseases were derived from the questionnaires. 
Quantitative ultrasound scanning was used to measure broadband ultrasound 
attenuation (BUA; db/MHz) and speed of sound (SOS; m/s) of the calcaneus with 
the use of the CUBA sonometer (McCue Ultrasonics, Winchester, UK). 
International Classification of Diseases (ICD) 9 and 10 diagnostic codes were 
used to ascertain fractures by site occurring in the cohort up to the end of March 
2007 for present analyses, a mean follow-up time of 7.7 years (SD=0.8).  
As bone characteristics differ considerably between men and women, sex-specific 
analyses were used throughout this Chapter. For assessment of the association 
between FEV1 and QUS measures, characteristics of participants in four sex-
specific quartiles of FEV1 were compared using one-way ANOVA for continuous 
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variables and chi-square test for categorical variables. Assumption of normality 
was checked beforehand for all continuous variables. Pearson’s correlation 
coefficients were estimated for the correlations between FEV1 and ultrasound 
characteristics of the participants. Univariate general linear models were used to 
assess the linear trend of crude and adjusted BUA in different quartiles of FEV1. 
To predict the sex-specific difference in BUA, multivariate linear regression 
models were run with FEV1 with different levels of adjustment. The Wald test was 
used to test the significance of β coefficients. Pre-specified interactions between 
FEV1 and other factors were checked. Regression models were rerun for different 
subgroups of participants.  
To assess the predictive power of FEV1 for incident osteoporotic fractures, 
characteristics of those who had developed hip fracture during the follow-up 
were compared with other participants. FEV1 and known fracture risk factors were 
entered into a Cox proportional-hazards model to determine their independent 
contribution to the risk of fracture. Hazard ratios of hip fracture for sex-specific 
quartiles of FEV1 were calculated in comparison to the lowest quartiles for men 
and women. FEV1 was also entered into models as a continuous variable. To 
enable comparisons between FEV1 and other continuous variables for prediction 
of fractures, we used intervals of approximately one standard deviation (0.5 
litres). Goodness-of-fit for different models were verified graphically by 
comparison of Kaplan-Meier curves for observed and predicted values. A set of 
pre-specified interactions between FEV1 and other factors was also checked, but 
not included in the final models due to non-significance. Values for continuous 
variables are expressed as mean ± SD throughout the Chapter unless otherwise 
stated. All the analyses were performed using Stata software, version 10.0 
(StataCorp LP., College Station, TX, USA). 
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4.4. Results  
4.4.1. Characteristics of the study participants 
After exclusion of 228 participants with unsatisfactory spirometry (due to 
mechanical problems, poor cooperation, coughing, or recent abdominal or chest 
surgery), 8,304 women and 6,496 men aged 42-81 years comprised the study 
population. Characteristics of the study population are summarised in Table 1. 
Mean (SD) of FEV1 was 2.1 (0.5) litre among women and 2.6 (0.7) litre among 
men. Men had significantly higher bone measures (both BUA and SOS) and 
experienced a lower number of hip fractures during the follow-up. Table 4.1 
shows the significant differences between women and men regarding key 
variables, supporting the need for sex-specific analyses. 
 
Table 4.1: Baseline characteristics of participants  
 Women Men P value 
   n=8,304 n=6,496  
Age (years) 61.6 (9.0) 62.9 (9.0) <0.001 
Height (cm) 160.9 (6.2) 173.9 (6.6) <0.001 
Weight (kg) 68.7 (11.8) 81.4 (11.5) <0.001 
Body Mass Index (kg/m2) 26.5 (4.4) 26.9 (3.3) <0.001 
Smoking  (Current) 664 (8.0%) 515 (7.9%) <0.001 
 (Former) 2,697 (32.5%) 3,609 (55.6%)  
 (Never) 4,876 (58.7%) 2,326 (35.8%)  
Alcohol intake (units/week)* 2 (6) 6 (12) <0.001 
History of fracture  620 (7.5%) 375 (5.8%) <0.001 
History of corticosteroid use 263 (3.2%) 162 (2.5%) 0.015 
FEV1 (litre) 2.1 (0.5) 2.6 (0.7) <0.001 
BUA (dB/MHz) 72.2 (16.5) 90.1 (17.6) <0.001 
SOS (m/sec) 1,624.7 (40.2) 1,645.2 (40.0) <0.001 
Hip fracture†  84 (1.0%) 36 (0.6%) 0.002 
Data are mean (standard deviation) or number of participants (percentage) 
* Values are medians (inter-quartile range) 
† Number of incident hip fractures up to March 2007 
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4.4.2. Respiratory function and quantitative ultrasound 
Significant and positive correlations were observed between FEV1 and BUA 
among both women (Pearson correlation coefficient r=0.32; P<0.001) and men 
(r=0.11; P<0.01). The corresponding coefficients for FEV1 and SOS were 0.26 for 
women and 0.08 for men (P<0.01 for both). Age, height, and weight also 
significantly correlated with both FEV1 and ultrasound measures. Given the high 
correlation of BUA and SOS in both women (r=0.72) and men (r=0.69), only BUA 
was used as the measure of bone health for further analyses. 
Figure 4.1 shows the crude and adjusted means of BUA using generalised linear 
modelling approach among different quartiles of FEV1 in both sexes. Multivariate-
adjusted mean BUA was higher by 3.7 dB/MHz among women and 2.9 dB/MHz 
among men from first to fourth quartile of FEV1. Although the magnitude of the 
difference was reduced after adjustment, there was still a significant linear trend 
for increment of BUA across quartiles of FEV1. The trend of increasing BUA with 
increasing FEV1 quartiles was more noticeable among women. 
 
Figure 4.1: Crude and adjusted mean of BUA in quartiles of FEV1 in EPIC-Norfolk  
BUA measures are adjusted for age, smoking status, height, body mass index, past 
history of fracture, and use of corticosteroid using generalised linear models. 
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Results of the multivariate linear regression models to predict heel BUA are 
summarised in Table 4.2. A significant and positive relationship between FEV1 
and BUA, independent of age, smoking, height, BMI, history of fracture, and use 
of corticosteroids was observed among both men and women. In the multivariate 
models, a unit change in FEV1 (1 litre) was associated with a statistically 
significant 2.21 dB/MHz difference in BUA among women and 1.47 dB/MHz 
difference in BUA among men. Excluding participants with self-reported 
respiratory disease or use of corticosteroids or bronchodilators did not materially 
alter the regression slopes (Table 4.2). 
 
 
 
Table 4.2: Crude and adjusted regression coefficients (standard errors) of FEV1 for 
prediction of calcaneal BUA  
  Women    Men  
 N β (s.e.) P value  N β (s.e.) P value 
Crude 8,304 10.08 (0.33) <0.001  6,496 2.69 (0.11) <0.001 
Adjusted for age 8,304 3.12 (0.39) <0.001  6,496 2.52 (0.36) <0.001 
Adjusted for age & smoking 8,183 3.13 (0.40) <0.001  6,402 2.18 (0.36) <0.001 
Multivariate adjusted* 8,175 2.21 (0.41) <0.001  6,391 1.47 (0.39) <0.001 
Multivariate adjusted*† 6,683 2.37 (0.47) <0.001  5,396 1.31 (0.45) 0.003 
* Adjusted for age, smoking status, height, body mass index, past history of fracture, and use of 
corticosteroids  
† Excluding participants with known respiratory diseases, bronchodilator users, and corticosteroid 
users 
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4.4.3. Respiratory function and hip fractures 
120 participants (84 women) developed a hip fracture during 114,346 person-
years of follow-up (64,049 person-years in women). Characteristics of participants 
who did or did not develop a hip fracture in the study period are summarised in 
Table 4.3. Women with subsequent fractures were significantly older, shorter, 
and lighter and had significantly lower ultrasound measures and FEV1 (1.7 litres 
in average comparing to 2.1 litres for others). Women with hip fracture were less 
likely to have used hormone replacement therapy, more likely to have a history of 
fracture in earlier life, and had lower intake of alcoholic drinks. Smoking was not 
different among these groups in women. Age, past history of fracture, FEV1, and 
ultrasound measures were significantly different between men with and without 
subsequent hip fracture (Table 4.3). Mean age of men with hip fracture was about 
8 years higher than other participants and they had lower FEV1 of about 0.7 litres 
on average compared to others.  
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Table 4.3: Comparison of characteristics of participants with and without subsequent hip fracture in EPIC-Norfolk study 
 Women  Men 
No Fracture Hip Fracture P value No Fracture Hip Fracture P value 
N 8,220 84  6,460 36  
Age (years) 61.4 (8.9) 70.7 (7.4) <0.001 62.9 (9.0) 71.0 (7.3) 0.004 
Height (cm) 161.0 (6.2) 159.6 (6.0) 0.047 173.9 (6.6) 172.8 (6.1) 0.292 
Weight (kg) 68.7 (11.8) 65.0 (11.4) 0.004 81.4 (11.5) 81.0 (13.3) 0.116 
BMI (kg/m2) 26.5 (4.4) 25.5 (4.1) 0.027 26.9 (3.3) 27.1 (4.1) 0.274 
Past history of any fracture 594 (7.3%) 19 (22.6%) <0.001 368 (5.7%) 6 (16.7%) 0.005 
Smoking  (Never) 4800 (59.1%) 54 (64.3%) 0.587 2305 (36.0%) 14 (38.9%) 0.926 
 (Current) 655 (8.1%) 5 (6.0%)  511 (8.0%) 3 (8.3%)  
 (Former) 2660 (32.8%) 25 (29.8%)  3583 (56.0%) 19 (52.8%)  
Alcohol intake (u/wk)* 2 (6) 1.5 (4) 0.003 6 (12) 6.5 (10.5) 0.587 
Corticosteroid use 258 (3.2%) 5 (6.0%) 0.143 160 (2.5%) 2 (5.6%) 0.242 
HRT (Never) 5447 (66.6%) 71 (84.5%) 0.002 - - - 
 (Current) 1749 (21.4%) 6 (7.1%)  - -  
 (Former) 978 (12.0%) 7 (8.3%)  - -  
FEV1 (litre) 2.1 (0.5) 1.7 (0.5) <0.001 2.9 (0.7) 2.2 (0.8) 0.004 
BUA (dB/MHz) 72.4 (16.4) 55.9 (14.7) <0.001 90.2 (17.5) 80.0 (18.3) <0.001 
SOS (m/sec) 1625.1 (40.0) 1589.6 (35.1) <0.001 1645.4 (39.8) 1610.4 (46.6) <0.001 
* Values are medians (interquartile range).  
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Table 4.4 shows the results of Cox regression models to predict hip fracture 
among participants. There was a trend of decreasing risk of hip fracture in 
subjects with higher FEV1. Multivariate models showed a significant reduction of 
about 47% in hip fracture risk per 1 litre increase in FEV1 in both sexes (Table 
4.4, right column).  
 
 
 
Table 4.4: Cox regression models by FEV1 for hip fractures in the EPIC-Norfolk 
study 
   FEV1 (litre) 
   FEV1 Quartiles Continuous 
   1st 2nd 3rd 4th Per 1 litre  
       
Women   n=2,072 n=2,093 n=2,062 n=2,077 n=8,304 
 Hip Fracture N (%) 49 (2.4%) 22 (1.1%) 9 (0.4%) 4 (0.2%) 84 (1.0%) 
 Crude HR 1 0.44  (0.27-0.73) 
0.18  
(0.09-0.38) 
0.08  
(0.03-0.23) 
0.21  
(0.14-0.31) 
 
Age-adjusted HR 1 0.71  (0.42-1.19) 
0.50  
(0.23-1.07) 
0.37  
(0.12-1.14) 
0.51  
(0.30-0.87) 
Multivariable-adjusted HR* 1 0.66  (0.39-1.12) 
0.46  
(0.21-1.01) 
0.32  
(0.10-1.00) 
0.53  
(0.31-0.90) 
        
Men   n=1,636 n=1,611 n=1,638 n=1,611 N=6,496 
 Hip Fracture N (%) 19 (1.2%) 9 (0.6%) 6 (0.4%) 2 (0.1%) 36 (0.6%) 
 Crude HR 1 0.49  (0.22-1.08) 
0.32  
(0.13-0.81) 
0.11  
(0.03-0.49) 
0.35  
(0.23-0.53) 
 
Age-adjusted HR 1 0.67  
(0.30-1.50) 
0.69  
(0.26-1.84) 
0.43  
(0.09-2.12) 
0.53  
(0.32-0.91) 
Multivariable-adjusted HR* 1 0.72  
(0.31-1.64) 
0.69  
(0.25-1.94) 
0.42  
(0.08-2.22) 
0.52  
(0.30-0.90) 
*Variables in the equation: FEV1 (forced expiratory volume in 1 second) age, body mass index, 
smoking habit, alcohol intake, past history of any fracture, broadband ultrasound attenuation, 
corticosteroid use (and history of hormone therapy for women)  
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Table 4.5 shows the results of sex-specific multivariate Cox regression analyses to 
predict hip fracture. FEV1 was a significant predictor of hip fractures among both 
men and women with a hazard ratio of about 0.6 per 1 SD (0.5 litres). Age, 
height, alcohol intake and BUA were the other significant predictors of hip 
fractures among women. The other significant predictors were age and BUA 
among men. Past history of fracture was associated with a marginally significant 
70% increased risk of hip fracture among women and a non-significant 130% 
increased risk among men (Table 4.5). 
 
Table 4.5: Cox proportional-hazard models to predict hip fracture among 8,304 
women and 6,496 men in the EPIC-Norfolk study 
 Women Men 
 β 
coefficient 
Hazard Ratio 
(95% CI) 
β 
coefficient
Hazard Ratio  
(95% CI) 
FEV1 (per 0.5 litre) -0.42* 0.66 (0.45-0.95) -0.44* 0.64 (0.43-0.96) 
Age (per 5 years) 0.41* 1.51 (1.25-1.81) 0.46* 1.58 (1.20-2.10) 
Height (per 5 cm) 0.26* 1.29 (1.07-1.57) 0.21 1.23 (0.94-1.63) 
Body Mass Index (per 4 kg/m2) -0.13 0.88 (0.69-1.11) 0.13 1.14 (0.77-1.70) 
Past history of any fracture (yes) 0.50 1.65 (0.99-2.81) 0.85 2.33 (0.89-6.08) 
Smoking (current) 0.12 1.14 (0.45-2.86) 0.34 1.41 (0.33-6.25) 
Alcohol intake (per unit/week) -0.06* 0.94 (0.89-0.99) 0.00 1.00 (0.97-1.03) 
BUA (per 20 dB/MHz) -0.88* 0.41 (0.29-0.59) -0.50* 0.60 (0.40-0.91) 
Corticosteroid use(yes) 0.13 1.14 (0.45-2.87) 0.24 1.27 (0.29-5.61) 
 * Statistically significant at level of p<0.05 
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4.5. Discussion  
To our knowledge, this is the first population-based study evaluating the 
association between respiratory function and bone health as assessed by 
quantitative ultrasound measurement and fracture incidence over time. In our 
study, there was a significant positive and continuous relationship between FEV1 
and BUA of the heel in middle-aged and older women and men.  The magnitude 
of this relationship, however, was not large after adjustment for covariates; the 
mean BUA measures of women and men in the highest FEV1 quartile were only 
5% and 3%, respectively, higher than the mean BUA of women and men in the 
lowest quartile (Figure 4.1). Furthermore, in multiple regression analysis, a 1 litre 
increase in FEV1 was accompanied by approximately 2.2 dB/MHz increase in 
BUA for women and 1.5 dB/MHz increase in BUA for men (Table 4.2), in 
comparison with a standard deviation of BUA around 17 dB/MHz. 
However, there was a significant and strong association between FEV1 and 
incidence of hip fracture, greater than might be predicted from the association 
with BUA. Indeed, this association remained significant even after adjustment for 
BUA and other known risk factors including age and past history of fracture 
(Table 4.4 and Table 4.5). The hazard ratio for 1 SD (0.5 litres) increase in FEV1 
was about 0.6 (95% confidence interval, 0.4–0.9) for both men and women. β 
coefficients provided in Table 4.5 can be used to compare the relative effect of 
different variables for prediction of hip fractures [161]. This shows that 1 SD 
increase in FEV1 was equivalent approximately to 0.5 SD increase in BUA among 
women (1 SD among men) and about 5 years decrease in age among both men 
and women (Table 4.5). This suggests that the relationship between respiratory 
function and bone health is independent of bone properties measured by 
quantitative ultrasound and FEV1 may be a useful marker of fracture risk 
independent of bone characteristics in older men and women.  Evaluation of the 
mechanisms by which FEV1 can affect the bone health is beyond the scope of this 
study, but we can suggest that inclusion of this measure (FEV1) in fracture 
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prediction charts, especially for hip fracture, might be helpful and needs further 
consideration. 
Currently we are facing a universal shift towards use of long-term fracture risk 
estimation in the field of osteoporosis research and clinical practice guidelines. 
The FRAX® tool, a newly-launched online program for estimation of 10-year 
absolute risk of fracture for individuals, is likely to be a source for future routine 
clinical practice in this field [24, 162]. This tool currently considers several 
clinical risk factors and BMD measurements in the femoral neck. The results of 
this tool can be replicated for different populations using prospective studies with 
long follow-ups. Moreover, other potential risk factors (including clinical, 
radiological and biochemical factors) can be added to or replaced with the 
current set of risk factors. While use of subjective measures like history of 
smoking or physical activity might be prone to several biases, more objective 
measures such as spirometry results may increase the accuracy of our risk 
estimates. Future studies need to consider this point and use it to improve the 
predictive power of forthcoming risk assessment tools.  
The first studies examining the association between respiratory function and bone 
health were in patients with pulmonary diseases. Some clinical studies in patients 
with cystic fibrosis and bronchial asthma found significant associations between 
measures of respiratory function and BMD [163-165]. It should be noted, 
however, that patients with these conditions are exposed to a variety of other 
factors that might impair their bone health (for instance, cystic fibrosis is 
associated with pancreatic malabsorption and bronchial asthma is often treated 
with long-term corticosteroids). Cross-sectional studies among community-
dwelling adults have shown a correlation between respiratory function and BMD 
measured with DXA [155-157]. Two cross-sectional studies from Cambridge, UK, 
found a positive and continuous relationship between FEV1 and BMD at the hip 
across the whole normal range of respiratory function in women and men [156, 
157]. This association was evident in young, middle, and older age groups almost 
to the same extent. After adjusting for potential confounding factors, mean hip 
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BMD of women in the highest FEV1 quartile was approximately 3-5% higher than 
the mean BMD in women in the lowest quartile [156]. This difference was 
slightly lower, but still significant, for men (2-3.5%) [157]. This magnitude is 
comparable to that observed for BUA in the current study. As far as we know, no 
prospective study, however, has investigated the predictive power of pulmonary 
function testing for osteoporotic fractures, or assessed the association of 
respiratory function and QUS measures among healthy members of the 
community.  
Impaired respiratory function is associated with morbidity [166] and mortality 
[166, 167]. Poor respiratory function predicts overall mortality, as well as death 
due to cancer [168], pulmonary disease [169], cardiovascular disease [166, 168], 
and stroke [166]. This relation could simply reflect the effect of cigarette smoking, 
respiratory illness, or other pre-existing diseases [170, 171]. Researchers have 
advised that the use of FEV1 as part of any health assessment of middle aged 
patients should be considered [168]. The current study shows that FEV1 can be 
used as a marker of bone characteristics as assessed by QUS. Moreover, even 
after adjustment for BUA in multivariate Cox regression analysis, FEV1 was a 
significant predictor of hip fracture. This suggests a potential association between 
respiratory function and some unmeasured bone characteristics or other fracture 
risk factors such as tendency to falls. One plausible explanation is that respiratory 
function and bone health both reflect common but as yet unknown determinants 
[156]. 
This study has some limitations. Respiratory function was evaluated using the 
better of two blow manoeuvres in this study. This may induce some imprecision 
in the estimated respiratory function as most of the recent guidelines recommend 
use of at least 3 blow attempts for determination of FEV1 [172, 173]. This is 
mainly due to the fact that the original design and start of the EPIC-Norfolk study 
goes back to 1992 before development of these guidelines and the investigators 
chose to continue with a consistent procedure of spirometry throughout the study 
follow-up [107]. Moreover, random measurement error in FEV1 values is more 
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likely to underestimate the magnitude of the relationship between FEV1 and BUA 
[174]. Other measures of respiratory function like FVC, PEF, and FEV1/FVC ratio 
did not add additional information to our results and we chose to only report 
FEV1 as the most widely used and straightforward measure.  
Participants in the baseline visit for this study (which was the second health check 
in EPIC-Norfolk) are likely to be healthier than general population. About 60% of 
participants in the original cohort returned for this health check and this may 
induce a healthy selection bias. We have previously compared characteristics of 
those who attended the second health examination with those who did not, and 
as expected, non-attendees were older [107]. However, selection of participants 
in the first instance and the method of follow-up were not related to or influenced 
by the exposure level in this study. Moreover, it is unlikely that the association 
observed in this study between respiratory function and bone health would be 
different or in the opposite direction in non-attending population. In fact, 
pathophysiology would suggest that the link between respiratory function and 
bone health would be stronger in people with poorer health status due to 
common risk factors like smoking and physical activity levels [97, 158-160]. This, 
though, needs evaluation in further studies. Dual-energy x-ray absorptiometry 
(DXA), as the current gold standard for bone density measurement, was also not 
used in this study. Although the method used for ascertainment of fractures (data 
linkage of all participants with National Health Service hospital records and death 
certification) has the advantage of ascertainment of all hospitalised fractures and 
does not rely on follow-up self reports which can be incomplete, there would be 
a potential for under-ascertainment of non-hospitalised fractures. Nevertheless, 
this method identifies the fractures with the most clinical impact. In particular, 
almost all of hip fractures are hospitalised in the UK. 
There is a well-established epidemiological relationship between smoking and 
respiratory function [160, 175] and several studies have suggested a significant 
association between smoking and fracture risk [97, 176]. In our study, the 
association between respiratory function and fracture risk appeared independent 
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of cigarette smoking habit. Though the association between respiratory function 
and fracture risk is independent of major known determinants like age, smoking, 
and bone ultrasound measures, we cannot exclude residual confounding from 
these or other unknown factors. However, the magnitude of the association 
indicates that residual or unknown confounding factors would have to be 
substantial to account for this association between respiratory function and 
fracture risk. 
This is the first population-based prospective study examining the association 
between respiratory function and bone health using both bone measurements 
(QUS method) and fracture endpoints. There is particularly a paucity of data on 
fracture risk determinants among men [177]. This study shows that the pattern of 
association between respiratory function and bone health is similar among men 
and women. These findings need replication in future prospective studies in 
different settings and different populations before being generalised and used in 
fracture risk prediction tools. If the association between FEV1 and hip fracture risk 
is confirmed, spirometry is a simple, feasible and low cost measurement that 
could be used in general practice to help in fracture risk prediction in older men 
and women. 
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The work presented in this Chapter has been published in: 
Moayyeri A. The association between physical activity and osteoporotic fractures: A review of the 
evidence and implications for future research. Annals of Epidemiology 2008 Nov;18(11):827-35 
Please see Appendix 5. 
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5.1. Abstract  
Physical activity helps maintain mobility, physical functioning, bone mineral 
density (BMD), muscle strength, balance and, therefore, may help prevent falls 
and fractures among the elderly. Meanwhile, it is theoretically possible that 
physical activity increases risk of fractures as it may increase risk of falls and has 
only a modest effect on BMD. This review aims to assess the potential causal 
association between physical activity and osteoporotic fractures from an 
epidemiological viewpoint. As the medical literature lacks direct evidence from 
randomised controlled trials (RCTs) with fracture endpoints, a meta-analysis of 13 
prospective cohort studies with hip fracture endpoint is presented. The current 
evidence base regarding the link between exercise and fracture risk determinants 
(namely, falls, BMD, and bone quality) are also summarised. Moderate to 
vigorous physical activity is associated with a hip fracture risk reduction of 45% 
(95% CI 31-56%) and 38% (95% CI 31-44%), respectively, among men and 
women. Risk of falling is suggested to be generally reduced among physically 
active people with a potential increased risk in the most active and inactive 
people. Positive effects of physical activity on BMD and bone quality are of a 
questionable magnitude for reduction of fracture risk. The complexity of 
relationship between physical activity and osteoporotic fractures points out to the 
need for RCTs to be conducted with fractures as the primary endpoint. 
 
 
80 
 
5.2. Introduction 
Risk for osteoporotic fracture is mainly determined by three factors: the risk of 
falling, bone strength, and force of impact in the event of a fall. Established risk 
factors for falls include older age, impaired balance and orthostatic hypotension, 
decreased reaction time, impaired vision and cognition, lower-extremity muscle 
weakness, decreased lean body mass, and overall impaired mobility [178-181]. 
Medications, particularly sedative and psychotropic drugs, alcohol intake, 
inappropriate footwear, and physical factors in the environment such as stairs, 
lighting, and streets have also been cited as important factors [178, 180]. Acute 
situational factors, including the force of movement, body position, location of 
impact, and protective responses during a fall also influence whether an injury 
will occur. Aside from the risk of falling, primary risk factors for osteoporotic 
fractures include low BMD, architectural deterioration of bone, older age, female 
gender, white race and lower body weight [41].  
Physical activity has been identified as a lifestyle factor that may influence the 
risk of falls and fractures among older adults. Physical activity is likely to 
influence the risk for fractures mainly through the musculoskeletal and 
neuromuscular systems and by direct influence on three main risk determinants of 
fracture (falls, bone density, and bone quality) [182, 183]. It is also important to 
consider that physical activity could increase risk for injurious falls because 
physical activities involve skeletal muscle movement that displaces the body's 
centre of gravity and balance. Not surprisingly, walking and going up and down 
stairs are the most common circumstances of non-syncopal falls, accounting for 
39% and 20% of events, respectively, among older adults [180]. However, as is 
the case with risk for sudden cardiac death, physical activity could have multiple 
long-term protective effects while simultaneously increasing acute risk for an 
event. It should be noted that hip and wrist fractures risk is thought to be 
influenced by both the tendency to fall and bone strength, while vertebral 
fractures have not been causally related to falls and may be more solely related to 
bone and muscle strength [184]. 
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Figure 5.1 shows a theoretical model of how physical activity may influence the 
risk for falls and fractures. 
 
 
 
Figure 5.1: Potential mechanisms for associations between physical activity and risk of 
falls and fractures 
 
 
 
 
In this Chapter, I aim to review the epidemiological evidence related to the 
association between physical activity and the risk of osteoporotic fractures among 
older adults. The association between physical activity and intermediate 
outcomes (namely, falls, BMD and bone quality) is summarised from review 
papers and the implications for future research are discussed from an 
epidemiological perspective.  
Physical Activity
(e.g. aerobic, resistance, 
balance, weight bearing)
Musculoskeletal Neuromuscular
Cardiorespiratory
Positive fall-related factors
↑ strength & lean muscle mass
↑ balance
↑ coordination 
↑ mobility
Negative fall-related factors
↑ acute fatigue
↑ time at risk
↑ environmental exposure (stairs, 
footwear, objects)
Bone-related factors
↑ bone mineral density
↑ bone quality
Falls
Hip & wrist fractures
Vertebral fractures
Mechanisms OutcomesRisk FactorsExposure
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5.3. Methods 
Given the enormous number of studies evaluating the effects of physical activity 
on bones, the literature search was restricted to find randomised controlled trials 
(RCTs), prospective studies and review articles on the topic. Peer-reviewed 
articles were identified in the PubMed Central using MeSH (Medical Subject 
Headings) terms “Motor Activity” and “Exercise” for the exposure and MeSH 
terms “Fractures, Bone”, “Osteoporosis”, “Bone Density”, “Densitometry, X-Ray”, 
“Accidental Falls”, and “Calcaneus ultrasonography” for primary and secondary 
endpoints. Various combinations of the search terms and a variety of limitations 
were employed to make specific searches for randomised controlled trials, 
prospective cohort studies (including nested case-control studies), and reviews. 
Searches were repeated without use of MeSH terms to find newly cited potential 
references. Reference sections of retrieved papers were also searched for 
citations. 
Studies were required to operationally define physical activity as bodily 
movement produced by skeletal muscles that results in energy expenditure [185]. 
Studies were included if they attempted to measure physical activity or exercise 
performed as part of leisure and occupation, but were excluded if they just 
evaluated participants’ ability or estimated fitness carrying out a particular 
physical activity. Other exclusion criteria were studies on younger adults (<40 
years old) and non-English articles.  
A particular attempt was made to find randomised controlled trials evaluating the 
direct association between physical activity and fractures among middle aged and 
older adults. These were trials in which physical activity was a primary 
component of the intervention and was used as a preventive strategy for fractures 
(not for treatment or rehabilitation). Protocols for the relevant RCTs were also 
searched in online databases (ClinicalTrials.gov and Cochrane Central Register of 
Controlled Trials). Despite these attempts, no RCT was found with fracture as the 
primary endpoint.  
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Out of 65 observational studies retrieved evaluating the direct association 
between physical activity and osteoporotic fractures, 21 studies fulfilled the 
inclusion criteria. A meta-analytic approach was utilised only for pooling the 
results of prospective studies with hip fracture endpoints given the concern about 
the validity and comparability of retrospective studies and the small number of 
studies with other osteoporotic fractures endpoints. Thirteen studies (out of 14 
retrieved) were entered into the meta-analysis. The study by Joakimsen et al. was 
excluded due to dissimilar classification of outcome (weight-bearing and non-
weight-bearing fractures instead of specific location of fractures) [186]. A pre-
tested data extraction form was used to derive the relative risks (RR) and 
confidence intervals for hip fracture in different levels of physical activity. When 
a study reported several RRs, the estimate judged to be the nearest to moderate or 
vigorous activity was used. Random-effects meta-analysis stratified for sex was 
performed using the metan procedure in Stata software, version 10 (Stata Inc., 
College Station, TX, USA) [187]. Weights for the included studies and estimates of 
heterogeneity were calculated and potential for publication bias was evaluated 
using funnel plots derived from the Begg-Mazumdar test [188]. Results of studies 
for intermediate outcomes (falls, BMD, bone quality) are mainly derived from 18 
review articles and meta-analysis papers.  
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5.4. Results 
5.4.1. Physical activity and hip fractures  
Numerous studies have evaluated the association between physical activity and 
bone health using different endpoints like fractures, risk of falls, and BMD. Hip 
fracture, as the most important type of osteoporotic fractures, has attracted 
considerable attention among researchers. Practically all patients with hip 
fracture seek clinical attention and this point facilitates use of hip fracture as an 
endpoint for epidemiological studies [189]. Most of the prospective studies 
evaluating the association between physical activity and hip fracture risk have 
found significant risk reductions among either men or women [41, 158, 186, 190-
200] . The NHANES I follow-up study found that women reporting moderate to 
vigorous physical activity had a 47% lower risk of hip fracture than those 
reporting no physical activity [190]. Nurses’ Health Study showed that active 
women with at least 24 metabolic equivalent (MET)–hours per week of activity 
had a 55% lower risk of hip fracture compared with sedentary women with less 
than 3 MET-hr/week [191]. Study of Osteoporotic Fractures found self-reported 
walking for exercise to be associated with a significant 30% reduction in hip 
fracture risk after 4.1 years and 40% after 7.6 years of follow-up in 
postmenopausal white women [41, 158]. Tromso study in Norway found similar 
protective effects of leisure and work physical activity on weight-bearing fracture 
sites (hip and ankle) among men but not among women [186].  
Meta-analysis of these studies (Figure 5.2) shows that moderate to vigorous 
physical activity is associated with a hip fracture risk reduction of 45% (95% CI 
31-56%) and 38% (95% CI 31-44%), respectively, among men and women. 
Studies for women comprise 79% of weight of the analysis and this is mainly due 
to underpowered studies among men and their imprecise relative risk estimates 
(as a result of lower incidence of fracture among men that demands studies with 
longer follow-ups in larger and older cohorts comparing to studies in women). 
Despite inconsistent approaches of different studies to measurement of exposure, 
their results indicate a high level of homogeneity (I2=7.4% for men and 2.5% for 
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women). Cochrane Q test for heterogeneity among studies is also non-significant 
and this confirms a relative consistency of the findings across the studies. The 
funnel plots, however, suggest a potential for publication bias given the absence 
of negative studies involving small sample sizes.  
While individual studies bear the risk of a type II error (finding no association by 
chance when there is a true association), this meta-analysis confirms that there is 
an association between physical activity and hip fracture (Figure 5.2). However, 
despite the relative consistency, magnitude of effect, biological plausibility, and 
diversity of populations across these prospective studies (some conditions of the 
Bradford Hill criteria for causation) [201], there is still a great need for 
randomised controlled trials as the observed association can be merely due to 
potential confounders. In the absence of RCTs, we have to rely on prospective 
cohort studies (a step down in the evidence hierarchy), not forgetting that 
causality cannot be proven in such observational studies. 
Health status is the most powerful confounder for the association between 
physical activity and osteoporotic fractures and it can only be treated 
appropriately by randomisation. Healthier individuals may choose to be active, 
while less healthy persons exercise less because of their illness. The causal link 
may be between the illness and fracture, and the illness and lack of exercise, not 
the fracture and lack of exercise. Conversely, persons with higher muscular 
capacity and function usually perform better in sports and are probably more 
likely to choose a physically active lifestyle. The genetically-inherited larger 
muscle mass and stronger bones may confer a lower fracture risk, not the higher 
activity level. Hence, even meta-analyses of these cohort studies cannot exclude 
the risk of confounding. In other words, the observed association may be a ‘real’, 
but confounded, association. 
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Figure 5.2: Meta-analysis of thirteen prospective studies for the association between physical activity and hip fracture. 
Study N Age 
(year)
Duration 
(year) 
Activity/Intensity Relative Risk and 95% CI
Women  
 Hoidrup et al. 2001 13,183 40-93 15 Moderate to vigorous activity
 Robbins et al. 2007 93,676 50-79 7.6 Exercise ≥12 MET-hr/week 
 Paganini-Hill et al. 1991 8,600 >70 9 Exercise >1 hr/day 
 Cummings et al. 1995 9,516 >65 4.1 Walking for exercise 
 Gregg et al. 1998 9,704 >65 7.6 Moderate to vigorous activity
 Feskanich et al. 2002 61,200 40-77 12 Exercise ≥24 MET-hr/week 
 Sorock et al. 1988 1,959 >65 4 Regular physical activity 
 Farmer et al. 1989 3,595 40-77 10 Moderate to vigorous activity
 Meyer et al. 1993 25,298 35-49 11 Intermediate work activity 
 
    
Men  
 Hoidrup et al. 2001 17,045 40-93 15 Moderate to vigorous activity
 Paganini-Hill et al. 1991 5,049 >70 9 Exercise >1 hr/day 
 Michaelsson et al. 2007 2,205 49-51 35 Exercise >3 hr/day 
 Meyer et al. 1993 27,015 35-49 11 Intermediate work activity 
 Mussolino et al. 1998 2,879 45-74 14 Moderate to vigorous activity
 Kuajala et al. 2000 3,262 >44 21 Vigorous activity 
 Sorock et al. 1988 1,151 >65 4 Regular physical activity 
 Wickham et al. 1989 1,419 >65 15 Moderate to vigorous activity
 
 
0 0.5 1 1.5
0 0.5 1 1.5
RR=0.62 (95% CI 0.56-0.69); I2=0.7%, P=0.43
RR=0.55 (95% CI 0.44-0.69); I2=7.4%, P=0.37
 87 
 
Consideration to unusual low weight of study by Meyer et al. may lead to some 
important implications for future research in this area. This study follows 52313 
participants for 11 years [194] but only accounts for about 5% of weights in the 
meta-analysis (Figure 5.2). This is mainly because of two factors. Firstly, 
participants of this study were younger comparing to other studies (35-49 years) 
and the rate of fracture among this population has to be lower (as depicted by 
observation of only 210 fractures in this case) [194]. Lower number of outcome 
events would inevitably lower the precision of estimates for any relative risk. 
Secondly, choice of the method for measurement of exposure shows its impact 
extremely in this case. They have divided physical activity to two main categories 
of “at work” and “during leisure” and classified each of them to sedentary, 
moderate, intermediate, and intense physical activity levels. This has also 
decreased their power in estimation of effects as the already low number of 
events should be divided between eight categories and one category, for instance, 
had no participants with fracture [194]. This problem is also evident, with lower 
impact, on some other studies included in the meta-analysis. 
Different reviews [202-209] point out to several case-control studies suggesting 
that hip fracture sufferers are more likely than controls to report being inactive in 
the recent past (before fracture) or earlier in their life. Reductions in the odds of 
fracture among women engaging in physical activity programs versus controls 
have typically ranged from 20 to 60% [203]. Analyses conducted among men 
have tended to find similar results but have typically lacked statistical significance 
due to smaller sample sizes [203, 206]. These findings are encouraging, but case-
control studies are inherently vulnerable to recall and detection biases and results 
can be heavily influenced by the selection of controls. Matching or adjustments 
have been used for different sets of variables in different studies and diverse 
definitions are used for the exposure [204]. Additionally, many of these studies 
depend on historical physical activity questionnaires, which have limited 
empirical testing of their reliability and validity. Of particular concern is the 
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measurement error due to recall bias attributed to fracture events. Publication 
bias related to this type of study should also be considered. 
 
 
 
5.4.2. Physical activity and other osteoporotic fracture sites 
Few epidemiologic studies have examined the association of physical activity 
with other fracture sites and the results are mainly non-significant [158, 186, 210-
216]. Two case-control studies found positive effects (non-significant) for 
vertebral fractures attributed to physical activity [210, 211]. The European 
Vertebral Osteoporosis Study (EVOS), including 6,646 women aged 50–79 years, 
of whom 884 had a vertebral deformity, showed that current walking or cycling 
for more than 30 minutes each day resulted in a 20% reduction in the risk of 
developing a vertebral deformity as compared to inactive women; there were no 
significant findings among men [216]. The prospective Study of Osteoporotic 
Fractures did not find total leisure-time physical activity or heavy chores to be 
related to vertebral fracture risk, but moderate to vigorous activity (> 2 hours/day) 
reduced the vertebral fracture risk by 33% as compared to no activity [158]. 
The situation seems to be in the opposite direction, however, for upper limb 
fractures. Two case-control studies found non-significant increased odds of wrist 
fracture associated with walking [213, 215]. Data from the Tromso study showed 
that among women, but not men, high levels of physical activity were related to a 
significant 50% increased risk of non-weight-bearing fracture sites, including the 
wrist, proximal humerus, hand, and finger [186]. The Study of Osteoporotic 
Fractures also found a nearly significant increased risk of wrist fracture associated 
with moderate to vigorous physical activity [158, 212]. Finally, among men 
enrolled in the Dubbo Osteoporosis Epidemiology Study in Australia, each 
standard deviation increase in leisure-time physical activity was associated with a 
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statistically non-significant 14% decrease in risk of any fragility fracture [214]. 
This suggests that physical activity has different impacts on different types of 
fracture and this issue needs more exploration in future studies.  
In summary, data from observational studies suggest that physical activity is 
associated with reduced hip fracture risk. This may be correct, but consistently 
replicated sampling bias and confounded association may have produced this 
observation. Evidence regarding vertebral and wrist fractures is even more 
limited. 
 
 
 
 
5.4.3. Physical activity and risk of falls 
Prospective observational studies evaluating the association of usual physical 
activity with risk of falling suggest a general decrease in risk while the most 
inactive and the most active persons may be at a higher risk (U-shaped 
association) [178, 181, 217-219]. Some studies have suggested increased risk of 
falls associated with certain types of physical activity (such as brisk walking and 
aerobics) [181, 217, 220]. All of these observations may be highly confounded by 
baseline mobility impairment of participants. Meanwhile, several randomised 
controlled trials of exercise programs to reduce falls have been reported [221-
234], of which the general results are still inconclusive. A pre-planned meta-
analysis of the studies involved in the Frailty and Injuries: Cooperative Studies of 
Intervention Techniques (FICSIT), a coordinated trial that consisted of eight 
independent studies [221, 228-230, 233, 234], showed a marginally significant 
10% reduction (RR = 0.90, 95% CI = 0.81-0.99) in falls risk associated with 
general exercise and a 17% reduction (RR = 0.83, 95% CI = 0.70-0.98) 
associated with balance training but no significant effect of endurance, resistance, 
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or flexibility training [230]. Many of other RCTs have found no significant 
differences between exercise interventions and controls, although some of these 
trials may have lacked statistical power [224-232]. This has resulted in the 
reviews of evidence concerning the role of physical activity in preventing falls to 
mainly advise for further research to be conducted in this field [203, 235-237]. 
The reasons for this inconclusiveness can be the use of different exercise 
modalities, multidisciplinary interventions in some studies [230, 233], and 
different definitions of outcome (single [219, 221, 222, 230, 234] versus multiple 
falls [225-227, 231]). 
 
 
 
 
5.4.4. Physical activity and bone characteristics 
Physical activity has direct effects on bone mineral density [238-241]. 
Randomised controlled trials suggest that exercise in elderly women prevents 
bone loss and may increase BMD by a few percentage points [207, 238, 242, 
243]. Brisk walking [220], stepping block training [244], weight-bearing training 
[226, 245], resistance training [246], and strength training [183, 247] are all 
training programs with reported benefits to the BMD of the spine. However, the 
exercise leads to a BMD benefit of questionable biological significance [41, 248, 
249]. For instance, aerobic exercise for 6-24 months, at best, stops bone loss or 
increases BMD by less than 3%, which can have little effect on the fracture risk 
[250, 251]. The results for the femoral neck are usually described as even less 
promising [220, 244]. One meta-analysis involving 230 postmenopausal women 
from six prospective randomised or non-randomised trials reported that aerobic 
activity for 8 to 24 months increased BMD in the hip by 2.4% compared to 
controls [252]. A similar meta-analytic approach for men found similar results 
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[253]. No randomised prospective study has been done to evaluate the skeletal 
effects of lifelong exercise. Observational studies suggest an association between 
lifelong and current exercise level and BMD in the elderly [211, 254]. This 
observation, however, may reflect either sampling bias or the possible long-term 
effects of exercise undertaken during growth. 
Our current knowledge of bone quality is severely limited and studies aiming to 
explore this factor are mainly restricted to quantitative ultrasound (QUS) 
measures. QUS parameters have been correlated with trabecular number and 
separation, elasticity, and the compressive strength of bone [63]. Few studies 
have shown a positive effect of leisure-time physical activity and brisk walking on 
QUS measures [255-258]. The interesting point is that non-weight-bearing 
exercises (like swimming) may have a similar positive effect on QUS measures as 
weight-bearing exercises [259, 260]. These data, however, should be interpreted 
with caution since the actual properties of QUS measures and the degree to 
which they are truly independent of BMD remains controversial [63]. 
In summary, no exercise modality has been shown in different RCTs to be 
consistently effective in reducing risk for falls. Positive effects of physical activity 
on spine and hip BMD, confirmed via several RCTs and meta-analyses, is still of a 
questionable magnitude for reduction of fracture risk. Limited evidence supports 
for a positive role of physical activity on bone quality. 
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5.5. Discussion  
A thorough search of literature on the topic did not reveal any randomised 
controlled trial specifically designed to evaluate the role of physical activity in 
reduction of fracture rates. Moreover, no protocol for such an RCT is registered in 
the U.S. National Library of Medicine registry for clinical trials (ClinicalTrials.gov) 
and the Cochrane Central Register of Controlled Trials. Obviously, the main 
factor that has prevented the research community so far from conducting an RCT 
with fracture endpoints is the enormous sample size needed for such a study. A 
sensitivity analysis for calculation of sample size indicates that even RCTs on 
high-risk populations with optimistic estimates of risk reduction need to involve 
thousands of participants.  
Table 5.1 shows the estimated sample sizes needed for various scenarios to 
conduct a 5-year trial with hip fracture as the primary endpoint. Probabilities of 
0.05 and 0.2 are considered for type I and type II errors, respectively [261]. The 
incidence rates for fractures are approximated by cumulative incidence rates 
based on estimates from a recent unpublished review. Expected rate ratios (70% 
as the initial) were optimistically derived from prospective cohort studies as there 
is no pilot RCTs on hand. This Table shows that, given the extreme low rates of 
hip fracture incidence among populations, anyone who wants to conduct an RCT 
even among high-risk individuals need to recruit a substantial number of 
participants (about 7,000 in two groups for high-risk women assuming a rate ratio 
of 75%). The task is much tougher for other low-risk groups like men. It should be 
noted that increasing these numbers by at least 20% is highly recommended to 
account for drop-outs and noncompliance (considering the long period of the 
study and the challenging intervention among elderly people). However, the 
benefits of physical activity extend beyond bone health and such a large RCT can 
be highly informative regarding different health outcomes (e.g., cardiovascular 
events, diabetes mellitus, hypertension, cognitive impairments, osteoarthritis, etc). 
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Table 5.1: Sample size estimation for randomised controlled trials of exercise in 
the prevention of hip fracture 
Rate Ratio Population  
Cumulative Incidence Rate Sample Size 
per Group Control Intervention 
0.70 European women 0.03 0.021 4812 
 Scandinavian women 0.04 0.028 3576 
 High-risk women (>65 years)  0.06 0.042 2341 
 European men 0.01 0.007 14696 
     
0.75 European women 0.03 0.0225 7129 
 Scandinavian women 0.04 0.03 5298 
 High-risk women (>65 years)  0.06 0.045 3467 
 European men 0.01 0.0075 21781 
     
0.80 European women 0.03 0.024 11452 
 Scandinavian women 0.04 0.032 8508 
 High-risk women (>65 years)  0.06 0.048 5565 
 European men 0.01 0.008 34998 
Model assumptions: 5-year trial, type I error: 0.05, type II error: 0.20, two-sided test, no drop-outs 
and 100% compliance 
 
 
 
 
Table 5.1 also shows that our assumption about rate ratio plays a very important 
role on determining the sample size needed for conducting such a study as even 
5% change in this ratio can have an immense impact on the estimated number of 
participants. Sample size of 4,812 per group for ideal intervention in European 
women will more than double to 11,542 per group with change of assumption 
from rate ratio of 70% to 80%. Clearly, the use of an aggregate endpoint (e.g., 
any fracture) could increase power by increasing event rates; however, the 
intervention may be less effective on non-hip fracture outcomes (expected rate 
ratio would be nearer to 1). 
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This review of the association between physical activity and risk of osteoporotic 
fractures suggests that a physically active lifestyle reduces the risk of hip fracture 
(based on strong evidence from observational studies). Although there is no direct 
evidence from fracture RCTs, the consistency of cohort studies and the strength of 
association (relative risk of about 60%) suggest that older adults should be 
encouraged to maintain a regularly active lifestyle. However, it is unclear 
whether physical activity is associated with the risk of osteoporotic fractures at 
sites other than the hip. Few studies have examined this issue and findings have 
been ambiguous.  
There is a big debate on the role of physical activity in prevention of falls. Given 
the U-shape association and increased risk of fall with certain types of exercise, 
the most optimistic estimates show a 10% reduction in risk of falls among the 
elderly. Whether a 10% reduction is considered important from a public health 
standpoint will depend on the burden of falls and fractures on the population, the 
financial costs of effective interventions, and whether extra benefits occur from 
these interventions. 
Exercise during adulthood produces small increments in BMD, or may prevent 
bone loss, but even if reaching a statistical significance, the increments in BMD 
are questionable in terms of reducing fracture risk in elderly persons. Given our 
restricted knowledge, comment on the impact of exercise on bone quality is more 
limited at present. The complexity of relationships between risk factors and 
fractures confirm the need for randomised trials to be done with fractures as the 
primary endpoint. Pathophysiologic reasoning may well mislead us in this 
situation [262]. RCTs would be required to ensure that this association is not 
confounded by pre-existing health status, but the sample size requirements would 
make such trials extremely costly and probably impractical. 
It should be noted that different types of exercise have different effects on various 
aspects of bone health. Exercise modalities aiming to improve risk of falls, BMD 
or bone quality may have opposing effects on the other factors and their overall 
impact on the risk of fracture may vary as it is a product of all these factors. Most 
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importantly, the current set of activities advised by practitioners mainly for 
cardiovascular benefits (e.g., for prevention of progress in hypertension or type II 
diabetes mellitus) [263, 264] may not be as ideal for the bones. Studies on 
various types of physical activity interventions could help refine the type and 
quantity of interventions necessary for optimal effects on fracture risk and to 
determine which subpopulations (e.g. institution-dwelling or home-dwelling 
older adults) will have the most to gain from structured exercise programs or 
leisure physical activities.  
Another issue that has not been considered by researchers so far is the cost 
imposed by physical activity on communities (e.g. training costs for exercise 
campaigns or the cost of additional nutritional requirements for exercisers). Cost-
effectiveness analyses as extensions to forthcoming RCTs are needed to fully 
evaluate risks and benefits of physical activity in association with osteoporotic 
fractures. 
Based on current available evidence, we cannot be convinced that there is a 
causal association between physical activity and osteoporotic fractures. The 
association might be quite similar to that of hormone replacement therapy and 
cardiovascular mortality (which was a protective factor in cohort studies and 
shown to be a risk factor in a large RCT) [265]. According to Bradford Hill 
criteria, potentially powerful confounders should be treated by experimental 
evidence [201]. The proof for causative association rests on a demonstration of a 
reduction in fractures by well-designed and well-executed, prospective, probably 
multi-centre, randomised controlled studies.  
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Chapter 6: Physical Activity  
 
 
 
 
 
 
 
 
 
 
 
The work presented in this Chapter has been published in: 
Moayyeri A, Besson H, Luben RN, Wareham NJ, Khaw KT. The association between physical 
activity in different domains of life and risk of osteoporotic fractures. Bone 2010 Sep;47(3):693-
700 
Please see Appendix 6. 
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6.1. Abstract 
A large body of epidemiological evidence suggests an inverse relationship 
between physical activity and risk of fractures. However, it is unclear how this 
association varies according to the domain of life in which the activity is 
undertaken. In this analysis of the European Prospective Investigation of Cancer- 
Norfolk study, we assessed total and domain-specific physical activity using a 
validated questionnaire (EPAQ2) in 14,903 participants (6,514 men, mean age 62 
yr) who also underwent quantitative ultrasound of the heel. After a median 
follow-up of 8 years, there were 504 fractures of which 164 were hip fractures. In 
multivariable linear regression analysis, broadband ultrasound attenuation (BUA) 
was positively associated with total and leisure time activities while showing no 
association with transportation and work activities. Home activities were 
associated with a lower BUA among younger participants. In multivariable Cox 
proportional-hazards models, moderate activities at home and in leisure time 
were associated with lower hip fracture risk among women (hazard ratios [HR] 
0.51 and 0.55, 95%CI 0.29-0.90 and 0.30-0.93, respectively). Among men, 
leisure time activities were associated with lower risk of hip fracture (HR=0.58; p 
for trend<0.001) whereas activities at home were associated with higher risk of 
any fracture (HR=1.25; p for trend=0.008). Walking for leisure or transport was 
associated with lower risk of fracture in both men and women. Multivariable 
fractional polynomial modelling showed a U-shaped association between home 
activities and fracture risk especially among women. This study suggests that 
different domains of physical activity may relate differently to fracture risk and 
these relationships may vary by age and sex.  
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6.2. Introduction 
Physical activity has been identified as a lifestyle factor that may influence the 
risk of falls and fractures among older adults. This appears to be mediated mainly 
through the musculoskeletal and neuromuscular systems by influencing three 
main risk determinants of fracture (falls, bone density, and bone quality) [182]. 
Observational studies strongly suggest that a physically active lifestyle reduces the 
risk of hip fracture (please see the meta-analysis in Chapter 5). However, it is 
unclear whether physical activity is associated with the risk of osteoporotic 
fractures at sites other than the hip [158, 186, 214, 216]. There is a debate on the 
role of physical activity in prevention of falls given the U-shaped association of 
physical activity with risk of falls, and increased risk of fall with certain types of 
exercise [178, 217, 219, 266]. Exercise during adulthood produces small 
increments in bone mineral density (BMD) [267, 268], or may prevent bone loss 
in the elderly [238, 252, 253], but any increments in BMD have questionable 
translation to reducing fracture risk in elderly people. Our current knowledge of 
the effects of physical activity on other characteristics of bone such as elasticity 
and micro-architecture (as measured by quantitative ultrasound) is also limited 
[258, 260]. 
Physical activity is undertaken in different contexts or domains: at home, during 
work, for transportation, and during leisure time (for sport or exercise). Due to the 
heterogeneity in how physical activity is assessed in different studies as well as 
the nature of the populations studied, with some being restricted to the working 
participants, our knowledge of the association between domain-specific activities 
and fractures risk is limited. This information may be important because activities 
performed in different domains of life are likely to differ between men and 
women and at different ages, which may affect the physical activity-disease 
associations. In this chapter, I aim to assess the associations between different 
domains of physical activity and bone strength (as measured by quantitative 
ultrasound of the heel) as well as fracture risk. 
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6.3. Methods 
Men and women in this study participated in the second health examination of 
EPIC-Norfolk. Full details of participant recruitment and study procedures have 
been described in Chapter 2. Briefly, between January 1998 and October 2000, 
15,515 participants completed the EPIC Physical Activity Questionnaire (EPAQ2) 
and returned for a clinical visit. EPAQ2 is a self-completed questionnaire that 
collects data on past year’s physical activity behaviours in a disaggregated way so 
that the information may be re-aggregated according to the dimension of physical 
activity of interest (please see Appendix 2 for a copy of the questionnaire). The 
questionnaire consists of four sections: activity in and around the home, during 
work, transportation to work, and recreational physical activity. With work here 
we meant being in paid employment or doing regular, organised voluntary work. 
All transportation and some domestic questions were designed specifically for this 
study, whereas the questions on occupational activity were derived from the 
Modified Tecumseh Occupational Activity Questionnaire that has been validated 
elsewhere [110]. The recreational section of the EPAQ2 was derived from the 
Minnesota Leisure Time Activity Questionnaire [111], with 30 predetermined 
sports selected according to their frequency and duration in a UK population (The 
Sports Council and The Health Education Authority, 1992) and six non-sportive 
activities, such as mowing the lawn, watering the lawn, digging, weeding, DIY 
(Do It Yourself; e.g. carpentry, home or car maintenance), and playing music, 
which are considered as activities undertaken in or around the home. Time spent 
participating in recreational activities was derived from responses to frequency 
and usual time per episode separately for each activity. The questionnaire was 
validated against an objective measure of energy expenditure (4-day heart-rate 
monitoring with individual calibration on four separate occasions over 1 year), 
and the repeatability of the questionnaire has also been demonstrated [109]. 
Intensity of physical activity in different domains was calculated by summing 
energy expenditure derived from applying published metabolic equivalent (MET) 
values to usual time spent in all activities and is expressed as MET-hours per 
week (MET.h/wk) [112].  
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Quantitative ultrasound scanning was used to measure broadband ultrasound 
attenuation (BUA; db/MHz) and speed of sound (SOS; m/s) of the calcaneus as 
described in Chapter 2. Anthropometric measures and behavioural variables 
(smoking and alcohol intake) were derived from second health examination of 
EPIC-Norfolk. Participants were followed for all health outcomes including 
fractures up to the end of March 2007 for present analyses. Fractures of skull, 
face, metacarpals, metatarsals, and phalanges were excluded from the analyses. 
Within each domain of physical activity, sex-specific quartiles of physical activity 
were computed. The associations between quartiles of physical activity in 
different domains and BUA were analysed using sex-specific linear regression 
models. Cox proportional-hazards regression was used to assess the associations 
between different levels of physical activity and prospective risk of fractures. To 
investigate the potential non-linearity of the association between physical activity 
and fracture risk, fractional polynomial modelling was used. Fractional 
polynomial modelling compares models with different combinations of linear and 
nonlinear transformations of continuous variables and selects the best fitting 
models. The method proposed by Royston and Sauerbrei [123] is a systematic 
and validated approach to investigate possible non-linear functional relationships. 
All regression models were adjusted for baseline values of age, height, body mass 
index (BMI), smoking status, and alcohol consumption. When examining the 
domain-specific association of physical activity with fractures, Cox models were 
additionally adjusted for BUA as well as the other domains of activity. Hip 
fracture was considered as a separate outcome for survival analysis. Risk 
modification by sex, age, and history of fracture as well as the interaction 
between the different domains of physical activity were tested by adding the 
respective interaction terms to the Cox models, and their significance was tested 
by the likelihood ratio statistic. All database management and statistical analyses 
were performed using Stata software, version 10.0 (StataCorp LP., College Station, 
TX, USA).   
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6.4. Results 
6.4.1. Characteristics of the study population  
After exclusion of participants with incomplete data, 14,903 were entered into 
the analysis. The mean age at baseline was 63 years among 6,514 male and 61.5 
years among 8,389 female participants. There were 504 fractures of any type in 
the study population of which 164 were hip fractures. Time to fracture from 
baseline assessment was 4.5 ± 2.2 years for all fractures and 4.7 ± 2.2 years for 
hip fractures. Average follow-up time was 7.5 ± 1.3 years. The mean physical 
activity at all domains was 114.2 ± 62 MET.h/week among men and 115.6 ± 49 
MET.h/week among women. Higher levels of physical activity at/around home 
was correlated with lower levels of leisure-time activities (Pearson correlation 
coefficient = -0.12; p<0.001), activities at work (coefficient = -0.33; p<0.001), 
and for transportation (coefficient = -0.17; p<0.001). There was no significant 
pair-wise correlation between other domains of physical activity.  
The baseline characteristics of the study population stratified by working status 
are summarised in Table 6.1. Participants not in paid employment were 11 years 
older, and 68% of all fractures (83% of hip fractures) occurred in this group. Both 
BUA and SOS were significantly higher among working participants and the 
history of fracture was twice as high in the nonworking women compared to 
working women. Among the nonworking participants, 29.4% were categorised as 
being active or moderately active compared with 72.3% in the working group. 
Differences in total physical activity between the two groups were largely 
explained by differences in occupational activity because the level of transport-
related activity was similar across all groups and the levels of home or leisure-
time activities were higher in the nonworking participants (Table 6.1).  
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Table 6.1: Baseline characteristics by working status among 14,903 participants 
of the EPIC-Norfolk study who completed EPAQ2 questionnaire 
  Women Men 
  
Working 
Participants 
n=3838 
Nonworking 
Participants 
n=4551 
Working 
Participants 
n=3313 
Nonworking 
Participants 
n=3201 
Age (yr) 55.9 (7.0) 66.4 (7.6) 57.3 (7.2) 68.9 (6.5) 
Height (cm) 162 (6.1) 160 (6.1) 175.1 (6.4) 172.7 (6.6) 
Weight (Kg) 68.6 (11.7) 68.7 (11.9) 82.2 (11.7) 80.5 (11.4) 
Body Mass Index (Kg/m2) 26.1 (4.3) 26.8 (4.4) 26.8 (3.3) 27.0 (3.3) 
Current smokers 356 (9.3%) 306 (6.8%) 285 (8.6%) 226 (7.1%) 
Alcohol intake (u/wk)* 4.9 (5.9) 4.1 (5.4) 10.5 (11.6) 9.1 (11.2) 
Physical activity (MET.h/wk)    
 All domains combined 137.6 (47.1) 97.2 (43.1) 146.1 (61.1) 80.9 (43.4) 
 At home 57.0 (26.9) 64.3 (30.6) 20.0 (15.8) 30.2 (23.8) 
 At work 46.8 (33.7) - 82.0 (53.5) - 
 For transportation 2.2 (5) 3.0 (6.6) 2.7 (7.0) 1.8 (3.7) 
 At leisure time 26.9 (24.2) 28.4 (26.6) 35.9 (29.9) 44.2 (34.9) 
History of fracture  179 (4.7%) 445 (9.8%) 175 (5.3%) 200 (6.3%) 
BUA (dB/MHz) 77.1 (15.6) 67.9 (16) 91.2 (17.2) 88.8 (17.9) 
SOS (m/s) 1637.2 (38.5) 1614.1 (38.6) 1648.4 (39.6) 1641.8 (40.1) 
Follow-up time (yr) 7.5 (1.1) 7.4 (1.5) 7.5 (1.2) 7.1 (1.8) 
Follow-up Person-years 28765 33061 24788 22879 
Any type of fracture  97 (2.5%) 263 (5.8%) 63 (1.9%) 81 (2.5%) 
Hip fracture  17 (0.4%) 105 (2.3%) 10 (0.3%) 32 (1%) 
Values are mean (standard deviation) for continuous variables and frequency (percentage) for 
categorical variables. BUA = broadband ultrasound attenuation; SOS = speed of sound 
* Values are medians (inter-quartile ranges) 
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6.4.2. Physical activity and heel ultrasound  
After adjustment for age, sex, history of fracture, BMI, smoking and alcohol 
intake, total physical activity energy expenditure was positively associated with 
BUA (linear regression coefficient 0.48, p < 0.001). Among subdomains of 
physical activity, leisure time and home activities were significantly associated 
with BUA (p<0.01) but in different directions. While higher leisure time activities 
were associated with higher levels of BUA (coefficient +0.76, p<0.001), more 
physical activity at home was associated with reduced BUA among both men and 
women (coefficient −0.42, p=0.006). These associations were observed in all 
working and nonworking men and women. Physical activity at work or for 
transportation was not associated with BUA. 
There was a significant interaction (effect modification) between age and physical 
activity at home for prediction of BUA (p=0.016). While higher amounts of 
physical activity at home were associated with a reduced BUA among younger 
participants (both men and women <65 years of age; p<0.001), there was no 
such association among older participants (p=0.2). Figure 6.1 shows the 
interaction between age and physical activity at home. Increased physical activity 
at home was associated with increased total physical activity in both age groups 
but it was associated with decrease in BUA only among younger participants. 
There was no significant interaction between sex, history of fracture, and any 
subdomain of physical activity.  
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Figure 6.1: Distribution of BUA in 4 quartiles of physical activity at or around home in 
different age groups of men and women 
* denotes significant difference at p<0.05 and ** at p<0.01. 
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In multivariable linear regression analysis, there was a significant positive 
association between stair climbing at home and BUA among both men and 
women (p<0.001; Figure 6.2). Cycling for leisure or transport was associated with 
a higher BUA only among men (P=0.021). Walking for leisure or transport was 
associated with increased BUA among both women and men but the association 
was not linear among men. Men with ≤ 90 minutes of walking per week showed 
a higher increase in BUA (average increase = 2.2 dB/MHz) compared to those 
with > 90 min/week (average increase = 1.9 dB/MHz). Swimming was associated 
with higher levels of BUA among both men (p=0.014) and women (p<0.001). 
Duration of TV viewing was significantly associated with BUA only among 
women. Women who reported higher TV watching durations had lower BUA 
(regression coefficient = -0.08, p<0.001). 
 
 
Figure 6.2: Mean of BUA in different groups of men and women based on number of 
flight of stairs climbed everyday at home or work 
* denotes significant difference at p<0.01. 
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6.4.3. Physical activity and risk of fracture  
 
Table 6.2 summarises the results of multivariable Cox regression analysis for the 
associations between different domains of physical activity and fractures in men 
and women. There was a U shaped association between total physical activity 
and risk of fracture among men. This shape of association was also observed 
between home and leisure time activities and hip fractures among women but not 
in men. Physical activity at home increased the risk of any fracture (in particular, 
clinical vertebral fractures) among men. However, leisure activities were 
associated with a linear and sizable decrease in hip fracture risk among men. 
Physical activity for transportation increased the risk of any fracture (in particular, 
wrist fractures) among men. Among working participants, there was a significant 
increase in fracture risk among moderately active women (Table 6.2).  
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Table 6.2: Associations between physical activity (PA; total and by domains) and fracture (any type and hip fracture) among 8,389 
women and 6,514 men participating in the EPIC-Norfolk study 
  Women  Men 
  Any type of fracture (360 events) Hip fracture (122 events)  Any type of fracture (144 events) Hip fracture (42 events) 
  
n HR 95% CI 
P  for 
linear 
trend 
N HR 95% CI 
P  for 
linear 
trend 
 
n HR 95% CI 
P  for 
linear 
trend 
n HR 95% CI 
P  for 
linear 
trend 
Total PA                  
 Quartile 1 136 1.00  0.237 60 1.00  0.537  40 1.00  0.062 21 1.00  0.576 
 Quartile 2 77 0.85 0.63-1.15  25 0.63 0.38-1.05   30 0.73 0.43-1.23  6 0.30 0.11-0.81  
 Quartile 3 78 1.07 0.78-1.47  21 0.86 0.50-1.48   32 1.07 0.64-1.79  8 0.66 0.27-1.58  
 Quartile 4 69 1.20 0.85-1.68  16 0.85 0.45-1.59   42 1.58 0.94-2.66  7 0.95 0.36-2.54  
PA at/around home                
 Quartile 1 100 1.00  0.306 41 1.00  0.237  24 1.00  0.008 7 1.00  0.503 
 Quartile 2 82 0.88 0.64-1.20  19 0.51 0.29-0.90   33 1.23 0.68-2.21  12 0.65 0.23-1.89  
 Quartile 3 95 0.87 0.64-1.19  33 0.61 0.35-1.04   32 1.70 0.98-2.93  9 1.01 0.40-2.57  
 Quartile 4 83 0.84 0.61-1.16  29 0.71 0.43-1.19   55 1.91 1.11-3.26  14 1.16 0.48-2.82  
PA at leisure time                 
 Quartile 1 109 1.00  0.686 45 1.00  0.914  42 1.00  0.346 17 1.00  0.001 
 Quartile 2 81 0.72 0.52-1.01  24 0.55 0.30-0.93   34 0.83 0.50-1.36  11 0.74 0.34-1.57  
 Quartile 3 80 0.88 0.64-1.22  27 0.89 0.52-1.52   37 0.93 0.57-1.51  9 0.48 0.20-1.13  
 Quartile 4 90 1.02 0.75-1.39  26 0.87 0.51-1.50   31 0.74 0.44-1.23  5 0.12 0.02-0.52  
PA for transportation                
 Quartile 1 326 1.00  0.894 119 1.00  0.097  118 1.00  0.012 39 1.00  0.721 
 Quartile 2 12 0.93 0.52-1.67  2 0.54 0.13-2.22   8 1.53 0.71-3.32  3 2.85 0.86-9.45  
 Quartile 3 9 0.83 0.41-1.69  0 - -   10 1.95 0.97-3.94  0 - -  
 Quartile 4 13 1.08 0.57-2.06  1 0.42 0.06-3.07   8 2.15 0.91-5.06  0 - -  
PA at work                 
 Quartile 1 32 1.00  0.310 7 1.00  0.560  15 1.00  0.277 3 1.00  0.123 
 Quartile 2 23 1.19 0.64-2.21  2 0.58 0.11-3.06   14 1.24 0.51-3.03  1 0.75 0.06-8.84  
 Quartile 3 28 1.98 1.07-3.64  5 1.51 0.36-6.37   16 1.36 0.55-3.35  1 1.12 0.09-14.6  
 Quartile 4 14 1.14 0.55-2.37  3 1.31 0.27-6.39   18 1.60 0.67-3.80  5 3.87 0.56-26.6  
HR = hazard ratio; CI = confidence interval; significant values at the level of p<0.05 are shown in boldface.  
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As depicted in Table 6.3, stair climbing at home was associated with a significant 
increased risk of hip fracture among men. House work activities (including 
preparing food, cooking, washing up, cleaning, shopping, caring for pre-school 
children and babies, and caring for handicapped, elderly or disabled people at 
home) were associated with lower risk of all fractures among women while 
accompanied higher risk of fractures of any type among men. Walking for leisure 
or transport for <90 min/week was associated with reduced risk of fracture (any 
type and hip fracture) among women. In combined analysis considering both 
men and women, walking for any duration was associated with reduced risk of 
fracture (any fracture HR = 0.74, 95%CI 0.58-0.93; hip fracture HR = 0.57; 
95%CI 0.37-0.87). There was no significant association between cycling, 
swimming or TV viewing and fractures among all participants (Table 6.3). 
Similarly, activities around home (including mowing the lawn, watering the lawn, 
digging, shovelling, weeding or pruning, and DIY) were not associated with 
fracture risk. 
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Table 6.3: Associations between different types of physical activity and fracture (any type and hip fracture) among 8,389 women and 
6,514 men participating in the EPIC-Norfolk study 
  Women Men 
  Any type of fracture (360 events) Hip fracture (122 events)  Any type of fracture (144 events) Hip fracture (42 events) 
  
n HR 95% CI 
P  for 
linear 
trend 
n HR 95% CI 
P  for 
linear 
trend 
 
n HR 95% CI 
P  for 
linear 
trend 
n HR 95% CI 
P  for 
linear 
trend 
Stair climbing at home                  
 None (n=5,336) 148 1.00  0. 172 43 1.00  0.843  47 1.00  0.131 5 1.00  0.009 
 < 10 stairs/day (n=6,436) 132 0.74 0.57-0.95  48 1.04 0.6-1.6   59 1.02 0.7-1.5  25 3.65 1.38-9.64  
 ≥ 10 stairs/day (n=3,131) 80 0.99 0.7-1.3  31 1.46 0.88-2.4   38 1.45 0.92-2.3  12 3.90 1.35-11.2  
Housework activity level*                  
 Low (n=4,796) 49 1.00  0.077 24 1.00  0.085  71 1.00  <0.001 23 1.00  0.608 
 Moderate (n=5,314) 132 0.58 0.40-0.85  36 0.34 0.19-0.61   52 1.76 1.18-2.60  11 0.85 0.40-1.81  
 High (n=4,793) 179 0.60 0.42-0.86  62 0.43 0.25-0.74   21 2.63 1.55-4.45  8 1.51 0.60-3.79  
Cycling for leisure/transport                  
 None (n=11,646) 320 1.00  0.846 113 1.00  0.704  106 1.00  0.101 40 1.00  0.252 
 ≤ 30 min/week (n=1,720) 19 0.67 0.4-1.12  4 0.62 0.2-1.7   17 1.24 0.7-2.26  2 0.35 0.05-2.6  
 > 30 min/week (n=1,537) 21 1.05 0.64-1.7  5 1.15 0.46-2.9   21 1.52 0.9-2.56  0 - -  
Walking for leisure/transport                  
 None (n=3,299) 115 1.00  0.115 50 1.00  0.049  46 1.00  0.123 16 1.00  0.078 
 ≤ 90 min/week (n=6,064) 125 0.71 0.5-0.94  39 0.56 0.35-0.9   55 0.82 0.5-1.27  19 1.03 0.5-2.11  
 > 90 min/week (n=5,540) 120 0.78 0.6-1.04  33 0.62 0.39-1.01   43 0.70 0.44-1.1  7 0.43 0.17-1.08  
Swimming                   
 None (n=9,783) 259 1.00  0.269 93 1.00  0.768  104 1.00  0.962 35 1.00  0.408 
 < once a week (n=2,710) 37 0.89 0.60-1.3  15 0.95 0.47-1.92   23 1.01 0.62-1.6  4 0.60 0.18-1.99  
 ≥ once a week (n=2,410) 64 1.23 0.9-1.65  14 0.92 0.51-1.67   17 0.98 0.55-1.7  3 0.70 0.21-2.32  
TV viewing                  
 < 3 hrs/day (n=8,028) 164 1.00  0.776 48 1.00  0.334  77 1.00  0.694 19 1.00  0.584 
 ≥ 3 hrs/day (n=6,875) 196 0.97 0.77-1.2  74 1.22 0.82-1.82   67 1.08 0.75-1.5  23 1.20 0.62-2.31  
HR = hazard ratio; CI = confidence interval; significant values at the level of p<0.05 are shown in boldface. 
* Low: <25 MET.h/week; Moderate: ≥ 25 & <55 MET.h/week; High: ≥ 55 MET.h/week (see text for description of housework activities) 
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Figure 6.3 depicts the associations between total and domain-specific physical 
activity and risk of hip fracture based on second-degree fractional polynomial 
modelling. Graphs show the hazard ratios (in logarithmic scale) and 95% 
confidence intervals for each level of physical activity (in units of MET.h/wk) 
compared to the mean level of physical activity in that population. Graphs for 
total physical activity show a significant risk of hip fracture among sedentary men 
and women with a sharp decrease in risk with moderate levels of physical activity 
and no further change with higher levels of activity. Home activities especially for 
women show a U-shaped association with the lowest risk among participants in 
the middle of the distribution and increased risk for participants with low and 
high levels of home activities. High levels of leisure time activities among men 
were associated with reduced risk of hip fracture (Figure 6.3). This Figure also 
shows that the absolute levels and range of physical activity in various domains 
are very different in men and women (horizontal axes). Therefore, while we can 
examine the relationship across the usual sex-specific quartiles, direct 
comparison between men and women are limited due to the different ranges of 
activity levels in different domains.   
In total, 2,623 of our participants reported practicing a high-impact exercise 
(including mountain climbing, aerobics, competitive running, tennis or 
badminton, squash, table tennis, football, rugby, hockey, cricket, rowing, 
basketball, volleyball, horse-riding, boxing, and wrestling) for at least once a 
month. None of 42 hip fractures in men and only 6 out of 122 hip fractures in 
women occurred in this population. Floor exercises (including stretching, 
bending, keeping fit, yoga, and dancing) were not associated with risk of fracture 
in our population.  
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Figure 6.3: Non-linear associations observed between physical activity and risk of hip 
fracture in EPIC-Norfolk study 
Fitted lines (solid) and 95% confidence intervals (dashed) are derived from Cox 
proportional-hazards regression analysis using fractional polynomial modelling. 
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6.5. Discussion 
This study shows that different domains of physical activity may relate differently 
to fracture risk and these relationships may vary by age and sex. Two main 
domains of physical activity associated with risk of fracture were home and 
leisure time activities. The associations observed between physical activity and 
bone ultrasound measures did not translate to fracture risk estimates as, for 
instance, physical activity at home was associated with lower heel BUA and 
lower risk of fracture among women. Multivariable fractional polynomial models 
showed a non-linear association between physical activity (especially at home 
domain) and fracture risk. There were noticeable differences in effects of physical 
activity on fracture risk between men and women.  
Total physical activity among our participants was not associated with 
prospective risk of all fractures. However, moderate physical activity was 
associated with a reduced risk of hip fracture (not significant for women but 
significant among men). Previous studies have also shown an association 
between physical activity and hip fracture but not with all fractures. Meta-analysis 
of 13 prospective cohort studies (Chapter 5) confirms that moderate-to-vigorous 
physical activity is associated with a hip fracture risk reduction of 45% (95% CI 
31-56%) and 38% (95% CI 31-44%), respectively, among men and women. It 
should be noted that most of these observational studies [190-193, 195, 197-199] 
have only considered leisure-time or recreational activities (which we have 
considered as a specific subdomain of physical activity in this study). Our results 
suggest that reduced risk of hip fracture among men is mainly mediated via 
leisure activities while this risk is reduced among women with moderate home 
and leisure time activities. 
More attention to physical activity at or around home as a risk factor for fracture 
is needed. This risk factor appears to relate differently to fracture risk among men 
and women. While moderate home activities in women are associated with a 
lower risk of hip fracture, increasing levels of home activities were linearly 
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associated with increased risk of any fracture among men. Particularly men who 
were very active at home had almost 2 times fracture risk compared to inactive 
men at home. Fractional polynomial modelling showed a U-shaped association 
with hip fracture only among women. More detailed examination of the nature of 
this relationship indicated that a major part of it is related to housework activities 
(Table 6.3). Similarly, stair climbing at home was associated with fractures 
differently in men and women. This finding needs verification in specifically 
designed studies, but there are a number of potential hypotheses for this 
observation. A possibility is that men who remain in the house are more likely to 
be frail and more fracture prone. Also, those who are less engaged in work or 
recreational activity might tend to over-report their housework activities, which 
leads to spurious observations. Other potential hypotheses include increased risk 
of falls in closed areas for men or unfamiliar environments.  
Among different types of physical activity, walking for leisure or transport showed 
a consistent association with fracture risk in our study. Previous studies have also 
confirmed the relationship between walking and BMD [248] and fracture risk [41, 
191]. In the Nurses’ Health Study among 61200 postmenopausal women 
followed for 12 years, moderate levels of walking were associated with 
substantially lower risk of hip fracture [191]. Study of Osteoporotic Fractures 
found self-reported walking for exercise to be associated with a significant 30% 
reduction in hip fracture risk after 4.1 years and 40% after 7.6 years of follow-up 
[41, 158]. European Vertebral Osteoporosis Study (EVOS) showed a 20% 
reduction in the risk of developing a vertebral deformity in women who walk for 
more than 30 minutes per day as compared to inactive women [216]. Clinical 
practice guidelines have recommended brisk walking and other weight-bearing 
exercises for prevention of fractures and treatment of osteoporosis [248, 269].  
Stair climbing has been shown to be associated with increased BMD among 
postmenopausal women [270]. We also found a positive association between 
stair climbing and ultrasound attenuation. However, this effect did not translate to 
reduced risk of fracture. This can be related to the increased risk of injurious falls 
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with stair-climbing at home [180]. TV viewing is shown to be related to less bone 
accrual in young children [271] and, in a previous analysis of the EPIC-Norfolk 
study, a significant negative association was observed in women between time 
spent watching television and heel BUA (which is confirmed in this analysis too) 
[272]. This association is not extended to the fracture risk in our population. 
Moreover, participation in high-impact exercise activities accompanied a 
significant reduction of hip fracture risk.  
Few studies have previously shown a positive effect of leisure-time physical 
activity and brisk walking on QUS measures [256, 257]. These associations are 
confirmed in this study. However, physical activity at or around home showed a 
significant association in the reverse direction which warrants consideration in 
future studies. Swimming was also associated with increased BUA as shown in 
previous studies [260] but this did not lead to lower fracture risk among 
swimmers. It should be noted that heel QUS cannot be considered a perfect 
surrogate for site-specific dual-energy X-ray absorptiometry (DXA) scans in 
prediction of osteoporotic fractures.   
Grouping of the physical activity subdomains and different activities in our study 
suggests for non-linear association of several aspects of physical activity and 
fracture risk. In particular physical activity at home and in leisure time as well as 
walking induced a decrease in fracture risk only among participants with 
moderate activity (no association with higher activity and even increased fracture 
risk with high activity at home among men). This is in concordance with previous 
studies evaluating the effects of physical activity on risk of falls among the elderly 
populations [178, 181, 217]. Attention to this point is necessary for evaluating the 
effects of different interventions and developing new strategies for prevention of 
falls and fractures [237].  
Our study has several methodological strengths, including its prospective design 
and the high proportion of individuals followed up. In addition, the population-
based sample of our study makes the results more generalisable compared with 
studies that have focused on defined groups. Limitations of this study are 
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common to most of the studies in the field. Although we have extensively 
validated EPAQ2 questionnaire in a large sample with sensible clinical measures 
[109], capability of a questionnaire to accurately estimate a multi-dimensional 
exposure like physical activity can always be questioned. EPAQ2 has not been 
specifically designed for evaluation of activities related to osteoporosis and 
fracture risk assessment. Hence, we could not evaluate the effects of weight-
bearing exercises or specific types of activities on our outcomes. The 
questionnaire has been filled once at the start of the study and the pattern and 
level of physical activity might have changed in some participants during 7.5 
years of follow-up. Physical activity at young ages may have long-lasting effects 
on bones and asking elderly participants about their activity levels in the past year 
might not be a good representation of the lifelong exposure. Another limitation of 
this study is lack of data on incident falls as a major determinant of risk of 
fractures. Other prospective studies with available data on incident falls may 
elucidate more details about the association between physical activity and 
fractures. Moreover, some of the trends of association between subdomains of 
physical activity and fracture risk have not reached to the significance level 
(especially for the hip fracture outcome) and this can be related to the limited 
power of this study to detect them. Further prospective studies or meta-analyses 
will be helpful to uncover such associations.  
In conclusion, engaging in moderate levels of home and leisure time activities are 
independently associated with reduced risk of hip fracture compared with being 
physically inactive. In contrast, physical activity at work and for transportation 
did not confer a fracture risk reduction. Walking is the activity most consistently 
associated with fracture risk reduction in both men and women. These findings 
may contribute to the recommendations about the kinds of physical activities 
which can help reduce fracture risk in older people. 
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7.1. Abstract 
Obesity has generally been associated with higher bone density and lower 
fracture risk. However, weight-related indices of obesity (such as body mass 
index) may relate differently to health endpoints from fat-related indices (such as 
body fat distribution and fat mass), as they may capture different dimensions of 
obesity and associated biological effects. We examined the association between 
percentage body fat (%BF) and prospective risk of fracture in the European 
Prospective Investigation into Cancer (EPIC)-Norfolk study. From 14,789 
participants (6,470 men) aged 42-82 years at baseline, 556 suffered a fracture 
(184 hip fractures) during 8.7 ± 0.8 years of follow-up. Risk of hip fracture 
decreased linearly with increasing %BF values among women but not among 
men. After adjustment for age, body mass index (BMI), smoking, history of 
fracture, alcohol intake and heel broadband ultrasound attenuation (BUA), the 
hazard ratio (95% CI) for a 10% higher %BF on risk of hip fracture was 0.56 
(0.39-0.79) among women and 0.92 (0.39-2.21) in men. The effect size in 
women was approximately equivalent to 5 years difference in age or 1 standard 
deviation (17 dB/MHz) higher BUA. A non-linear negative association was also 
observed between %BF and risk of ‘any type of fracture’ among women but not 
men. Percentage body fat appears to predict hip fracture risk in women 
independently of BMI and with an effect size comparable to bone heel 
ultrasound. This effect was not observed in men. Understanding differences in 
relationships between different indices of obesity (such as %BF and BMI) as well 
as sex differences may help elucidate the metabolic and other underlying 
mechanisms involved in bone health and fracture risk. 
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7.2. Introduction 
Obesity and osteoporosis are two major epidemics of the modern world. It is 
estimated that globally there are more than 1 billion overweight adults of whom 
at least 400 million are obese with the definition of body mass index (BMI) over 
30 kg/m2 [273]. National surveys have shown that, for instance, more than 22% 
of the population of UK and 30% of US citizens are obese [274, 275]. 
Osteoporosis is another major public health problem, characterized by excessive 
skeletal fragility and susceptibility to low-trauma fracture among the elderly. 
Globally between 30% and 50% of women and 13% and 30% of men will suffer 
from a fracture related to osteoporosis in their lifetime [276]. Recent studies 
suggest that there might be some relationships between obesity and osteoporosis 
at molecular and clinical levels [277]. 
Fat mass is a component of total body weight and one of the indices of obesity. 
Body fat mass and bone mineral density (BMD) are known to be under strong 
genetic regulation and the association between fat mass and fracture 
susceptibility may be plausible from a genetic point of view [278]. Several lines 
of clinical evidence support a beneficial effect of fat mass on increasing BMD, 
hence reducing the risk of osteoporosis [279-283]. In contrast, several other 
groups have suggested that excessive fat mass may not protect against 
osteoporosis [284-287]. Both groups have compelling evidence from in vitro and 
in vivo studies and several potential biological mechanisms have been proposed 
for either direction [288, 289]. These inconsistent findings reflect the inherently 
complicated nature of this relationship and call for new approaches and strategies 
to explore the potential effects of fat mass on bone [289]. 
Epidemiological studies have reported a non-linear relationship between BMI (a 
combined measure of weight and height) and risk of osteoporotic fractures [94]. 
Meta-analysis of 12 prospective studies on about 60,000 men and women 
suggested that most of the effect of BMI on non-hip fractures is probably mediated 
by the effects of weight on BMD (as adjustment for BMD removed most of the 
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observed association), but at the hip there is a component which is BMD-
independent [94]. However, it is not clear what proportion of the BMI association 
may be related to the fat component of body weight. Importantly, there is only a 
limited number of prospective studies with fracture outcomes and direct 
assessment of body fat [285, 290, 291]. Most of the previous clinical studies have 
used dual-energy X-ray absorptiometry (DXA) for assessment of both fat mass and 
bone mass. Bioelectrical impedance analysis (BIA) is another known valid 
method for evaluation of body fat in obese persons [292]. Moreover, while DXA 
only measures the density of the bone, other techniques such as bone ultrasound 
are known to reflect elasticity and micro-architecture of the bone and to predict 
fractures as effectively as DXA [77, 78]. There are limited evidence from studies 
using these bone measurements [293, 294]. In this Chapter, we assess the 
association between fat mass (as measured by BIA) and quantitative ultrasound of 
the heel and prospective risk of fracture in EPIC-Norfolk population.  
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7.3. Methods 
This study uses data from the second health examination of EPIC-Norfolk study 
and prospective follow-up from this date. Full details of participant recruitment 
and study procedures have been described in Chapter 2. Briefly, 15,786 of EPIC-
Norfolk participants returned for a second health examination and were assessed 
by several health measurements including quantitative ultrasound (QUS) of the 
heel and bioelectrical impedance analysis. Electrical resistance (Ω) was assessed 
using a standard bio-impedance technique (Bodystat, Isle of Man, UK). This 
method has previously been shown to be valid [114] and reliable [115]. Total 
body water and fat-free mass were calculated using the impedance index 
(height2/resistance), body weight and resistance according to published equations 
[116]. Fat mass was calculated as body weight minus fat-free mass. Percentage 
body fat (%BF) was fat mass expressed as percentage of total weight. 
Height and weight were measured in light clothing without shoes. Height was 
measured to the nearest millimetre using a free-standing stadiometer (CMS 
Weighing Equipment Ltd., London, UK). Weight was measured to the nearest 100 
grams using calibrated digital scales (Salter Industrial Measurement Ltd., West 
Bromwich, UK). Body mass index (BMI) was calculated as the weight in 
kilograms divided by the square of the height in meters. Quantitative ultrasound 
scanning was used to measure broadband ultrasound attenuation (BUA; db/MHz) 
and speed of sound (SOS; m/s) of the calcaneus as described in Chapter 2. Due to 
high correlation between BUA and SOS (pairwise correlation coefficient = 0.73), 
only BUA was considered as the outcome for this analysis. Smoking status and 
alcohol consumption were derived from the questionnaires. Participants were 
followed for different health outcomes including fractures up to the end of March 
2008 for present analyses. Fractures of skull, face, metacarpals, metatarsal, and 
phalanges were excluded from the analyses. 
The associations between fat and bone measures as well as fracture risk are 
suggested not to follow a linear trend. Moreover, methods like categorisation of 
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patients according to arbitrary cutpoints or percentiles have less statistical power 
to detect associations. We conducted regression analysis using fractional 
polynomial modelling to explore the association between %BF and BUA with 
and without adjustment for BMI. Fractional polynomial modelling proposed by 
Royston and Sauerbrei [123] is a systematic approach to investigate possible non-
linear functional relationships of continuous variables. This method compares 
models with different combinations of linear and nonlinear transformations of 
continuous variables (first- and second-degree transformations) and selects the 
best fitting model with backward elimination. In case of no significant difference 
between models, the model with lower degrees of freedom (linear rather than 
first- and second-degree models) will be selected as the best fitting model. Cox 
proportional-hazards regression analysis with fractional polynomial modelling 
was used to assess the associations between %BF and prospective risk of 
fractures. All regression models were adjusted for age, history of fracture, smoking 
status, and alcohol consumption. Cox models were additionally adjusted for 
BUA. Effects of %BF on BUA and fracture risks are specifically illustrated in 
models with and without adjustment for BMI. Hip fracture was considered as a 
separate outcome for survival analysis. All database management and statistical 
analyses were performed using Stata software, version 10.0 (StataCorp LP., 
College Station, TX, USA).   
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7.4. Results 
7.4.1. Characteristics of the study population 
After exclusion of participants with incomplete data, 14,789 participants were 
entered into the analysis. The mean age at baseline was 63 years among men and 
61.8 years among women. Percentage body fat (%BF) was significantly higher 
among women as compared to men (39.7±9.1% vs. 23.5±6.1%; p < 0.001). 
Comparison of baseline characteristics of participants according to quartiles of 
%BF (Table 7.1) shows that, apart from history of fracture (and age for men), other 
known risk factors of fracture were significantly different among participants with 
different levels of fat mass. As expected, there was a strong linear association 
between BMI and %BF in both men and women. Crude mean BUA generally 
increased with higher levels of fat mass among men and women (Table 7.1).  
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Table 7.1: Characteristic of EPIC-Norfolk participants according to percentage 
body fat quartiles  
  Percentage body fat  
  Quartile 1 Quartile 2 Quartile 3 Quartile 4 P 
value Women  (<34%) (34-39%) (39.5-45%) (>45%) 
  n=2,198 n= 2,116 n=1,964 n=2,041  
Age (years)  60.6 (9.7) 61.3 (9.1) 62.1 (8.7) 62.1 (8.3) <0.001 
Height (cm)  161.9 (6) 161.3 (6) 160.5 (6) 159.9 (6) <0.001 
Weight (kg)  58.6 (6.6) 65.4 (7.0) 70.9 (8.1) 80.7 (11.4) <0.001 
BMI (kg/m2)  22.3 (2.0) 25.1 (2.0) 27.5 (2.4) 31.5 (3.9) <0.001 
Current smoking  222 (10.2%) 173 (8.2%) 128 (6.6%) 139 (6.9%) 0.001 
Alcohol intake (units/wk)* 2.5 (6) 2.5 (6) 2 (5.5) 2 (4.5) 0.004 
Past history of fracture  171 (7.8%) 152 (7.2%) 133 (6.8%) 156 (7.7%) 0.6 
BUA (dB/MHz) 68.6 (17.1) 71.5 (16.3) 72.9 (15.3) 76.0 (16.1) <0.001 
SOS (m/sec)  1621.2 (43) 1624.2 (40) 1625.1 (39) 1629.2 (37) <0.001 
Incident hip fracture  53 (2.4%) 37 (1.7%) 24 (1.2%) 20 (1.0%) <0.001 
Any incident fracture  122 (5.5%) 96 (4.5%) 83 (4.2%) 92 (4.5%) 0.2 
      
Men (<20%) (20-23%) (23.5-27%) (>27%)  
  n=1,724 n= 1,572 n=1.596 n=1,578  
Age (years)  63.0 (9.5) 62.9 (8.9) 62.9 (8.9) 62.8 (8.7) 0.9 
Height (cm)  174.5 (6.8) 173.9 (6.5) 173.9 (6.4) 173.4 (6.6) <0.001 
Weight (kg)  71.5 (7.4) 78.5  (7.1) 83.9 (8.1) 92.4 (11.0) <0.001 
BMI (kg/m2)  23.5 (1.8) 25.9 (1.5) 27.7 (1.7) 30.7 (2.9) <0.001 
Current smoking  175 (10.2%) 119 (7.6%) 105 (6.6%) 115 (7.4%) <0.001 
Alcohol intake (units/wk)* 5.5 (10.5) 6 (11.5) 6.5 (12.5) 6.5 (13.5) 0.004 
Past history of fracture  94 (5.5%) 88 (5.6%) 78 (4.9%) 105 (6.7%) 0.2 
BUA (dB/MHz) 88.3 (18.5) 90.0 (17.5) 91.3 (16.9) 90.8 (16.8) <0.001 
SOS (m/sec)  1648.2 (41) 1647.5 (40) 1644.8 (39) 1640.4 (38) <0.001 
Incident hip fracture  17 (1.0%) 8 (0.5%) 10 (0.6%) 15 (1.0%) 0.3 
Any incident fracture  40 (2.3%) 36 (2.3%) 44 (2.8%) 43 (2.7%) 0.7 
Data are mean (standard deviation) or number of participants (percentage) 
* Values are median (interquartile range) [Kruskal-Wallis test for P values] 
BMI: body mass index; BUA: broadband ultrasound attenuation; SOS: speed of sound 
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7.4.2. Percentage body fat and heel ultrasound   
Figure 7.1 shows the association between %BF and BUA in multivariable-
adjusted fractional polynomial models with and without further adjustment for 
BMI. As depicted in upper left graph, %BF was positively associated with BUA 
among women which then became a negative linear association after adjustment 
for BMI (lower left graph, Figure 7.1). Before adjustment for BMI among men, 
there was a non-linear positive association between %BF and BUA with steeper 
slope among participants with low fat mass (upper right graph, Figure 7.1). 
However, this association also became negative after adjustment for BMI (lower 
right graph, Figure 7.1). Models including BMI for both sexes showed a significant 
and positive association between BMI and BUA (non-linear among men). This 
suggests that the positive association observed between %BF and BUA was 
mainly accounted for by BMI, which is highly correlated with %BF. The residual 
association between fat and bone ultrasound appeared to be negative after 
adjustment for BMI. 
 
Figure 7.1: Association between percentage body fat and heel BUA among 14,789 EPIC-
Norfolk participants  
All models are adjusted for age, history of fracture, smoking status and alcohol intake. 
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7.4.3. Percentage body fat and fracture risk 
During 122,330 person-years of follow-up, 556 fractures of any type (163 in men) 
occurred in EPIC-Norfolk participants of which 184 (50 in men) were hip 
fractures. Time to fracture from baseline assessment was 5.0 ± 2.5 years for all 
fractures and 5.4 ± 2.5 years for hip fractures. Average follow-up time was 8.3 ± 
1.6 years. Table 7.1 shows that, in univariate analysis, higher levels of fat mass 
were associated with lower risk of hip fracture among women. This association 
was also evident in the multivariable Cox proportional-hazards regression 
analysis with different levels of adjustment for clinical variables. Table 7.2 shows 
that, among women, age-adjusted %BF was significantly associated with lower 
risk of hip fracture and adding BMI to the model did not change the association. 
Further adjustment for BUA did not materially change the results (model 3 in 
Table 7.2) indicating that the relationship between fat mass and fracture risk is 
independent of bone characteristics as measured by heel ultrasound. Table 7.3 
shows the Cox model with all variables (model 4 in Table 7.2). The effects of 
10% decrease in %BF (which is approximately 1 standard deviation of %BF in 
women) on risk of hip fracture among women was almost equal to 5 years 
increase in age and 1 standard deviation (17 dB/MHz) lower BUA. BMI was not a 
significant predictor of hip fracture for women in this model. There was no 
significant association between %BF and fracture risk among men in univariate 
(Table 7.1) and multivariable analyses (Table 7.2 and Table 7.3). The best fitting 
models for both men and women were linear and Figure 7.2 depicts the linear 
decrease in hazard of hip fracture attributed to %BF among women but not men.  
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Table 7.2: Association between percentage body fat and risk of hip fracture with 
different levels of adjustment for known risk factors 
Hazard ratios (HR) and 95% CI are estimated for 10% increase in percentage 
body fat from Cox proportional-hazards regression models indicated. Details of 
model 4 are shown in Table 7.3. 
 Women Men 
 HR 95% CI P value HR 95% CI P value 
Models with adjustment for:       
1: Age  0.62 0.49-0.77 <0.001 1.00 0.61-1.62 0.9 
2: Age and BMI 0.56 0.39-0.80 0.001 0.88 0.35-2.16 0.8 
3: Age, BMI and BUA  0.55 0.38-0.78 0.001 0.92 0.39-2.20 0.8 
4: 
Age. BMI, BUA and other 
clinical factors* 
0.56 0.39-0.79 0.001 0.92 0.39-2.21 0.8 
*These clinical factors include: history of fracture, smoking status and alcohol intake 
 
 
 
 
Table 7.3: Multivariable Cox proportional-hazards regression model for 
prediction of prospective risk of hip fracture among EPIC-Norfolk participants  
Continuous variables are standardised to make sensible comparisons. 
 Women  Men 
 HR 95% CI P value  HR 95% CI P value 
Percentage body fat (per 10%) 0.56 0.39-0.79 0.001  0.92 0.39-2.21 0.8 
Body mass index (per 4 kg/m2) 1.24 0.93-1.67 0.14  1.16 0.62-2.16 0.6 
Age (per 5 years) 1.69 1.47-1.95 <0.001  1.83 1.48-2.27 <0.001 
History of fracture 1.54 0.98-2.44 0.06  1.98 0.83-4.69 0.12 
Current smoking 0.97 0.45-2.1 0.9  0.72 0.25-2.02 0.5 
Alcohol intake (unit/week) 0.95 0.91-1 0.034  1.01 0.98-1.03 0.5 
BUA (per 17 dB/MHz) 0.61 0.48-0.77 <0.001  0.63 0.47-0.86 0.003 
HR: Hazard Ratio; CI: Confidence interval; BUA: broadband ultrasound attenuation 
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Figure 7.2: Association between percentage body fat (%BF) and risk of hip fracture 
among participants of EPIC-Norfolk study 
Fitted lines (solid) and 95% confidence limits (dashed lines) are from fractional 
polynomial models with and without adjustment for body mass index (BMI) in women 
(left graphs) and men (right graphs). All models are adjusted for age, history of fracture, 
smoking status, alcohol intake and BUA. 
 
 
 
The inverse association was also observed between %BF and risk of ‘any type of 
fracture’ among women (Figure 7.3). Before adjustment for BMI the association 
appeared to be best modelled by a second-degree fractional polynomial curve 
with the lowest hazard seen around mean percentage body fat of 40% (upper left 
graph; p<0.001); after adjustment for BMI, the relationship appeared to be a first-
degree fractional polynomial with continuous but decrease in fracture risk with 
higher %BF (lower left graph, p=0.006). Table 7.4 shows the hazard ratios for 
different categories of %BF in comparison to mean fat category (35%-45%). This 
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Table shows that, while low values of %BF are accompanied with substantially 
high risk of any fracture (e.g. more than double risk for women with <20% fat 
mass compared to women with 40% fat mass), higher values of %BF are 
associated with moderately lower risk of fracture (e.g. women with >55% fat mass 
had about 20% lower risk of fracture compared to mean). Again there was no 
significant association among men (Table 7.4). 
 
 
 
Figure 7.3: Association between percentage body fat (%BF) and risk of any type of 
fracture among participants of EPIC-Norfolk study 
Fitted lines (solid) and 95% confidence limits (dashed lines) are from fractional 
polynomial models with and without adjustment for body mass index (BMI) in 
women (left graphs) and men (right graphs). All models are adjusted for age, 
history of fracture, smoking status, alcohol intake and BUA. 
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Table 7.4: Hazard Ratios (HR) and 95% CI for different levels of percentage body 
fat compared to the mean level (35-45%) among female EPIC-Norfolk participants  
The values are from a Cox proportional-hazards regression model (1st degree 
fractional polynomial) for prospective risk of any fracture adjusted for age, body 
mass index, history of fracture, smoking status, alcohol intake and heel 
broadband ultrasound attenuation.  
 
%BF Range HR 95% CI No of Women No of fractures 
<20% 2.30 1.26-4.17 38 5 
20-25% 1.57 1.14-2.18 229 23 
25-35% 1.20 1.05-1.36 2511 116 
35-45% 1.00 - 3502 157 
45-55% 0.89 0.81-0.97 1571 68 
>55% 0.81 0.69-0.94 468 24 
HR: Hazard Ratio; CI: Confidence interval 
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7.5. Discussion 
This study observed an inverse association between body fat mass and risk of 
fracture among women but not men. Similar to most previous studies, we 
observed an inverse association between fat mass and bone properties (as 
measured by heel ultrasound in our study), but this association did not translate 
into increased risk of fracture as might be expected. In fact, risk of hip fracture 
among women almost halved with each 10% increase in percentage body fat 
(Table 7.3) and a non-linear reduction in risk was also observed for any type of 
fracture. Part of the longstanding controversy in the literature about effects of fat 
on bone might be explained by these opposite relationships with bone 
measurements and fracture risk. Differences in findings in different studies may 
also reflect lack of consideration of possible sex difference and variable 
adjustment for body mass index. Moreover, our study indicates that fat and bone 
may be non-linearly related. This may also explain the variable relationship 
observed in different studies between BMI and fracture risk since BMI, which is 
not associated with fracture risk independently, may be variably related to fat 
mass in different population groups.   
Including both BMI and %BF into the same model may be questioned by some 
researchers. While both variables share the factor of weight and are correlated, 
they reflect different aspects of obesity which are of interest both aetiologically 
and clinically. For example, men and women defined as obese by BMI>30 kg/m2 
might have different contents of fat and muscle in their bodies (fatty obese vs. 
muscular obese). Body weight and BMI encompass different components 
including body organs, bone, muscle, and fat mass altogether. It is not clear that 
the associations observed between BMI and fracture risk, which is not consistent 
across different studies, is related to the effects of weight (as the big picture 
comprising all components) on bone or the effects of different components of 
weight. Including both BMI and %BF into the same regression model in our study 
showed that fracture risk is related to the fat component of weight but 
independent of weight itself. This, of course, needs sufficient statistical power to 
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have a stable model given the correlation between variables, which we achieved 
using the large number of our participants.  
We observed the protective effects of fat mass on hip and other fractures only 
among women. Although it is possible that lack of significant association among 
men in our study was due to low power for finding such association, there is no 
obvious trend towards risk increment or decrement with higher values of %BF in 
men. It is notable that the range of %BF in men was much narrower than in 
women. Previous studies have also suggested this sex-specific association 
between fat mass and BMD [283]. Hormonal differences between sexes are 
proposed as the mechanism for this effect. Oestrogen reduces osteoclast-
mediated bone resorption and stimulates osteoblast-mediated bone formation 
[295]. After secretion of oestrogen from ovaries ceases in post-menopausal 
women, extragonadal oestrogen synthesis in fat tissue (mediated by the enzyme 
aromatase) [296] becomes the dominant oestrogen source and this may lead to 
the protective effects of fat mass on bone in post-menopausal women. Androgen-
deficiency resulted from hypogonadism contributes to bone loss in 20-30% of 
elderly men, but this association is not affected by the body fat mass in men 
[297]. 
Several other mechanisms have been proposed for how fat mass may relate to 
bone characteristics: these mechanisms may act in both positive and negative 
directions with respect to bone health. The interplay between these processes in 
each individual might ultimately determine net beneficial or detrimental effects of 
fat mass on bone health. Two mechanical explanations for the effect of fat mass 
on bone are the cushioning effects of fat pads on bony areas, such as the hip 
[298], and increased bone strength in response to the greater mechanical loading 
imposed by higher body mass [287]. Meanwhile, adipose tissue is known not to 
be just an inert organ for energy storage [288]. It expresses and secrets a wide 
variety of biologically active molecules such as oestrogen, leptin [299, 300], 
adiponectin [299, 301], resistin [302], and interleukin-6 [303]. The secretion of 
these hormones as well as bone-active hormones from the pancreas (including 
132 
 
insulin, amylin, and preptin) [304-306] may contribute to the complex 
relationship between fat mass and bone. Moreover, adipocytes and osteoblasts 
both originate from a common progenitor, the pluripotential mesenchymal stem 
cell. These stem cells display an equal propensity for differentiation into 
adipocytes or osteoblasts, and the balance of the differentiation is regulated by 
several interacting pathways that may contribute to the final effect of fat mass on 
bone [289]. 
An important finding of our study is that fat mass is a protective factor against hip 
fracture independently of bone density measured using heel QUS. Most cross-
sectional studies assessing the relationship between fat and bone have used hip or 
lumbar DXA with inconsistent findings [279-287]. Few studies have also used 
heel ultrasound for bone assessment. Kroke et al. [294] used a skinfold thickness 
method to estimate fat and lean mass and reported a significant association with 
heel BUA among pre- and post-menopausal women. Assantachai et al. [293] also 
reported a significant negative association in categorical analysis for BUA. All 
these studies have used bone measures (either DXA or QUS) to estimate the 
potential impact on fracture risk. However, our results indicate that the 
relationship between fat mass and prospective fracture risk is largely independent 
of bone measurements. In models for prediction of fracture using %BF further 
adjustment for heel QUS did not materially changed the association (Table 7.2). 
This suggests that simple extrapolation of the relationship between fat mass and 
bone density to estimate fracture risk is unlikely to be satisfactory. In other words, 
a single cross-sectional bone measurement (either QUS or DXA) may not 
represent bone health in the complicated relationship with fat mass and future 
studies have to use prospective designs with fracture outcomes. 
We explored non-linear associations in our study and observed an interesting 
shape of association between %BF and risk of ‘any type of fracture’. Fractional 
polynomial modelling is an easy and widely-available method from an array of 
statistical methods recently developed for investigating non-linear associations. 
Use of this or similar methods (e.g. regression splines) merit a greater role in 
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epidemiology and future population-based studies evaluating the association 
between fat and bone health may wish to consider them. Selection of the factors 
to adjust in multivariable models may also have a significant impact on the final 
models observed in these studies as, for instance, adjustment for BMI substantially 
influenced the nature of the association in our study. Whether or not BMI is taken 
into account may explain some of the inconsistent results for fat mass reported 
from different studies in the literature [287]. 
Our study has several methodological strengths, including its prospective design 
and population-based sample that makes our results more generalisable. A 
potential limitation of this study is low power to detect associations especially for 
hip fracture and among men. Although there was virtually complete follow up of 
the cohort using routine record linkage with national hospitalisation data, only 
fractures that needed admission to hospitals were ascertained for this study. This 
might have resulted in underestimation of the rate of fracture in our population. 
However, hospitalised fractures are arguably the ones with the most clinical 
impact. We were also not able to exclude fractures due to high trauma such as 
car accidents; however, it is very hard to distinguish between osteoporotic and 
non-osteoporotic fractures among the elderly involved in an accident and some 
researchers recommend considering all fractures in this population as 
osteoporotic.  
In conclusion, our study indicates that higher body fat mass is associated with 
lower risk of fracture among women but not in men. This relationship appeared 
to be independent of body mass index, and also of bone characteristics as 
measured by heel ultrasound. Clarifying the nature of this relationship may help 
us to understand the different mechanisms involved in fracture risk which can 
inform preventive strategies in the future.   
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Chapter 8: Importance and Applications of 
Absolute Fracture Risk 
 
 
 
 
 
 
 
 
 
 
The work presented in this Chapter has been published in: 
Moayyeri A. The importance and applications of absolute fracture risk estimation in clinical 
practice and research. Bone 2009 Aug;45(2):154-7 
Please see Appendix 7. 
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8.1. Introduction  
Currently we are facing a universal shift towards use of absolute fracture risk 
estimation in the field of osteoporosis research and clinical practice guidelines. 
Recent attempts by the “World Health Organisation Scientific Group for 
assessment of osteoporosis at the primary health care level” have resulted in a 
clinical tool for estimation of 10-year absolute risk of fracture in different 
populations [24, 162]. This online tool, namely FRAX®, aims to shift the previous 
clinical practice (which was mainly based on defining osteoporosis using a single 
bone density assessment) to a more clinically relevant practice, which combines 
information gained from clinical risk factors and bone mineral density (BMD) 
measurement to an estimate of absolute fracture risk and categorises patients 
using this measure. The field is open now to medical researchers working on 
osteoporosis assessment and diagnosis who can either try to estimate and validate 
10-year absolute risk figures in their populations (using various epidemiological 
study designs and biostatistical approaches) or try to calculate country-specific 
risk thresholds for patient categorisation (using principles of health economics 
and mathematical modelling). Clinicians also need to familiarise themselves with 
the concept and try to utilise the upcoming results in their clinical practice. 
10-year absolute risk of fracture is an easily understood measure for most 
clinicians and patients as it is a direct assessment of the main clinical event at 
which preventive interventions are aimed. This measure may lie somewhere 
between about 0-5% for young healthy men and women without fracture risk 
factors and up to about 50-80% for older women with established osteoporosis. 
Unlike traditional classification of patients for osteoporosis which only considers 
BMD testing results, absolute risk charts (like the ones produced by the FRAX® 
team) can take into account other clinical risk factors known to influence risk of 
osteoporotic fractures (such as age, sex, past or parental history of fracture, body 
mass index, smoking, alcohol consumption, medications and comorbidities) 
[307]. These values can be measured for populations with different characteristics 
(sex, age, ethnicity, etc). Conventional statistical models such as Poisson or Cox 
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regression (available via most of statistical packages) or other mathematical 
modelling approaches have been shown to be efficient tools for pulling together 
all the available and relevant information for prediction of 10-year absolute risks 
of fracture [51, 102, 308-310]. Thresholds for categorisation of patients using 
absolute risk measures may well differ in different countries taking into account 
cost-effectiveness and affordability of different drug regimens and competing 
health priorities.   
Although the main idea behind absolute risk estimation approach is more 
systematic management of patients with the use of derived estimates, the value of 
this approach in clinical practice and research is by no means restricted to this 
subject. As part of this thesis, I have worked on estimation of 10-year absolute risk 
of fracture for EPIC-Norfolk participants. Please see Chapter 9 for detailed 
methods and Chapters 10 and 11 for specific applications of the models. With 
reference to some of these results, in this Chapter I will review a number of the 
new applications for and opportunities created by absolute risk measures from an 
epidemiological perspective. 
 
 137 
 
8.2. Introducing new risk factors 
There is a critical distinction in epidemiology between an ‘associated factor’ and 
a ‘risk factor’. In the osteoporosis literature, there are numerous factors suggested 
to be associated with the disease (as determined by BMD testing) or osteoporotic 
fractures and the number of these factors (including biochemical variables, 
lifestyle factors, anthropometrical or structural characteristics of bone, etc) is 
increasing. Some of these observed associations are perceived to be etiologically 
linked with fractures (presumably due to a biological background). However, 
when assessed in an epidemiological framework, any association, even an 
etiologic one, should satisfy certain criteria to be accepted as an independent 
‘risk factor’ [201]. The main principles are persistence of the association after 
adjustment for other known risk factors as well as increase in our predictive 
power for the outcome by adding the ‘new’ risk factor to our set of risk factors. 
While the first principle is usually taken into account with the use of a 
multivariable regression analysis, the second principle (increase in the predictive 
power) is generally neglected. Use of absolute fracture risks can help researchers 
with this issue. 
This topic is of vital importance especially for introducing new techniques into 
clinical practice for assessment of osteoporosis. All the new radiological 
techniques or biochemical assays need to demonstrate that they add some useful 
information to the current practice of BMD testing using DXA assessment. In other 
words, they can predict fractures independently from BMD. We have examined 
this for quantitative ultrasound (QUS) measurement in the EPIC-Norfolk study. 
Please see Chapter 11 for details. In summary, two models were constructed for 
prediction of fractures. One model only used BMD measures and the other used 
both BMD and QUS measures. After calculation of 10-year absolute risk of 
fracture using each of these models, participants were categorised into three 
groups of low-, intermediate-, and high-risk. Groupings based on two models 
were then compared. Figure 11.1 shows that, while most of participants were 
categorised into the same risk groups using both models, there was a 
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considerable amount of discordance between the results of two models. About 
17% of total participants were reclassified to other categories using the model 
including QUS measure. Comparison of the predicted risks and observed risks 
further revealed that the predicted values using the model including both BMD 
and QUS measures were more accurate. Therefore, we were able to confirm that 
BUA adds useful information to our predictive power. 
The method described above can be extended for direct comparison of known 
risk factors (e.g. can we use BUA in place of BMD for fracture prediction?) or use 
of surrogate markers (e.g. can we use magnetic resonance imaging [MRI] in place 
of bone biopsy for the assessment of bone quality?). Statistical methodology 
supporting the use of absolute risk categorisation is progressing fast and we are 
now able to compare predictive power of models with different sets of risk 
factors. Conventional methods such as sensitivity/specificity and receiver 
operating characteristics (ROC) curves have proved to be incompetent for 
comparison of discriminative power of models introducing new variables to pre-
defined sets of risk factors [311]. Pepe et al. [312] have shown the statistical 
privileges of an absolute risk-derived curve (named as ‘predictiveness curve’). 
This method increases our power for comparison of two risk factors inside a set of 
fixed risk factors and needs to be considered more in osteoporosis research. 
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8.3. Distributions of fracture risk 
Having estimated a 10-year probability of fracture for all participants in a 
prospective study, researchers would be able to look at the distribution of the risk 
in the populations from different aspects. Careful inspection of the risk scattering 
in different sub-populations and comparison of risk estimates at different levels of 
known risk factors would help in acquisition of better understanding of the 
exposure-outcome relationships. We know that different risk factors may interact 
with each other in predicting risk of fractures among individuals. The term 
interaction (or effect modification) in epidemiology describes a situation in which 
two or more risk factors modify the effect of each other with regard to the 
occurrence or level of a given outcome [313]. Although these interactions are 
usually identified using the incidence rates of outcome in different levels of 
exposures (to estimate attributable risk or relative risk models), distribution of 
absolute risks at different levels of exposure can provide better alternative to this 
method as it provides multivariate-adjusted estimates for comparison. 
Figure 8.1 shows an example of interaction observed between age and sex for 
prediction of 10-year absolute risk of fracture among EPIC-Norfolk participants. 
The effect of age on fracture risk is modified by different handling of sex in the 
multivariable Cox proportional-hazard models. In the pooled sex-stratified 
analysis, in which men and women both entered into the same model, 10-year 
probability of fracture showed a greater proportional increase among men (from 
0.6% to 4.4%) and less among women (from 1.2% to 9.5%) in different age 
groups. However, when estimates were based on two different models for men 
and women, the increase in fracture risk was steeper among women (from 0.9% 
to 11%) compared with men (from 1.1% to 3.1%). This shows that the association 
between age and fracture risk is not identical in different genders. Alongside the 
biological implications of these sorts of findings, they would be of great 
importance for the field of risk assessment since generalisation of risk estimates at 
one level of a contributory variable to other levels would not be justified 
anymore.  
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Figure 8.1: 10-year absolute risk of fracture based on sex-specific and pooled (sex-
stratified) models in EPIC-Norfolk study  
 
 
An important point is that, while because of limited data researchers may derive 
absolute risks for a particular population (e.g., women at age 70 years) and then 
estimate the absolute risks for other groups (e.g., men at age 60 years) based on 
the relative risks observed in other studies, these assumptions do not necessarily 
hold. Therefore, we need more directly observed estimates of absolute risk from 
real data on populations. This is the rationale for conducting studies in different 
populations in different countries, and different age and sex groups rather than 
assuming that the absolute risk estimates derived from a particular population can 
be modelled appropriately for other populations.  
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8.4. Public health perspective  
Attention to the risk distributions can also help public health agencies consider 
other aspects of disease burden for estimation of appropriate thresholds. The 
impact of a health program to prevent fractures in the next 10 years is obviously 
linked to the risk distribution in the target population. Figure 8.2 presents this 
distribution for women of different ages in the EPIC-Norfolk study. In this figure, 
percentiles of 10-year absolute risk (derived from sex-specific proportional-
hazards model with adjustment for all known confounders) have been estimated 
for women in different age groups. Inspection of both horizontal and vertical axes 
can provide useful information for economic analysis in order to inform choice of 
risk thresholds. For instance, a reference line on the horizontal axis marks the 
absolute risk cut points to identify 5% of women with the highest risk of fracture 
in each age group (these cut points go up from 1.6% in women aged 40-49 years 
to 15.7% in women aged 70-79 years).  
 
Figure 8.2: Age-specific distribution of 10-year absolute risk of fracture among 14,032 
female participants of the EPIC-Norfolk study 
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The usual question of ‘at what absolute risk should patients (of a particular group) 
be treated?’ could be replaced with ‘what is the absolute risk level if we choose to 
treat a certain fraction of high-risk population (in a particular group)?’ For 
instance, health economic studies may suggest that we can only afford to treat 
20% of highest-risk women in East Anglia. EPIC-Norfolk study suggests that the 
10-year absolute fracture risk corresponding to this number for the whole 
population of women is about 5%. Figure 8.2 shows that none of women in the 
40-49 year age group and almost all of the women in 70-79 years would be 
eligible for treatment in this case. About 2% of women aged 50-59 years and 
35% of women aged 60-69 years would also be eligible for treatment. This type 
of questioning is more relevant to national health authorities as they would need 
a better idea of the impact and potential economic burden of disease outcomes 
(here fractures) on the community. Presentations like Figure 8.2 can also be 
extended to show fracture risk in sub-populations with certain characteristics 
(such as those with history of fracture or corticosteroid therapy). 
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8.5. Absolute risk versus relative risk 
It is generally accepted that we need to base our clinical actions on absolute risks 
rather than relative risks (RRs) [314, 315]. We do not treat patients on the basis 
that they are, for instance, at two fold increased risk of fracture comparing to 
some other patients. Nevertheless, RR estimates are needed to evaluate the 
relative importance of different risk factors in inducing future fractures. The 
problem arises, however, when we want to derive absolute risk estimates from 
RRs. 
The association between fracture risk and known risk factors like age and BMD is 
commonly expressed in multiplicative measures. RRs of fracture per 5 years 
increase in age or per 1 standard deviation fall in BMD are typical values 
reported in the osteoporosis literature. However, this practice assumes that risk 
increases multiplicatively with advance in age or fall in BMD, which has been 
shown to be incorrect [315]. Nordin and colleagues [316] showed that it is 
misleading to express the effect of BMD or any other variable on fracture risk in 
terms of a simple multiplicative factor. Johnell et al. [46] also showed that RR for 
1 SD change in BMD ranged from 1.8 (1.4-2.2) in Z-score of -4 to 1.2 (1.0-1.4) in 
Z-score of +4. Moreover, translating these RR measures to absolute risk would be 
more problematic considering the potential interactions between different risk 
factors (as discussed above). For instance, Figure 1.6 shows the range of RRs for 
previous history of fracture across age groups. Hence, estimates of absolute 
fracture risk directly calculated from prospective studies (and not from RR 
estimates from different sources) are more accurate and reliable.  
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8.6. Comparison of drug efficacy 
Despite the new advances in the field of methodology and reporting of clinical 
trials, there are still several difficulties for application of efficacy measures derived 
from these studies into clinical practice. Traditionally, relative risk reduction 
(RRR) is the main measure of efficacy reported in clinical trials. Most of the 
clinical trials now also report absolute risk reduction (ARR) and most clinicians 
are searching for number needed to treat (NNT; which is the reciprocal of ARR) 
[317] in their quick glances over trial results. However, it is still unclear which of 
these measures should be generalised to other patient groups as the current 
practice still lacks the necessary attention to the absolute risk distribution in the 
start of the studies.  
Clinical trials for new drugs in the field of osteoporosis usually recruit their 
participants from high-risk populations. Given the obvious constraints from 
funding sources and considering the overall low incidence of outcomes, trials 
need to select these populations to reach their results in a shorter timeline. Thus, 
most trials recruit only women of older ages (usually >65 years old) with history 
of fracture (clinical or sub-clinical vertebral fractures) or diagnosed osteoporosis 
(using DXA assessment). Based on these characteristics, most of these participants 
would have a 10-year fracture probability of more than 20% or 30% [162]. 
However, we need to generalise the results of these studies to people with lower 
absolute fracture risk in order to define thresholds for cost-effective treatment 
initiation. There can be two main assumptions for this generalisation; one is 
assumption of similarity of RRR and the other is assumption of similarity of ARR 
(or NNT) across risk distribution. While the first assumption is more backed up by 
the practitioners in the field, both of these assumptions might be far from reality 
and can be misleading for calculation of risk thresholds. 
Suppose a drug has been studied in people with 10-year absolute fracture risk of 
20% and shown to reduce the risk by 5% (ARR=5% so NNT=20). The RRR would 
be 1 - (15% / 20%) = 25% in this case. The solid line in Figure 8.3 shows the 
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distribution of 10-year absolute risk of fracture in a hypothetical population 
without treatment. This can be considered risk of a major osteoporotic fracture in 
a relatively young population (50-55 years old) as more than half of population 
has a 10-year risk of ≤5%. The dashed and dotted lines show the distribution of 
risk after treatment with the drug assuming a fixed RRR and a fixed ARR, 
respectively. Figure 8.3 shows that, although the risk distributions attributed to 
any of these assumptions are very similar in a high-risk population, there would 
be a considerable difference in the number of low-risk people who would 
presumably benefit from this drug. For instance, about 65% of the population 
would be considered as reaching 10-year absolute risk of ≤5% after treatment 
given a fixed RRR assumption but this number would be 80% for fixed ARR 
assumption. This difference could have an immense impact on the cost-
effectiveness of the drug.  
 
 
Figure 8.3: Effects of different assumptions for generalisation of drug efficacy measures to 
populations with lower risk of fracture  
The solid line represents risk distribution in a hypothetical population. Each of other lines 
represents a scenario for the change in the risk distribution after treating all the 
population with a particular drug. 
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There are arguments for and against both of these assumptions but it seems that 
both can be misleading for generalisation of the observed drug effect to other risk 
bands. Fixed ARR assumption is obviously implausible for low-risk populations 
since some people would reach an absolute risk of null, which means complete 
prevention of fractures in the next 10-years [318]. Fixed RRR assumption can also 
be turned down with some biological reasoning. For instance, if a drug increases 
femoral neck BMD by 0.01 g/cm2 (equal to 1.5% of baseline BMD) in a study of 
high-risk patients, which of these numbers should be generalised to low-risk 
population (absolute number or percentage)? Moreover, what would be the effect 
of assumed change in BMD on fracture risk in this low-risk group? It should be 
noted that different biological pathways may have different impacts on different 
patient groups and the drugs usually affect only one pathway. Recently, Johnell et 
al. [46] in a meta-analysis on large prospective studies, showed that the risk 
gradient (relative risk per SD decrease in femoral neck BMD) for hip fracture 
decreases from around 3.7 at age 50 to around 1.9 at age 85. In the example 
above, if the high-risk study patients are very old post-menopausal women, the 
impact of BMD change on fracture risk might be lower (presumably as a result of 
increased risk of falls in this population) [319]. If we want to generalise the results 
to women of age 50-55 years, this much BMD change (either 0.01 g/cm2 or 
1.5%) would have more impact on fracture risk as the role of BMD on fractures 
would be more prominent in this age group.  
This argument supports the idea that clinical trials need to report explicit 
measures of absolute fracture risk in their recruited populations [320]. This will 
help clinicians using the FRAX® or other tools assess the generalisability of the 
results of a clinical trial to a particular patient. Moreover, it would be ideal if 
researchers consider empowering their studies for further sub-group analysis of 
the results in different categories of absolute risk. This would enable us to explore 
the association between effect size of the drugs and baseline risk of populations 
and to find more accurate measures for generalisation of the results to lower risk 
populations. 
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8.7. Conclusion  
Different measures of risk (relative risk and absolute risk) may be used for different 
purposes but they do not always give the same answer. While the conventional 
practice is based on relative risks for estimation of exposure effects or drug 
efficacies, absolute risk measures are needed for clinical practice (individual-
level) and public health policy-making (population-level). After recent launch of 
FRAX®, the clinical practice in the field of osteoporosis will be shifting towards 
more use of absolute risks. Research bodies also need to consider this factor more 
in their practice. This is particularly important for estimation of distribution of 
fracture risks in different populations and economic risk-benefit analyses to find 
intervention thresholds.  
In this Chapter, I discussed about several drawbacks of relative risks that support 
more attention to absolute risk measures as the surrogate. Generalisation of 
relative risk of fractures for different risk factors might be misleading given the 
interaction between different risk factors. Relative risk reductions derived from 
RCTs may not be generalisable to other populations given the impact of baseline 
fracture risks and the effects of competing factors not affected by the treatment. 
Absolute risks, on the other hand, may bring new opportunities for introduction of 
new ‘risk factors’ as well as for risk categorisation from a public health 
perspective. All of these arguments suggest that researchers working on diagnosis 
and prevention of osteoporotic fractures need to be more explicit about the 
distribution of absolute fracture risk in their study populations. In the next 
Chapter, I present the results of my work for estimation of absolute risk of fracture 
in EPIC-Norfolk study.  
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The work presented in this Chapter has been published in: 
Moayyeri A, Kaptoge S, Luben RN, Wareham NJ, Bingham S, Reeve J, Khaw KT. Estimation of 
absolute fracture risk among middle-aged and older men and women: the EPIC-Norfolk 
population cohort study. European Journal of Epidemiology 2009;24(5):259-66 
Please see Appendix 8. 
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9.1. Abstract  
While estimates of relative risks associated with risk factors such as age and bone 
mineral density (BMD) may be of interest for etiologic and comparative purposes, 
clinical questions such as who might benefit most from preventive interventions 
or BMD monitoring depend on estimates of absolute fracture risk. In this study of 
the original cohort of EPIC-Norfolk cohort including 25,311 participants (11,476 
men) aged 40-79 years in 1993-1997, 10-year absolute risk of fracture in men 
and women were calculated using the baseline survivor function in multivariable 
Cox proportional-hazards models adjusting for age, sex, history of fractures, body 
mass index, smoking, and alcohol intake. In comparison of those without history 
of fracture vs. those with history of fracture, the 10-year absolute risk of any 
fracture in men ranged from 1.0% vs. 1.2% at age 40 years to 3.0% vs. 4.4% at 
age 75 years. The respective estimates in women ranged from 0.7% vs. 1.0% at 
age 40 years to 9.3% vs. 17.2% at age 75 years. Statistically significant 
interaction between age and sex was found (p < 0.001), which contributed to the 
differences in predicted absolute fracture risks for men and women at different 
ages. Our study shows the need for population-specific data to develop efficient 
well calibrated algorithms for assessment of fracture risk. The interaction observed 
between sex and age points to the need for further prospective studies among 
men. 
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9.2. Introduction 
There is an emerging consensus that, besides estimating relative risks associated 
with risk factors for osteoporotic fractures, we also need to express fracture risk 
using absolute risk estimation [51, 55, 315, 321]. While estimates of relative risks 
associated with risk factors such as age and bone mineral density (BMD) may be 
of interest for etiologic and comparative purposes, absolute fracture risk is more 
relevant for deciding which patients are at the highest priority for preventive 
interventions. FRAX®, a newly developed fracture risk assessment tool by the 
World Health Organization (WHO) Scientific Group, has recently become 
available to help clinicians in their decision-making for middle-aged and older 
patients [24, 162]. This tool gives estimates of 10-year probability of major 
osteoporotic and hip fractures using clinical risk factors and BMD measurements 
in men and women from nine different countries. 
Absolute risks of fracture will enable both researchers and clinicians to obtain a 
better idea about the distribution and magnitude of risk in different age and sex 
groups. Given the recent methodological advances in the field of epidemiology of 
osteoporosis and biostatistical modelling, more population-specific estimates of 
10-year probability of fracture are expected soon to be available for clinical 
practice in different countries. Moreover, the estimates of absolute risk of fracture 
might be highly variable within as well as between countries given the extent of 
variation in fracture incidence among the elderly in different parts of the world 
[29, 322, 323]. In the United Kingdom, for instance, uniformly lower rates of hip 
fracture have been reported in parts of East Anglia compared to other parts of 
England and Wales [324]. In this Chapter, I report the estimates of absolute 
fracture risk from EPIC-Norfolk study. 
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9.3. Methods  
The detailed design and procedures for EPIC-Norfolk study have been described 
in Chapter 2. In this study, 25,639 participants of the baseline health examination 
(1993-1997) were considered. Anthropometric measures (height, weight, and 
BMI), smoking status, and alcohol consumption assessed in this health 
examination were used as fracture risk factors. International Classification of 
Diseases (ICD) 9 and 10 diagnostic codes were used to ascertain fractures by site 
occurring in the cohort up to the end of March 2007, an average of 11.3 years 
(SD=1.5; range 9.2-14.1). 
Multivariable Cox proportional-hazard regression models [325] were used to 
model the association between incident fractures and age, history of fracture, 
BMI, smoking status, and alcohol intake in both genders. Although likelihood 
ratio tests and global measures of model fit (Bayesian and Akaike's information 
criteria) showed that BMI and smoking were not associated with fracture risk in 
our population, we preferred to keep them in the final models in order to make 
our models comparable to the clinical risk profile of FRAX® and other studies in 
the field. Cox models with up to second-degree fractional polynomial terms [326] 
for age were used to assess potential deviations from the expected log-linear 
shape of association between age and fracture risk, for which no significant 
deviations from linear association were found in both men and women. 
Discriminative ability of the models was evaluated using Harrell’s C index [327], 
a concordance measure for survival data analogous to the area under a receiver 
operating characteristic (ROC) curve that takes into account censored 
observations over time in its calculation. The C-index corresponds to the 
probability that for a randomly selected pair of subjects, of whom at least one is 
observed to suffer a fracture, the person who fractures first has higher predicted 
absolute risk of fracture than the other [327]. Departure from the proportional 
hazards assumption was evaluated by tests based on scaled Schoenfeld residuals 
for each covariate. 
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10-year and 5-year absolute risk of fractures for any participant were calculated 
using the baseline survivor function and the estimated log hazard ratios for the 
variables in each model. In general, the Cox regression model for the hazard of 
fracture at time t after baseline given k explanatory variables X1, X2, ...., Xk 
included in the model is of the form:  
 
h(t | X1, X2, .., Xk) = h0(t) × exp(b1X1 + b2X2 + ... + bkXk) 
 
where h0(t) is the baseline hazard at time t and b1, b2, ..., bk are the log hazard 
ratios for the k explanatory variables. h0(t) represents the instantaneous rate of 
failure expected at time t for a person with zero values of all covariates and the 
cumulative baseline hazard H0(t) at time t is obtained by integrating h0(t). The 
baseline survival at time t, i.e. Pr(T > t), is then given by: 
 
S0(t) = exp(- H0(t)) 
 
and the survival for a person with covariate values X1, X2, ..., Xk is obtained as 
S0(t) ^ exp(b1X1 + b2X2 + ... + bkXk). Hence, our 10 year risk of fracture was 
calculated as: 
 
Pr(T ≤ 10) = 1 - S0(10) ^ exp(b1X1 + b2X2 + ... + bkXk). 
 
Values for absolute risks of fracture in men and women at different ages and with 
or without a history of fracture were calculated and tabulated. We used a split-
sample approach for internal validation of our models by designating a randomly 
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sampled 75% of the participants (10,376 women and 8,607 men) to a derivation 
set and the remaining 25% (3,459 women and 2,869 men) to a validation set. 
Sex-specific Cox models were developed in the derivation set and the results 
were applied to the validation set. Predicted 10-year probabilities of fracture 
based on these models were compared with the observed risk of fracture in the 
validation set using the Hosmer-Lemeshow goodness-of-fit test [328]. This test 
works by partitioning the observations into 10 equal sized groups (deciles) 
according to their predicted probabilities. Then a test statistic is calculated for 
each group of observations based on comparison of the observed and predicted 
risks. Sum of this statistic follows a chi-squared distribution (with 10 degrees of 
freedom) and a non-significant p value for this test shows the absence of evidence 
for disparity of observed and estimated probabilities.  
We used sex-specific models because the risk profiles in men and women are not 
similar and gender would not suffice the assumption of proportional hazard to be 
entered into the models as a simple variable. However, since it is widely claimed 
that the risks associated with different clinical risk factors are similar among men 
and women, a sex-stratified model was also used to check out this assumption. In 
stratified Cox proportional-hazards regression models, each stratum is permitted 
to have a different baseline hazard function, while the coefficients of the 
remaining covariates are assumed to be constant across strata [325]. This method 
can be used to make graphical checks of the proportional hazards assumption for 
covariates. All database management and statistical analyses were performed 
using Stata software, version 10.0 (StataCorp LP., College Station, TX, USA). 
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9.4. Results 
9.4.1. Characteristics of the study population 
After exclusion of participants with incomplete follow-up data, 25,311 
participants (11,476 men) were entered into our analyses. Baseline characteristics 
of the study population are shown in Table 9.1. Participants with fracture were 
significantly older and had more history of fracture compared to participants 
without fracture and women with fracture had lower height and alcohol intake 
compared to other women. There were statistically significant differences 
between men and women with respect to all baseline factors and number of 
incident fractures. Out of 925 incident fractures reported, 334 (36%) were hip 
fractures, 154 (17%) were clinical spinal fractures, and 219 (24%) were wrist 
fractures. 1,749 of the participants had a past history of fracture at the time of the 
first visit. As shown in Table 9.2, the number of women with a past history of 
fracture increased with age while the numbers remained fairly steady at around 
6% in men aged 45 and above. 
 
 
Table 9.1: Baseline characteristics of participants in the EPIC-Norfolk study 
  Women 
 
Men 
 
  Fracture No Fracture Fracture No Fracture 
  n=649 n=13,186 P value n=276 n=11,200 P value 
Age (years) 64.7 (8.4) 58.1 (9.2) <0.001 61.9 (9.7) 59.0 (9.3) <0.001 
History of fracture 117 (11.1%) 936 (7.1%) <0.001 25 (9.1%) 654 (5.8%) 0.02 
Height (cm) 160.2 (6.3) 161.0 (6.2) 0.002 174.4 (6.4) 174.0 (6.6) 0.3 
Weight (kg) 67.4 (12.4) 68.0 (11.8) 0.2 80.7 (11.9) 80.4 (11.5) 0.6 
Body Mass Index (kg/m2) 26.2 (4.5) 26.2 (4.3) 0.9 26.5 (3.4) 26.5 (3.3) 0.9 
Current smoking 64 (9.9%) 1,508 (11.4) 0.2 38 (13.8%) 1,362 (12.2%) 0.4 
Alcohol intake (units/wk)* 1.5 (0.5-4.5) 2.5 (0.5-6.5) <0.001 7 (2-16.5) 6 (2-14) 0.2 
Data are mean (standard deviation) or number of participants (percentage) 
* Data are median (inter-quartile range) 
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Table 9.2: Distribution of participants in different groups of age, sex, and past 
history of fracture  
 Women  Men 
Age 
With history of 
fracture 
Without history 
of fracture 
 
With history of 
fracture 
Without history 
of fracture 
40-44 years 15 (2.5%) 581  15 (3.5%) 417 
45-49 years 101 (3.3%) 2,938  129 (5.7%) 2,128 
50-54 years 74 (4.1%) 1,744  81 (5.7%) 1,341 
55-59 years 143 (5.6%) 2,422  129 (6.0%) 2,020 
60-64 years 158 (9.5%) 1,512  87 (6.0%) 1,367 
65-69 years 293 (12.1%) 2,138  147 (6.8%) 2,005 
70-74 years 207 (15.1%) 1,161  75 (5.9%) 1,190 
75-79 years 66 (17.5%) 312  21 (5.7%) 348 
Total 1,057 (7.6%) 12,808  692 (6.0%) 10,915 
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9.4.2. Fitting the models 
The results of sex-specific Cox models are presented in Table 9.3 in terms of 
hazard ratios and 95% confidence intervals for any incident fracture and hip 
fractures. BMI and smoking were not significantly associated with fracture risk in 
any model. History of fracture lost its statistical significance as a predictor of hip 
fracture in model for men considering the small number of hip fracture outcomes 
in this group (n=89). As shown in the bottom of Table 9.3, the C-index values 
estimated in the validation dataset were comparable to those estimated in the 
derivation dataset, which provides reassurance on the internal validity of the risk 
prediction model. The Hosmer-Lemeshow test for calibration did not show any 
evidence of statistically significant differences between observed and predicted 
10-year risks (p = 0.9 for women and p = 0.08 for men), confirming internal 
validity of the fitted models. Number of predicted and observed fractures 
according to deciles of predicted risk of any fracture among men and women are 
shown in Table 9.4.  
 
Table 9.3: Hazard ratios (HR) and 95% confidence intervals (CI) for risk factors to 
predict prospective risk of fracture in different Cox proportional-hazards models  
 Any fracture  Hip fracture 
 
Women 
(649 cases) 
Men
(276 cases) 
 
Women
(245 cases) 
Men 
(89 cases) 
 HR (95% CI) HR (95% CI)  HR (95% CI) HR (95% CI) 
Age (years) 1.08 (1.07-1.09) 1.04 (1.02-1.05)  1.14 (1.12-1.16) 1.15 (1.11-1.18) 
History of fracture 1.92 (1.57-2.36) 1.53 (1.01-2.31)  1.59 (1.14-2.20) 1.73 (0.87-3.45) 
Body Mass Index (kg/m2) 0.99 (0.97-1.01) 0.99 (0.96-1.03)  0.96 (0.93-0.99) 0.95 (0.89-1.01) 
Smoking status (current) 1.10 (0.85-1.43) 1.19 (0.84-1.68)  1.19 (0.77-1.83) 1.38 (0.74-2.56) 
Alcohol intake (units/wk) 0.98 (0.97-1.00) 1.01 (1.01-1.02)  0.99 (0.97-1.02) 1.01 (0.99-1.03) 
C-index (95% CI)      
 Derivation dataset 0.70 (0.67-0.72) 0.60 (0.55-0.64)  0.78 (0.75-0.81) 0.79 (0.74-0.85) 
 Validation dataset 0.72 (0.67-0.76) 0.63 (0.56-0.70)  0.82 (0.78-0.87) 0.79 (0.72-0.86) 
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Table 9.4: Observed and predicted number of fractures in deciles of predicted 
risk of any fracture based on sex-specific Cox models 
  Women  Men 
Decile of risk  Observed Predicted HL Observed Predicted HL 
 
1  14 13.25 0.04 20 11.85 5.67 
2  15 17.66 0.41 14 14.04 0.00 
3  28 21.50 2.00 21 15.93 1.63 
4  28 26.83 0.05 9 17.88 4.48 
5  30 34.00 0.48 14 19.90 1.78 
6  43 43.21 0.00 24 22.03 0.18 
7  58 55.37 0.13 21 24.44 0.50 
8  71 71.31 0.00 21 27.26 1.47 
9  89 94.07 0.29 31 30.65 0.00 
10  141 144.32 0.09 47 40.45 1.10 
Total  517 521.53 3.49 222 224.43 16.81 
 
HL: Hosmer-Lemeshow statistic  
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9.4.3. Estimation of absolute fracture risk  
Table 9.5 presents 10-year absolute risks of any incident fracture and incident hip 
fracture in men and women of different ages. Figure 9.1 shows the corresponding 
predicted risks with respect to fracture history. Part A of this Figure shows that, 
while both men and women had a low absolute risk of about 1% below the age 
of 50 years, women with previous history of fracture experienced a steep increase 
in fracture risk after this age and their 10-year absolute risk rose to about 17% at 
the age of 75 years. For men this rise was less steep and reached about 5% at the 
age of 75 years. Part B of the Figure 9.1 shows a more steep increase in risk of hip 
fracture among men in comparison to any incident fracture, although this 
increase was still lower than age-related increase in risk observed in women. 
About 85% of women aged ≥ 65 years (3616 out of 4258) had a 10-year fracture 
risk of less than 10% and 3712 out of 3844 (97%) men aged ≥ 65 years had a 10-
year fracture risk of <5%.  
 
 
Table 9.5: 10-year absolute risk (%) of any incident fracture and hip fracture 
according to sex-specific Cox proportional-hazards regression models  
  Women  Men 
Age (years)  Any fracture  Hip fracture  Any fracture Hip fracture 
40  0.7  0.07  1.0  0.02 
45  1.1  0.1  1.2  0.05 
50  1.6  0.2  1.4  0.1 
55  2.3  0.5  1.7  0.2 
60  3.3  0.8  1.9  0.3 
65  4.9  1.6  2.3  0.7 
70  7.1  3.2  2.7  1.4 
75  10.9  6.4  3.1  2.6 
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Figure 9.1: 10-year absolute risk of A) any fracture and B) hip fracture among 25,311 
men and women in EPIC-Norfolk study 
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We examined sex-stratified models and compared them to sex-specific models in 
order to look at the pattern of association between other covariates and risk of 
fracture in men and women. While in sex-specific models the association 
between covariates and fracture risk can be different between men and women, 
in sex-stratified models these associations are considered to be similar (i.e. 
constant proportional hazards) but with different baseline hazards across strata of 
men and women. In our analysis, there were noteworthy differences in the risks 
predicted by sex-stratified vs. sex-specific models for any incident fracture. In 
general, stratified analysis predicted lower absolute risks for women and higher 
absolute risks for men compared to the sex-specific models. The C-index for 
discrimination of any incident fracture from the sex-stratified model was 0.661 
(95% CI 0.643 – 0.679), which was intermediate between that seen in sex-
specific models for women 0.701 (95% CI 0.681 – 0.722) and men 0.598 (95% 
CI 0.560 – 0.635). In particular, the pattern of association between age and 
fracture risk was notably different between the models (as depicted and discussed 
in Figure 8.1 and previous Chapter). The interaction term between age and sex 
included in the stratified model was highly significant (coefficient=0.04, 
P<0.001). The model with included interaction term outperformed the basic 
model (confirmed by lower Akaike's information criterion for the first model). The 
difference between predicted risks using models with and without interaction was 
more notable especially among older participants. Overall, the comparison 
between sex-stratified and sex-specific models shows the weakness of the 
assumption of constant proportional hazards for covariates between men and 
women. Therefore, separate modelling and analysis for men and women, when 
possible, is recommended.  
  
 161 
 
9.5. Discussion 
This study estimated absolute risks of fracture from a population-based 
prospective study in England. Using time-to-event data modelled in Cox 
proportional-hazards regression, we found that 10-year probability of fracture was 
approximately 1% in both men and women aged 40-45 years rising to about 17% 
for women and 5% for men aged 75 years with a previous history of fracture. 
There was a significant effect modification between sex and age of participants in 
this cohort. This suggests that the association between age and fracture risk is 
different in men and women. This has a particularly important methodological 
impact as it suggests that, when estimating absolute risk of fracture among men, it 
is not reliable to generalise the results of female studies to men. Direct evidence 
from studies in men is needed for this purpose.   
Previous studies have estimated 5-year, 10-year, or lifetime absolute risk of 
fracture in different populations using different statistical and mathematical 
modelling approaches [51, 102, 308-310, 329]. The first study to estimate 10-
year probability of fracture is based on the Sweden population register of 
fractures. In that study [51], a mathematical model was devised which combined 
pooled estimates of relative risk from a meta-analysis [45] with U.S. normative 
BMD data and Swedish fracture incidence records to provide absolute risk 
estimates. Comparison of our results with the figures provided by that study shows 
a considerable difference between the absolute risks in Swedish and British 
populations. Figure 9.2 shows that 10-year absolute risk of fracture increases to 
about 27% in Swedish women ≥75 years (compared to 11% in our population) 
and men from Sweden are also at higher risk compared to British women in any 
age group. Although there is a possibility of overestimation of the risk of fracture 
in the Swedish population (due to several assumption made for computation of 
fracture and mortality risks) and underestimation of fracture risks in the present 
study (as a result of potential under-registration of fractures in a healthier 
population), the considerable difference between the two studies (Figure 9.2) 
points out to the need for population-specific data for calculation of absolute risks 
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of fracture. Although the estimates of relative risks attributed to different risk 
factors might be fairly generalisable between populations [307], unknown factors 
that relate absolute to relative risks vary with age, sex and geography in a way 
that cannot be predicted. Therefore, clinical and public health authorities need to 
consider population structure and fracture incidence from direct evidence in their 
respective communities.  
 
 
 
 
Figure 9.2: Comparison of 10-year absolute risk of fracture estimated in this study with a 
Swedish population study 
Swedish data is reproduced from Reference [51].  
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This point is particularly important for development of country-specific guidelines 
for diagnosis of osteoporosis and evaluation of fracture risks. To our knowledge, 
the only country so far that has tried to shift its practice towards use of absolute 
risks is Canada. In June 2005, Osteoporosis Canada (OC) and the Canadian 
Association of Radiologists released their recommendation for BMD reporting in 
postmenopausal women and older men (please see Table 1.3) [91, 321]. These 
recommendations have altered the fundamental approach to BMD utilisation 
shifting the emphasis from the relative risk conferred by WHO T-score categories 
to 10-year absolute risk of fractures. However, the risk estimates and 
categorisation criteria in this guideline are mainly based on the published 
Swedish data (with some interpolation of age and T-score groups) [321]. Further 
studies testing the impact of this guideline on practice of Canadian physicians 
were also based on the same data [330, 331]. Our study shows that the cut-offs 
chosen by the Canadian researchers for low and high fracture risk in their 
population (10% and 20%, respectively) are not applicable to our population (as 
very few participants had a risk of >20% in our study). Canadian researchers may 
also need in future to rely more on their population-based studies for estimation 
of their country-specific absolute risks of fracture.  
It should be appreciated that, in order to be used for specific populations, our 
method for calculation of absolute fracture risk (Cox regression) requires time-to-
event data derived from prospective population-based cohort studies with more 
than 10 years of follow-up for at least a part of the population. This is demanding 
and few studies so far have used this method [329]. Cox regression as a semi-
parametric method has some advantages compared to parametric statistical 
methods like Poisson regression, which is the method utilised by the WHO 
Scientific Group to develop FRAX® tool [24, 162]. Because of lack of BMD 
measurements in 90% of participants in the EPIC-Norfolk study and some 
differences between variables entered into models we cannot directly compare 
our model with the FRAX® estimates for UK. With the growing awareness in the 
research community about the burden of osteoporotic fractures and because of 
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ongoing prospective studies, it would be reasonable to anticipate population-
specific absolute risk measures becoming available for individual countries.  
For the purpose of clinical practice, absolute fracture risks in individual patients 
have to be categorised as high-risk (indicated for treatment), medium-risk 
(suggested for further evaluation), or low-risk (lifestyle and dietary advice). 
Thresholds for this categorisation may vary greatly depending on several factors 
like effectiveness and affordability of treatment regimens as well as patient 
characteristics and preferences. It is expected that these thresholds should be 
calculated from population-specific cost-effectiveness models that incorporate 
measures of absolute risk for individuals with the costs and benefits of treatment, 
willingness-to-pay of the healthcare funders and individual preferences.  
The main limitation of this study is the lack of BMD assessment at the beginning 
of follow-up. This was mainly related to the primary health outcomes in the initial 
plan for EPIC-Norfolk study, which were cardiovascular events and cancers. 
However, a small fraction of participants (about 1,500 men and women aged 65-
76 years) underwent BMD assessment using dual-energy X-ray absorptiometry 
(DXA) as well as quantitative ultrasound (QUS) of the heel. A majority of 
participants who attended the second health check about 4 years later underwent 
QUS, which was highly predictive of future fractures in this population [77]. Due 
to the small number of participants with BMD measurement, we have not entered 
BMD as a variable into our models. However, the lack of assessment for BMD 
does not diminish the validity of the methods and results of this study although 
these additional measures are likely to improve the power of the models to 
predict fractures in individuals.  
Other limitations of this study are the potential for under-registration of fracture 
outcomes in the cohort population (due to fractures not necessarily being 
managed in hospitals, emigration of participants, miscoding or misclassification of 
fractures and other problems inherent to automated linkage programs like 
ENCORE), inclusion of healthier population for follow-up, and not including 
older people (>80 years) in the cohort. In particular, although the study 
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population resembles the UK population in general characteristics, participants in 
such a study are likely to be healthier and have lower fracture rates. Nevertheless, 
a previous study also suggested that the incidence rates of fracture among the 
elderly residents of East Anglia is lower compared to other parts of the UK [324]. 
The results of this study, therefore, need validation before generalisation to other 
parts of UK for clinical practice. 
There are several points of strength with the methodology used in this study. Cox 
proportional-hazard modelling is a powerful and precise method that is easily 
available to all researchers via several statistical packages. Models can be 
adjusted for different risk factors as well as mortality in the cohorts and there is a 
potential for meta-analysis of prospective studies (using individual-level data) 
within countries and populations. Moreover, our large number of male 
participants followed for a long period of time enabled us to look for the 
interaction between sex and age as major determinants of fracture risk. 
In conclusion, this study showed a lower absolute risk of fracture for the elderly 
population of East Anglia compared to other northern European populations. This 
urges further attention to population-specific estimates for clinical applications. 
Additionally, the interaction observed between sex and age in this study suggests 
that more prospective studies among older men are required to achieve more 
reliable estimates of fracture risks in this group. In order to clinically apply the 
results of this study and other similar estimates of fracture probability (e.g. FRAX® 
tool), we need population-specific thresholds (or absolute risk cut-offs) using cost-
effectiveness models of the current available treatments of osteoporosis. The field 
is highly open to future research. 
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Chapter 10: Heel QUS vs. Hip DXA for Absolute 
Fracture Risk Estimation 
 
 
 
 
 
 
 
 
The work presented in this Chapter has been published in: 
Moayyeri A, Kaptoge S, Dalzell N, Luben RN, Wareham NJ, Bingham S, Reeve J, Khaw KT. Is 
QUS or DXA better for predicting the 10-year absolute risk of fracture? Journal of Bone and 
Mineral Research 2009 Jul;24(7):1319-25 
Please see Appendix 9. 
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10.1. Abstract 
Although quantitative ultrasound (QUS) is known to be correlated with BMD and 
bone structure, its long-term predictive power for fractures in comparison to dual-
energy X-ray absorptiometry (DXA) is unclear. We examined this in a sample of 
men and women from EPIC-Norfolk study who had both heel QUS and hip DXA 
between 1995 and 1997. From 1,455 participants (703 men) aged 65-76 years at 
baseline, 79 developed a fracture over 10.3±1.4 years of follow-up. In a sex-
stratified Cox proportional-hazard model including age, height, body mass index, 
prior fracture, smoking, alcohol intake and total hip BMD, 1 SD decrease in BMD 
was associated with a hazard ratio (HR) for fracture of 2.26 (95% CI 1.74-2.95). In 
the multivariable model with heel broadband ultrasound attenuation (BUA) in 
place of BMD, HR for 1 SD decrease in BUA was 2.04 (95% CI 1.55-2.69). 
Global measures of model fit showed relative superiority of the BMD model 
whereas the area under the ROC curve was slightly higher for the BUA model. 
Using both Cox models with BMD and BUA measures, we calculated exact 10-
year absolute risk of fracture for all participants and categorised them in groups of 
<5%, 5% to <15%, and ≥15%. Comparison of groupings based on two models 
showed a total re-classification of 28.8% of participants with the greatest re-
classification (about 40%) among the intermediate- and high-risk groups. This 
study shows that the power of QUS for prediction of fractures among the elderly 
is at least comparable to that of DXA. Given the feasibility and lower cost of 
ultrasound measurement in primary care, further studies to develop and validate 
models for prediction of 10-year risk of fracture using clinical risk factors and 
QUS are recommended. 
168 
 
10.2. Introduction 
Many trials have been conducted in the field of osteoporosis over the last decade 
and several treatments have proven efficacy for reduction of fracture risk. Today, 
a major challenge is to better identify individuals at high risk of fracture who 
would benefit from intervention. To identify patients at high risk of fractures, dual 
X-ray absorptiometry (DXA) is widely accepted as the reference method for 
measuring bone mineral density (BMD) [81]. At the population level, a decrease 
in BMD is associated with a significant increase in fracture risk. However, at the 
individual level, BMD assessment is quite sensitive but not specific for prediction 
of fractures. This is explained partly by the fact that DXA measures BMD only, a 
surrogate of bone strength that is also influenced by bone architecture and hip 
geometry, and partly by the fact that the occurrence of fracture depends on other 
clinical risk factors [332]. 
Quantitative ultrasound (QUS) of the calcaneus, developed in the past two 
decades, is expected to provide information on bone structure and density [117, 
333]. Previous studies suggest that QUS parameters are influenced by the 
mechanical properties of bone, which in turn are determined by the amount of 
bone, the bone’s material properties (e.g., bone mineralisation and elasticity), and 
its structural properties (e.g., bone architecture) [140, 334-336]. The pattern of 
absorption of a range of wavelengths of sound is called the broadband ultrasound 
attenuation (BUA; expressed in dB/MHz) and transmission of sound through bone 
can be quantitatively assessed by the speed of sound (SOS; expressed in m/s). 
Recent research has shown that ultrasonic assessments of the calcaneus are 
significantly discriminative and predictive of osteoporotic fractures independently 
of hip BMD [337-343]. In fact, major prospective studies have shown that QUS 
measurements are predictors of hip fracture with a similar performance to hip 
DXA measurements [344-349].  
The significant growth in use of QUS has been based on the affordability of the 
technology and the potential of sound waves to probe multiple bone properties 
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such as bone density, microarchitecture, and elasticity. The cost of the devices is 
much lower compared to DXA scanners and, hence, QUS might be more 
appropriate compared to DXA assessment for use in primary care. This, however, 
depends on the performance of QUS for prediction of osteoporotic fractures in 
the long term. Several studies have tried to compare the predictive power of QUS 
and DXA for various types of fractures, but they have used different methods of 
comparison and the overall results are still inconclusive [335, 350]. 
Currently, the use of absolute fracture risk estimation in the field of osteoporosis 
research and clinical practice guidelines has come to the forefront since that is 
what matters to the patients and the health care providers. The ‘World Health 
Organization (WHO) scientific group for assessment of osteoporosis at the 
primary health care level’ have developed the FRAX® tool (based on DXA and 
clinical risk factor) for estimation of 10-year absolute risk of fracture in different 
populations [24, 162]. Similar methods can now be applied for comparison of 
different radiological techniques or clinical risk factors to predict long-term 
absolute risk of fracture. We aimed in this study to compare models based on 
clinical risk factors and DXA with those using QUS measures obtained 
simultaneously for estimation of 10-year absolute risk of fracture in elderly men 
and women. 
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10.3. Methods 
This study has been done on a subset of 1,511 men and women aged ≥ 65 years 
from EPIC-Norfolk study who collaborated with the European Prospective 
Osteoporosis Study (EPOS) [108]. Full details of participant recruitment and study 
procedures for EPIC-Norfolk have been described in Chapter 2. A subset of 
participants in the original EPIC-Norfolk study (≥ 65 years of age and without 
DXA-confirmed diagnosis of osteoporosis) was invited to a bone densitometry 
study about 18 months after the baseline visit. An information sheet detailing the 
purpose of the study was sent to eligible subjects. Over the period of May 1995 to 
January 1998, 1,511 participants underwent hip BMD measurements using a 
Hologic 1000 W bone densitometer (Hologic Inc, Bedford, MA). BMD (in gr/cm2) 
of the total hip region was used for this study. All measurements were done by 
the same operator and an experienced independent operator reviewed all scans 
to ensure consistency of positioning of the hip regions [351, 352]. In the same 
day, 1,458 of these participants also had a QUS assessment in the heel by a 
CUBA sonometer (McCue Ultrasonics, Winchester, UK). The means of at least 
two measures of BUA and SOS (on left or right calcaneus) were used for analysis 
in this study. Demographic, anthropometric and lifestyle variables were collected 
at the time of bone measurements. Detailed procedures are described in Chapter 
2. For this study, participants were followed up to the end of March 2007, an 
average of 10.3 years (SD=1.4; range 8.2-13.1).  
Multivariable Cox proportional-hazard regression models were used to model the 
association between incident fractures and potential risk factors. Two separate 
models, one including total hip BMD and the other including BUA of the heel, 
were constructed with age, past history of fracture, BMI, smoking status, and 
alcohol intake as the covariates in both models. Both models were stratified for 
sex. For comparison of performance of models, different global measures of 
model fit were used. These measures included Bayesian information criterion 
(BIC) [353], Akaike’s information criterion (AIC) [354], deviance information 
criterion (DIC) [355], likelihood ratio chi-squared statistic, Nagelkerke’s and Cox-
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Snell R-squared [356], and D-statistic [357]. Lower values for the three 
information criteria and higher values for other measures indicate better fitness of 
the proportional-hazard models. Harrell’s C-index (which is equivalent to area 
under the ROC curve for survival data) was used as the measure of discrimination 
[327]. Calibration, which refers to the ability of a model to match predicted and 
observed outcome rates across the entire spread of the data, were compared 
between two models using the Hosmer-Lemeshow chi-squared statistic [328]. 
This measure compares observed and predicted outcomes over deciles of risk and 
higher values for its p value indicate better calibration of the model (i.e., a less 
significant difference between expected and observed rates).  
For further comparison of the two models, 10-year absolute risk (probability) of 
fractures for each participant was calculated using the baseline survivor function 
and the estimated log hazard ratios for the variables in each model. Please see 
Chapter 9 for detailed methods for calculation of these absolute risks. All 
participants were assigned to two different 10-year probabilities of fracture using 
Cox models including hip BMD or heel BUA as covariates. Participants were then 
categorised into three groups with absolute risks of <5%, 5% to <15%, and ≥15% 
based on these two models. Unlike other ultrasound devices that report 
combined measures of BUA and SOS (namely, quantitative ultrasound index 
[QUI] for Sahara and Stiffness Index [SI] for Achilles devices), there is no 
combined measure for CUBA sonometer. Substitution of SOS for BUA resulted in 
poorer prediction in all models (BIC = 995.3 vs. 991.9) and inclusion of SOS with 
BUA did not result in better prediction (BIC = 992.4 vs. 991.9). Hence, only the 
models including BUA are reported here as representative of QUS measures.  
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10.4. Results 
10.4.1. Characteristics of the study population 
In sum, 1,455 participants aged 65-76 years (703 men, mean age 69.5 ± 3 years) 
were entered into the analysis. Three participants were excluded due to 
incomplete data. The characteristics of study participants are summarised in 
Table 10.1. Bone characteristics were higher on average among men. Mean total 
hip BMD was 0.944 ± 0.140 gr/cm2 among men and 0.767 ± 0.125 gr/cm2 
among women. Mean BUA of the calcaneus was 88.3 ±18.2 dB/MHz among 
men, which was significantly higher than the mean 63.5 ± 15.4 dB/MHz for 
women. During 15,567 person-years of follow-up, 79 participants (61 women) 
developed a fracture. The Pearson correlation coefficient was 0.47 for total hip 
BMD and heel BUA.   
 
 
 
Table 10.1: Characteristics of the study population  
  
Men 
n=703  
Women 
n=752 
Age (years)  69.6 (3.1)  69.4 (2.9) 
Height (cm)  172.8 (6.3)  159.5 (5.8) 
Body Mass Index (kg/m2)  26.5 (3.1)  26.5 (4.1) 
Past history of fracture  40 (5.7%)  109 (14.5%) 
Current smoking  62 (8.8%)  48 (6.4%) 
Alcohol intake (units/week)*  5 (10.5)  1.5 (5) 
Total hip BMD (g/cm2)  0.944 (0.140)  0.767 (0.125) 
Heel BUA (dB/MHz)  88.3 (18.2)  63.5 (15.4) 
Heel SOS (m/s)  1668.4 (44.5)  1631.4 (38.4) 
Follow-up time (years)  10.4 (1.1)  10.2 (1.6) 
Any incident fracture†  18 (2.6%)  61 (8.1%) 
Data are mean (standard deviation in parenthesis) or number of participants (percentage in 
parenthesis); BMD = bone mineral density, BUA = broadband ultrasound attenuation, SOS = 
speed of sound 
* Median (inter-quartile range in parenthesis) 
† Number of incident fractures up to March 2007 
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10.4.2. Comparison of heel QUS and hip DXA by model performance 
Two sex-stratified proportional-hazard models including BMD and BUA are 
shown in Table 10.2. Most of the variables entered into the models were 
significant predictors of fractures. Table 10.2 shows that the hazard ratio (HR) for 
a 1 standard deviation (SD) decrease in total hip BMD was 2.3 (95% CI 1.7-3.0) 
compared with 2.0 (95% CI 1.6-2.7) for a 1 SD decrease in BUA. Table 10.3 
compares the performance of two models. Global measures of model fit 
(including different information criteria, likelihood ratio test, R-squared estimates 
and D-statistic) showed relative superiority of the BMD model while the area 
under the ROC curve was 0.6% higher for the BUA model (Table 10.3). High 
Hosmer-Lemeshow p values confirmed that both models were adequately 
calibrated (distribution of expected and observed fractures are shown in Table 
10.4). In general, performances of both models were fairly similar. 
 
 
Table 10.2: Sex-stratified multivariable Cox proportional-hazard models using 
total hip BMD or heel BUA included in the predictors  
 BMD Model BUA Model 
Variable Hazard Ratio P value Hazard Ratio P value
Age (year)  1.13 (1.05-1.22) 0.001  1.12 (1.04-1.21) 0.003 
Height (cm)  1.04 (1.00-1.08) 0.051  1.04 (1.00-1.08) 0.084 
Body mass index (kg/m2)  1.05 (0.99-1.12) 0.096  1.02 (0.96-1.09) 0.432 
Past history of fracture   2.24 (1.34-3.73) 0.002  2.31 (1.40-3.84) 0.001 
Current smoking  2.15 (1.09-4.24) 0.027  2.18 (1.11-4.29) 0.024 
Alcohol intake (units/week)  1.03 (1.00-1.06) 0.048  1.02 (0.99-1.05) 0.132 
Total hip BMD (per SD decrease)  2.26 (1.74-2.95) <0.001  - - 
Heel BUA (per SD decrease)  - -  2.04 (1.55-2.69) <0.001 
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Table 10.3: Measures of model fit for comparison of the Cox models including 
total hip BMD and heel BUA as predictors 
  BMD Model   BUA Model  
Global measures    
 Bayesian Information Criterion (BIC) 981.6  991.9 
 Akaike’s Information Criterion (AIC) 944.7  955.1 
 Deviance Information Criterion (DIC) 930.7  941.1 
 Likelihood ratio chi-square (df) 69.2 (7)  58.8 (7) 
 Nagelkerke’s R2 9.4%  8.0% 
 Cox-Snell R2 4.7%  4.0% 
 D-statistic 1.63  1.50 
Discrimination     
 C-index (area under ROC curve) 67.9%  68.5% 
Calibration    
 Hosmer-Lemeshow P value  0.46  0.62 
Lower values of the BIC, AIC, and DIC and higher values of all other statistics, including the 
calibration P values, indicate better fit of a model. 
 
Table 10.4: Observed and predicted number of fractures in deciles of risk based 
on Cox models including total hip BMD and heel BUA as predictors 
  BMD Model  BUA Model 
Decile of risk  Observed Predicted HL Observed Predicted HL 
 
1  0 0.71 0.71 0 1.09 1.09 
2  3 1.43 1.75 0 2.07 2.10 
3  1 2.15 0.62 2 2.96 0.32 
4  3 2.91 0.00 4 4.04 0.00 
5  1 3.96 2.27 5 5.38 0.03 
6  7 5.34 0.53 7 6.91 0.00 
7  7 7.47 0.03 6 8.92 1.02 
8  10 10.26 0.01 10 11.69 0.27 
9  18 14.86 0.74 12 17.04 1.69 
10  24 32.82 3.07 28 35.63 2.17 
Total  74 81.92 9.74 74 95.73 8.68 
 
HL: Hosmer-Lemeshow statistic   
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10.4.3. Comparison of heel QUS and hip DXA by absolute  fracture 
risk 
For the next stage of the analysis, two new variables containing estimated 10-year 
absolute fracture risk using the BMD and BUA models were generated. The 
estimated fracture risks using the BUA model (median 4.2%, interquartile range 
[IQR] 2.0%-8.0%) were higher than estimated risks using the BMD model 
(median 3.1%, IQR 1.5%-7.1%; Wilcoxon signed-ranks test p value < 0.001). 
Table 10.5 compares the classification of participants based on two models into 
three risk categories (10-year risk of <5%, 5% to <15%, and ≥15%). Most of the 
participants were classified into the same category of risk using each model. 
However, 419 participants (28.8%) were re-classified using different models. 45 
out of 112 participants (40%) assigned to the high-risk group (10-year risk of 
≥15%) using the BMD model were re-classified to a lower risk group according to 
the BUA model. The greatest re-classifications (about 40%) were observed among 
the groups with intermediate and high risk of fracture. While most of the 
participants were re-classified to adjacent categories, 10 participants categorised 
as low-risk (<5% risk) using the BMD model were re-classified to high-risk (≥15% 
risk) according to the BUA model and 6 of high-risk participants based on the 
BMD model were re-classified as low-risk using the BUA model (Table 10.5). The 
distribution of the participants in different categories based on the two models is 
shown graphically in Figure 10.1.  
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Table 10.5: Observed and expected risks of fracture using Cox proportional-
hazard models based on BMD or BUA   
 10-year fracture risk in BUA model  
10-year fracture risk in BMD model 
0 to <5% 5% to <15% ≥15% 
Total re-
classified
  
0 to <5%  
Number of participants, n 728 201 10  
Participants classified in each stratum  
by the BUA model, % 
77.5 21.4 1.1 22.5% 
Observed 10-year risk, % 1.2 4.0 10.0  
   
5% to <15%   
Number of participants, n 99 241 64  
Participants classified in each stratum  
by the BUA model, % 
24.5 59.7 15.8 40.3% 
Observed 10-year risk, % 6.1 7.5 17.2  
   
≥15%   
Number of participants, n 6 39 67  
Participants classified in each stratum  
by the BUA model, % 
5.4 34.8 59.8 40.2% 
Observed 10-year risk, % 0 15.4 22.4  
Each stratum of risk according to the Cox model with BMD is categorised according to the stratum 
of risk predicted by the Cox model with BUA 
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Figure 10.1: Distribution of 10-year absolute fracture risk based on two Cox proportional-
hazard models among 1,455 EPIC-Norfolk participants  
Bars show the percentage of participants categorised to the specific risk bands using the 
BUA model. The numbers on top of each bar show the observed 10-year fracture risk 
during the study period for that particular population. 
 
 
 
 
 
As we had followed up most of the participants for more than 10 years, we were 
able to calculate observed 10-year fracture risk (which is the incidence rate of 
fracture in the first 10 years of follow-up). Table 10.5 and Figure 10.1 also report 
the observed fracture risks for different categories. These numbers show that the 
estimated fracture risks based on the BUA model were relatively more compatible 
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with the observed risks particularly in the intermediate- and high-risk groups. For 
instance, the right side of Figure 10.1 shows that none of participants categorised 
as high-risk based on the BMD model but as low-risk using the BUA model 
experienced a fracture during follow-up. Similarly, 17% of those categorised as 
intermediate-risk based on the BMD model but re-classified as high-risk using the 
BUA model developed a fracture. In general, observed risks were closer to the 
estimated fracture risks using the BUA model for participants with higher risks of 
fracture based on any model. 
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10.5. Discussion 
To our knowledge, this is the first study that uses calculated 10-year absolute risks 
of fracture for comparing QUS with DXA for their ability to predict fractures. Our 
results indicate that, while the conventional statistical methods show a relatively 
similar performance for both BMD and BUA models, there is a significant 
difference between two models regarding categorisation of patients to different 
risk bands. Global measures of model fit showed relative superiority of the model 
based on clinical risk factors and BMD whereas the area under the ROC curve 
was slightly higher for the model with clinical risk factors and BUA. Nevertheless, 
almost one in three of the participants (28.8%) were re-classified to a different 
category when 10-year absolute risk of fractures was considered. Estimated 
fracture risks based on the BUA model were closer to the observed fracture risk 
compared to the BMD model particularly for participants with higher risks of 
fracture. These findings suggest that QUS and DXA measure somewhat different 
aspects of bone strength and, suggest that hitherto QUS measurement has been 
under-rated for the prediction of long-term risk of fractures among the elderly. 
Since 1984, when QUS measures began to be applied in bone research [358], it 
has been hypothesised that ultrasound may give information not only about the 
bone density but also about architecture and elasticity [333]. A growing number 
of researchers have used QUS to assess bone status for prediction of osteoporotic 
fracture risk and various studies have found a lower [337], an equal [339-341, 
344, 345, 348], or a higher [342] prediction value than the one obtained with 
DXA. Relative risks or hazard ratios have been the most widely-used measures of 
association in prospective studies to compare predictive power of QUS and DXA 
[344-349]. However, these measures may not be perfect for comparison of these 
methods as they may only reflect the superiority of one method for estimation of 
short-term risk of fractures. Five out of six major prospective studies in this field 
have followed their participants for less than 3 years [344-348] and the only long-
term study showed similar hazard ratios for BUA and femoral neck BMD [349]. 
Moreover, generalisation of relative risks derived from prospective studies that 
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only used QUS measurements might be problematic since we need to consider 
the effect of clinical risk factors and their potential interactions with these 
measurements.  
It has been recently appreciated that the clinical practice should be founded on 
the estimation of absolute fracture risk in long term and using a multitude of risk 
factors. The measurement of a single risk factor can only capture one aspect of 
the likelihood of the outcome when the disease is multifactorial, and in 
osteoporosis for instance, assessment with BMD captures a minority of the 
fracture risk. The increase in risk with age is approximately sevenfold greater than 
that can be explained on the basis of BMD alone [359]. This has been the basis 
for development of the FRAX® tool by the WHO scientific group. This online 
program for estimation of 10-year absolute fracture risk for individuals currently 
considers several clinical risk factors and BMD in the femoral neck [24, 162]. 
FRAX® is likely to be a basis for future routine clinical practice in the field of 
osteoporosis. While the FRAX® methodology is the current best choice as it 
captures all the relevant information and summarises it to a single sensible 
measure for clinicians (i.e., 10-year probability of fractures), other potential risk 
factors (including clinical, radiological and biochemical factors) can be added to 
or replaced with the current set of risk factors. Our results suggest that BUA can 
be considered as a suitable alternative to BMD in such models. 
Glüer and Hans [360] have suggested four potential strategies on how to use 
ultrasound clinically. The first strategy, the estimated BMD approach, suggests 
use of QUS for estimation of BMD and then use of that BMD estimate for fracture 
risk assessment. This approach is unsatisfactory due to low coefficients of 
correlation observed in different studies (including our study) between heel 
ultrasound and axial DXA as well as the poor predictive power of peripheral DXA 
[360]. Another strategy, the ‘prescreening’ approach, uses a threshold for QUS 
(presumably derived from a cross-sectional study) so that all subjects with a QUS 
result below this threshold would be referred for DXA assessment. This is 
particularly problematic given the extent of assumptions for derivation of the 
 181 
 
threshold as well as the view to BMD as the gold standard for fracture risk 
estimation [360]. The third strategy, the composite approach, categorises subjects 
as high-, intermediate-, and low-risk and subjects with intermediate risk would be 
referred for further assessment (DXA, bone biomarkers, or second independent 
QUS at a different site). This strategy depends greatly on identification of other 
diagnostic techniques that add predictive power to QUS. The fourth strategy, the 
stand-alone approach, therefore seems to be optimal among these approaches. It 
considers replacement of BMD with a QUS measure for fracture risk prediction 
[360]. Considering the advances put forward by the FRAX® method, and given 
the results of our study which shows a similar performance of the models based 
on QUS and DXA for risk prediction, similar models can be built using clinical 
risk factors and QUS measures for estimation of 10-year absolute fracture risk and 
application in clinical practice.  
It should be noted that ultrasound devices have some technological drawbacks 
that have precluded their widespread utilisation in bone assessment hitherto. An 
important factor is the precision of the devices. The short-term in vivo precision of 
BUA varies between 2.0 and 3.5%, depending upon the device and the site of 
measurement. Since a 2–3% precision of calcaneal BUA generates a least 
significant change that is about 6–9 times larger than the average annual loss rate 
in postmenopausal women [361], QUS devices cannot be good candidates for 
monitoring response to therapy. Moreover, there are no criteria for diagnosis of 
osteoporosis using QUS measurements. It has been shown that the -2.5 SD 
criterion for osteoporosis cannot be applied to many QUS devices [362] and, 
because of the technological differences between devices, results cannot be 
extrapolated from one device to another [361]. However, QUS instruments have 
some advantages: they are radiation-free, portable, and inexpensive [350]. 
Therefore, given the predictive power of QUS compared to DXA observed in this 
study, using a stand-alone approach may be the most cost-effective approach for 
fracture risk assessment [360]. This issue needs further attention of researchers 
working in this field.  
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This study has some limitations. The most important one is the choice of 
thresholds for categorisation of participants. We acknowledge that these 
thresholds must ideally come from population-specific cost-utility or cost-
effectiveness studies that combine absolute risk measures, age structure of the 
population, cost and efficacy of the therapies, and the value (or utility) of fractures 
in the community. Currently, however, there is no such study using absolute risk 
estimates in the UK (as for other parts of the world) and we had to rely on 
arbitrary thresholds. We considered the distribution of incident fracture cases in 
our study population and the estimated fracture risks using both models in this 
study. Given the low incidence of fractures in our population, we chose to 
consider about 10% of participants as high-risk and about 30% as intermediate-
risk. This translated to cut points of 5% and 15%. If we were to use previously 
suggested thresholds (such as the thresholds of 10% and 20% for risk 
categorisation suggested by Siminoski et al.) [363], we would have only 4% of 
participants as high-risk and about 11% as intermediate-risk based on both 
models.  
The other potential limitation of this study is the representativeness of the study 
population. Although it was population-based, there is a potential for `healthy 
participant’ recruitment into the EPIC-Norfolk study as well as this particular 
analysis [352]. Healthy participants are more likely to complete food diaries and 
questionnaires and consent to undergo several diagnostic procedures. The 
incidence rate of fractures was very low according to UK norms in our 
participants (about 5 per 1000 person-years). However, it should be noted that 
previous studies from East Anglia have shown that the rate of fracture in this 
region is considerably lower compared to other parts of UK [324]. Given the 
follow-up procedure in the EPIC-Norfolk study, only fractures that needed 
admission to hospitals or recorded in the general practices were considered for 
this study. This may have led to an underestimation of fracture rate in our study 
compared to other populations, although only minor fractures (e.g., of digits or 
ribs) are thought not to attract clinical attention. Nevertheless, this is not likely to 
have confounded the comparison of the results for models based on BUA and 
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BMD unless there was an independent interaction with the composition of the 
sample. In any case, the results of this study need validation in other settings 
before generalisation to other populations. 
In conclusion, we estimated 10-year absolute risk of fracture for comparison of 
models based on BMD and BUA as fracture predictors. We found that, while the 
conventional statistical methods showed a similar performance for both models, 
almost one in three participants were re-classified to a different risk band using 
different models. Although individuals were categorised to different risk bands, 
both models classified a similar fraction of participants to each risk band. 
Interestingly, estimated fracture risks based on the BUA model were closer to the 
observed fracture risks. These results suggest that QUS has at least a similar 
performance compared to DXA in prediction of long-term fracture risk among 
elderly men and women. Given the lower cost and affordability of ultrasound 
measurement in primary care, further studies to develop and validate models for 
prediction of 10-year risk of fracture using clinical risk factors and QUS are 
recommended.   
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Chapter 11: Heel QUS as a ‘Risk Factor’ for 
Fracture 
 
 
 
 
 
 
 
 
 
The work presented in this Chapter has been published in: 
Moayyeri A, Kaptoge S, Dalzell N, Luben RN, Wareham NJ, Bingham S, Reeve J, Khaw KT. The 
effect of including quantitative ultrasound assessment in models for estimation of 10-year absolute 
risk of fracture. Bone 2009 Aug;45(2):180-4 
Please see Appendix 10. 
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11.1. Abstract 
The role of quantitative ultrasound (QUS) in clinical practice is debatable. An 
unanswered question is that whether combining QUS and BMD measurements 
could improve the prediction of fracture risk. We examined this in a sample of 
men and women from EPIC-Norfolk study who had both heel QUS and hip DXA 
between 1995 and 1997 and were followed for any incident fracture up to 2007. 
From 1,455 participants (703 men) aged 65-76 years at baseline, 79 developed a 
fracture over 10.3 ± 1.4 years of follow-up. Two separate sex-stratified Cox 
proportional-hazard models were used including clinical risk factors and total hip 
BMD. Heel broadband ultrasound attenuation (BUA) was also included in the 
second model. Global measures of model fit, area under ROC curve, and the 
Hosmer-Lemeshow statistic showed relative superiority of the model including 
BUA. Using each model, we calculated 10-year absolute risk of fracture for all 
participants and categorised them in groups of <5%, 5% to <15%, and ≥15%. 
Comparison of groupings showed a total re-classification of 16.6% of participants 
after inclusion of BUA with the greatest re-classification (30.7%) among the group 
with intermediate risk. Adding a QUS measurement to models based on clinical 
risk factors and BMD improves the predictive power of models and suggests that 
further attention should be paid to QUS as a clinical tool for fracture risk 
assessment. 
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11.2. Introduction 
Quantitative assessment of osteoporosis and estimation of fracture risk relies 
mainly on bone mineral density (BMD) measurements using radiologic methods 
such as dual-energy X-ray absorptiometry (DXA) and quantitative computed 
tomography (QCT). A limitation of these techniques is that BMD measurements 
are dependent on the amount of mineral in the bone and not on bone structure 
and bone tissue quality. However, trabecular architecture is an important 
parameter in assessing bone strength. Although it turned out to be a modest 
predictor of bone architecture, this encouraged the development of quantitative 
ultrasound (QUS) techniques in the past years [117, 118]. 
Several studies have documented the ability of QUS measurements to 
discriminate between individuals with or without fractures and to predict fracture 
risk independently of hip BMD. In cross-sectional studies, calcaneal QUS 
significantly differentiates women with hip fracture from controls [338, 339, 341, 
343, 364-367] and major prospective studies have concluded that QUS 
measurements are predictive of osteoporotic fractures [344-347, 349]. A recent 
large-scale prospective study showed that the combined use of clinical risk 
factors and QUS measures is a promising tool to assess hip fracture probability in 
elderly women [368]. QUS prediction was found to be partly independent of hip 
DXA measurements and similar in the magnitude of the association [335, 350, 
361]. However, despite these advances QUS has not yet been included in the 
routine assessment of osteoporotic patients. As Durosier et al. [335] have pointed 
out, a major problem that precludes comparison of most published studies and 
interpretation of their results is that they use different measures of association 
(such as relative risks, odds ratios, and absolute risks) and performance of the tests 
(i.e., sensitivity/specificity or area under receiver operating characteristics [ROC] 
curve). 
There is an emerging consensus among researchers that fracture risk assessment 
needs to shift toward estimation of long-term absolute risk of fracture for 
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individuals. It is necessary to consider the effects of including QUS measures into 
models for estimation of 10-year absolute fracture risk and observe whether QUS 
can add useful information to the current models based on DXA measures. As 
discussed in Chapter 8, adding new information to prediction models is a 
necessary principle for accepting a measure as a ‘risk factor’. In this Chapter, this 
will be evaluated for heel QUS. I compared models based on clinical risk factors 
and BMD for estimation of 10-year absolute risk of fracture with and without 
QUS measures included in the models.  
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11.3. Methods 
This study was done in the group of EPIC-Norfolk participants who underwent hip 
DXA and heel QUS measurements on the same day. Please see Chapters 2 and 
10 for full details of participants’ recruitment and health examination procedures. 
Demographic, anthropometric and lifestyle variables of 1,511 participants were 
collected at baseline examination (1993-1997). Participants were followed up to 
the end of March 2007 for different fracture outcomes (excluding fractures of 
skull, face, metacarpals, metatarsals, and phalanges).  
Two separate multivariable Cox proportional-hazard regression models stratified 
by sex [325] were used to model the association between potential risk factors 
and incident fractures. The first model included age, past history of fracture, BMI, 
smoking status, alcohol intake, and total hip BMD as predictors. The second 
model included BUA in addition to these variables. For comparison of 
performance of models, different global measures of model fit including Bayesian 
information criterion (BIC), Akaike’s information criterion (AIC), deviance 
information criterion (DIC), likelihood ratio chi-squared statistic, Nagelkerke’s 
and Cox-Snell R-squared, and the D-statistic were used. Interactions (effect 
modifications) between different factors entered into both models were sought 
and verified using the AIC and BIC of the models and likelihood ratio tests. 
Discrimination was measured by Harrell’s C-index (which is the equivalent of an 
area under ROC curve for survival data). Calibration, which refers to the ability of 
model predictions to match the observed outcome rates across the entire spread 
of the data, was compared between two models using the Hosmer-Lemeshow 
chi-squared statistic. This measure compares observed and predicted outcomes 
over deciles of risk and a significant p value for this statistic shows lack of 
calibration of the model (i.e., there exists a significant difference between 
expected and observed rates). Generally p values >0.1 can be considered as 
satisfactory for calibration of the models [328]. 
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In the next stage of analysis, 10-year absolute risk of fractures for any participant 
was calculated using the baseline survivor function and prediction coefficients for 
different models (details are described in Chapter 9). Every participant was 
assigned to two different 10-year fracture risk using models with and without 
BUA. Predicted risks based on two models were compared using the non-
parametric Wilcoxon signed-ranks test. Participants were then categorised into 
three groups with absolute risks of <5% (low-risk), 5% to <15% (intermediate-
risk), and ≥15% (high-risk) based on these two models and compared. These cut-
offs were chosen according to the distribution of fracture risk in our population 
and a priori to the analysis. Inclusion of SOS measures into the models did not 
materially change the results of BUA models and we chose not to include them in 
this study. All database management and statistical analyses were performed 
using Stata software, version 10.0 (StataCorp LP., College Station, TX, USA).  
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11.4. Results 
11.4.1. Characteristics of the study population 
After exclusion of those with incomplete data, 1,455 participants aged 65-76 
years (703 men) contributed to the analysis. The characteristics of study 
participants are summarised in Table 11.1. As expected, the three bone 
characteristics (BMD, BUA and SOS) were higher on average among men 
compared to women. During an average of 10.3 years of follow-up (SD=1.4; 
range 8.2-13.1) for all participants, which accounted for 15,567 person-years, 79 
participants suffered a fracture, of whom 61 were women.  
 
 
 
Table 11.1: Characteristics of the study participants  
  
Men 
n=703  
Women 
n=752 
Age (years)  69.6 (3.1)  69.4 (2.9) 
Height (cm)  172.8 (6.3)  159.5 (5.8) 
Body Mass Index (kg/m2)  26.5 (3.1)  26.5 (4.1) 
Past history of fracture  40 (5.7%)  109 (14.5%) 
Current smoking  62 (8.8%)  48 (6.4%) 
Alcohol intake (units/week)*  5 (10.5)  1.5 (5) 
Total hip BMD (g/cm2)  0.944 (0.140)  0.767 (0.125) 
Heel BUA (dB/MHz)  88.3 (18.2)  63.5 (15.4) 
Heel SOS (m/s)  1668.4 (44.5)  1631.4 (38.4) 
Follow-up time (years)  10.4 (1.1)  10.2 (1.6) 
Any incident fracture†  18 (2.6%)  61 (8.1%) 
Data are mean (standard deviation) or number of participants (percentage); BMD = bone mineral 
density, BUA = broadband ultrasound attenuation, SOS = speed of sound 
* Median (inter-quartile range) 
† Number of incident fractures (including hip, spine, wrist, and shoulder) up to March 2007 
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11.4.2. Fitting the models including heel QUS 
Table 11.2 shows the results of sex-stratified Cox proportional-hazard regression 
models with and without BUA included as a covariate. Most of the variables 
entered into the models were significantly associated with fracture risk. The 
hazard ratio (HR) for any fracture per standard deviation decrease in total hip 
BMD was 2.3 (95% confidence interval 1.7-3.0) without BUA in the model and it 
reduced to 1.9 (95% CI 1.4-2.5) after inclusion of BUA. Table 11.2 also shows 
that BUA was significantly associated with fracture risk even with BMD in the 
model (HR=1.6, 95% CI 1.2-2.1). 
 
 
 
 
Table 11.2: Sex-stratified multivariable Cox proportional-hazard models with and 
without BUA included in the predictors  
  Model with BUA  Model without BUA 
Variable  Hazard Ratio P value  Hazard Ratio P value 
Age (year)  1.12 (1.04-1.21) 0.002  1.13 (1.05-1.22) 0.001 
Height (cm)  1.05 (1.01-1.09) 0.019  1.04 (1.00-1.08) 0.051 
Body mass index (kg/m2)  1.07 (1.00-1.13) 0.040  1.05 (0.99-1.12) 0.096 
Past history of fracture   2.07 (1.25-3.44) 0.005  2.24 (1.34-3.73) 0.002 
Current smoking  2.12 (1.08-4.18) 0.029  2.15 (1.09-4.24) 0.027 
Alcohol intake (units/week)  1.03 (1.00-1.06) 0.055  1.03 (1.00-1.06) 0.048 
Total hip BMD (per SD decrease)  1.91 (1.43-2.54) <0.001  2.26 (1.74-2.95) <0.001 
Heel BUA (per SD decrease)  1.59 (1.18-2.13) 0.002  - - 
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Table 11.3 compares the performance of the models with and without BUA on 
three major aspects. All of the global fit measures (including different information 
criteria, likelihood ratio, R-squared estimates, and the D-statistic) showed 
enhanced model fit, although of a small magnitude, for the model including BUA. 
Discrimination was also improved in the model with BUA, with C-index being 
larger by about 2% (Table 11.3). Both models were adequately calibrated as 
shown by high p values from the Hosmer-Lemeshow test in Table 11.3. Details of 
estimated Hosmer-Lemeshow statistics have been shown in Table 11.4. 
 
 
 
 
Table 11.3: Measures of model fit for comparison of the Cox proportional-hazard 
models with and without BUA 
  Model with BUA Model without BUA 
Global measures   
 Bayesian Information Criterion (BIC) 979.7 981.6 
 Akaike’s Information Criterion (AIC) 937.6 944.7 
 Deviance Information Criterion (DIC) 921.6 930.7 
 Likelihood ratio chi-square (df) 78.4 (8) 69.2 (7) 
 Nagelkerke’s R2 10.6% 9.4% 
 Cox-Snell R2 5.3% 4.7% 
 D-statistic 1.81 1.63 
Discrimination    
 C-index (area under ROC curve) 69.8% 67.9% 
Calibration   
 Hosmer-Lemeshow P value  0.62 0.46 
Lower values of the BIC, AIC, and DIC and higher values of all other statistics, including the 
calibration P values, indicate better fit of a model. 
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Table 11.4: Observed and predicted number of fractures in deciles of risk based 
on Cox models with and without BUA as predictor 
  Model with BUA   Model without BUA 
Decile of risk  Observed Predicted HL Observed Predicted HL 
 
1  0 0.79 0.80 0 0.71 0.71 
2  1 1.54 0.19 3 1.43 1.75 
3  1 2.33 0.77 1 2.15 0.62 
4  3 3.27 0.02 3 2.91 0.00 
5  6 4.49 0.53 1 3.96 2.27 
6  4 5.81 0.59 7 5.34 0.53 
7  8 7.74 0.01 7 7.47 0.03 
8  4 10.90 4.72 10 10.26 0.01 
9  19 16.56 0.40 18 14.86 0.74 
10  28 36.77 2.80 24 32.82 3.07 
Total  74 90.20 10.83 74 81.92 9.74 
 
HL: Hosmer-Lemeshow statistic 
 
 
 
11.4.3. Impact of heel QUS on absolute fracture risk estimation 
For the next stage of our analysis, two new variables containing predicted 10-year 
absolute risk of fracture using models with and without BUA were created. 
Wilcoxon signed-ranks test showed that the estimated fracture risks using the 
BUA model (median 3.5%, interquartile range [IQR] 1.6%-7.4%) were higher 
than estimated risks using the model without BUA (median 3.1%, IQR 1.5%-
7.1%; p value = 0.039). The difference between two models does not necessarily 
show more accurate estimates for the model including BUA.  
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Table 11.5 compares the classification of participants based on two models into 
three risk categories. Most of the participants were classified into the same 
category of risk using both models. However, one in six participants (16.6%) 
were classified to a different category according to the model used. About 22% of 
participants assigned to the high-risk group (10-year risk of ≥15%) using the 
model without BUA were re-classified to a lower risk group after inclusion of 
BUA into models. The greatest re-classification (30.7%) was observed among the 
group with intermediate risk. Most of the participants were classified to adjacent 
categories; only one participant with 10-year fracture risk of ≥15% based on 
model without BUA was categorised to <5% risk category after inclusion of BUA 
(Table 11.5).  
 
Table 11.5: Observed and expected risks of fracture using Cox proportional-
hazard models with and without BUA as a predictor 
 10-year fracture risk in model with BUA  
10-year fracture risk in model without BUA
0 to <5% 5% to <15% ≥15% 
Total re-
classified
  
0 to <5%  
Number of participants, n 847 92 0  
Participants classified in each stratum  
by the model including BUA, % 
90.2 9.8 0.0 9.8% 
Observed 10-year risk, % 1.4 6.5 -  
   
5% to <15%   
Number of participants, n 77 280 47  
Participants classified in each stratum  
by the model including BUA, % 
19.1 69.3 11.6 30.7% 
Observed 10-year risk, % 5.2 8.6 14.9  
   
≥15%   
Number of participants, n 1 24 87  
Participants classified in each stratum  
by the model including BUA, % 
0.9 21.4 77.7 22.3% 
Observed 10-year risk, % - 12.5 20.7  
Each stratum of risk according to the Cox model without BUA is categorised according to the 
stratum of risk predicted by the Cox model with BUA 
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The distribution of the participants in different categories based on the two 
models is shown graphically in Figure 11.1. Table 11.5 and Figure 11.1 also 
report the observed fracture risks for different categories. As we had followed up 
most of the participants for more than 10 years, we were able to calculate 
observed 10-year fracture risk (which is the incidence rate of fracture in the first 
10 years of follow-up). These numbers show that the estimated fracture risks 
based on the model with BUA were more compatible with reality. For instance, 
the left side of Figure 11.1 shows that the observed risk for participants 
categorised to <5% risk based on model without BUA and 5% to <15% based on 
model with BUA was about 7%. The same is true for the right hand side of the 
Figure 11.1 as the observed risk for the participants categorised to intermediate 
risk band was 13%. Models including BUA showed a marginal superiority as the 
observed risks among reclassified participants within the intermediate risk group 
were close to the risk thresholds (5% and 15%). 
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Figure 11.1: Distribution of 10-year absolute fracture risk based on Cox proportional-
hazard models with and without BUA among 1,455 EPIC-Norfolk participants 
Bars show the percentage of participants categorised to the specific risk bands using the 
model including BUA. The shading of the bars refers to the fracture risk from the model 
including BUA. The numbers on top of each bar show the observed fracture risk during 
the study period for that particular population.  
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11.5. Discussion 
To our knowledge, this is the first study that evaluates the effects of inclusion of 
QUS measurements in prediction models for incident fracture risk using 
prospective data for 10-year absolute risk of fracture. We found that, while there 
is a small difference with regard to conventional statistical measures between 
prediction models with and without BUA, the resulting change in the estimates of 
10-year fracture risk would be of sufficient magnitude to re-classify one in six of 
participants to other risk categories. Area under the ROC curve increased by 2% 
for the model including BUA and global measures of model fit showed relative 
superiority of the model with BUA. However, categorisation of participants to 
three risk bands showed a discordance of 16.6% between two models and the 
risk estimates in the re-classified groups were closer to the observed risks in our 
population. 
Recently, due to increased public awareness and the introduction of novel and 
effective treatments for osteoporosis, there has been a raise in the demand for 
bone densitometry services. QUS has been introduced in the past two decades as 
an alternative technology to DXA and a large body of evidence supports the idea 
that QUS measurements can discriminate patients with fracture and predict 
incident fracture risk independently and similarly to BMD measurements [343, 
345, 346, 348, 349, 365, 368]. The widespread availability of both QUS and 
DXA equipments raises the question of whether a combination of QUS and BMD 
measurements could improve the prediction of fracture risk [360]. The answer to 
this question, however, remains uncertain as different studies have reached 
different conclusions hitherto [350]. The EPIDOS study supported this 
combination as the incidence of hip fracture among women with values above 
the median for both calcaneal BUA and femoral neck BMD was 2.7 per 1000 
person-years compared with 19.6 per 1000 person-years for those with values 
below the median for both measures [345]. The Study of Osteoporotic Fractures 
(SOF), on the other hand, suggested that BUA may be a reasonable surrogate for 
BMD to screen for high-risk older women, but the utility of BUA to define further 
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a group of individuals at a very high risk for fracture is modest [344]. The debate 
on this issue continues in smaller cross-sectional studies [337, 340, 369, 370]. 
An important drawback common to all these reports is the retrospective or short 
follow-up design of the studies that compared QUS and DXA for fracture 
prediction. Most of the prospective studies have followed their participants for 
less than 3 years [344-347]. However, it seems necessary to compare the long-
term predictive power of different technologies for prediction of fractures in order 
to have a better estimate of their performance. Moreover, clinical practice is 
currently shifting towards considering these long-term estimates. The FRAX® tool 
is likely to be a major resource for use in routine clinical practice in this field [24, 
162]. This tool currently considers several clinical risk factors and BMD 
measurements in the femoral neck. The results of this tool can be replicated for 
different populations using prospective studies with long follow-ups. Moreover, 
other potential risk factors (including clinical, radiological and biochemical 
factors) can be added to these estimations. In the current study, we examined the 
effects of inclusion of BUA into models for calculation of 10-year fracture risk 
when all models contain clinical risk factors and BMD measures. Our results 
confirm that combining QUS measures with clinical and BMD measures can 
have an impact as it re-classifies about 17% of participants to other risk 
categories.  
Our study has some limitations. The main limitation, which applies not only to 
this study but also to the whole osteoporosis risk-assessment field, is the choice of 
thresholds for categorisation of participants. We know that these thresholds must 
come from population-specific cost-utility or cost-effectiveness studies that 
combine absolute risk measures, age structure of the population, cost and efficacy 
of the therapies, and the value (or utility) of fractures in the community. Currently, 
there is no such study using absolute risk estimates in the UK (as well as other 
parts of the world) and we had to rely on some arbitrary thresholds. We 
considered distribution of incident fracture cases in our study population as well 
as the estimated fracture risks based on both models in this study. Given the low 
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incidence of fractures in our population, we chose to consider about 10% of 
participants as high-risk and about 30% as intermediate-risk. This translated to cut 
points of 5% and 15%. Choosing other previously suggested thresholds [363] 
yielded similar results (data not shown) as, for instance, thresholds of 10% and 
20% for risk categorisation showed about 14% total re-classification between two 
models.  
The other potential limitation of this study is the representativeness of the study 
population. There is a potential for healthy subject recruitment of participants into 
the EPIC-Norfolk study as well as this particular analysis since healthy subjects 
are more likely to participate in long-term prospective studies and consent to 
undergo several diagnostic procedures. The incidence rate of fractures was low 
according to the UK norms (about 5 per 1000 p-y in our participants compared to 
about 20 per 1000 p-y in other parts of UK [4, 371]). About 85% of our 
participants had an estimated 10-year fracture risk of less than 10% based on 
either model. However, it should be noted that previous studies from East Anglia 
have shown that the rate of fracture in this region is much lower compared to 
other parts of UK for unknown reasons, possibly related to a healthier lifestyle 
and higher levels of physical activity [324]. Given the follow-up procedure in the 
EPIC-Norfolk study, which is based on surveillance of hospital admissions 
throughout England and Wales for all participants, only fractures that needed 
admission to hospitals were considered for this study. This may have led to an 
underestimation of fracture rate in our study population compared to other 
populations, even though only minor fractures (e.g., of digits or ribs) are thought 
likely to avoid hospital attention. Nevertheless, the association found in this study 
between BUA and fracture risk as well as its impact on re-classification of 
participants is unlikely to change with recruitment of higher risk individuals 
unless there was an independent interaction between these factors and the 
composition of the sample. In any case, the results of this study need to be 
validated in another study setting before generalisation to other populations.  
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In conclusion, we estimated 10-year absolute fracture risk for comparison of 
models with and without QUS measures included as a predictor of fractures. Our 
method of comparison can be regarded as a new application for absolute fracture 
risk calculation and may be used with other presumably important risk factors 
(such as clinical, radiological and biochemical risk factors) to assess whether they 
can add useful information to the current risk prediction models. Our results show 
that combining QUS measures into models based on clinical risk factors and 
BMD provides useful information that helps to more accurately categorise 
patients according to their risk of fracture. This suggests that further attention 
should be paid to QUS as a useful clinical tool for prevention of fractures. 
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Chapter 12: Discussion 
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12.1. Interpretation of the main findings 
Various projects of this thesis have contributed to the field of epidemiology and 
risk assessment of osteoporotic fractures. The first part of the thesis looked at 
different risk identifiers for fractures. These included clinically-applicable 
`measured height loss’ and `respiratory function’ measures. Non-linear 
associations between physical activity as well as body fat mass with osteoporotic 
fractures were also assessed in this part. The second part of the thesis dealt with 
absolute risk of fracture and the methods and applications of it in the field of 
fracture risk assessment, which is a really hot topic in the current research world. 
We developed a method for estimation of absolute fracture risk using individual-
level prospective data and applied it for comparison of two radiological measures 
of bone and then showed the independent contribution of bone ultrasound for 
improvement of absolute risk measures.  
Currently, measuring changes in height over time is not a routine practice among 
clinicians caring for the elderly. Creating charts with detailed measurements of 
height in consecutive visits is easily applicable in all general and geriatric clinics 
throughout the world. Our study shows that a rapid loss of height (e.g. >2 cm 
over a period of 4 years) can be an indicator of osteoporosis and increased risk of 
fracture. This may also be an indicator of frailty and susceptibility to other morbid 
outcomes in this older population and needs verification in other studies. 
Similarly, assessment of respiratory function using a simple and inexpensive 
device can inform the clinicians about the risk of osteoporotic fractures in their 
patients. FEV1 may also be an indicator of general health status of individuals as 
another EPIC-Norfolk analysis showed that it independently predicts self 
perceived physical well-being across the whole normal distribution of respiratory 
function [372]. 
Physical activity by nature is a difficult exposure to measure, especially in a 
prospective setting. My review on the associations between physical activity and 
different fractures or surrogate bone outcomes showed a complex, and sometimes 
 203 
 
conflicting, relationship. While moderate physical activity is surely protective 
against hip fractures, it may act differently or in opposite direction on other 
fractures or in higher intensities. Moreover, its impact on bone density and bone 
quality seems to be of a questionable magnitude and, therefore, most of it effects 
of fracture risk might be related to muscle functions and reduced risk of falls 
among the elderly. It is important to notice that a physically active lifestyle 
includes assessment of activities in all domains of life, which has been considered 
in the EPAQ2 questionnaire. Our study showed different patterns of association 
between physical activity in different domains of life and prospective risk of 
fractures among men and women. Alongside direct information derived from our 
findings, non-linear associations observed in our study will inform researchers 
about the factors to consider when designing future trials on this subject. 
Inter-relationships between bone and fat tissues have recently taken attention of 
researchers in the field of bone research. Most of previous epidemiological 
studies considered obesity indices like weight or body mass index as their 
covariate for assessment of fracture risk. However, it is now shown that fat mass 
as a lively tissue may have different effects on the function and properties of bone 
in cellular and tissue levels. In this sense, consideration to the risk of fracture 
attributed to the fat content of individuals may have a great impact on our 
understanding about these mechanisms. Meanwhile, the association between 
body fat mass and fracture risk does not follow a linear trend and adjustment for 
BMI changes the association noticeably. These impose immense problems for 
analysis of data in epidemiological studies and have resulted in challenging 
controversies in the literature. Use of fractional polynomial modelling in our 
study empowered us to assess the non-linear association between fat mass and 
fracture risk considering its independence from body mass index. 
Estimation of 10-year absolute risk of fracture is gradually becoming the routine 
practice for clinicians in this field. This practice is recommended by the WHO 
and many other academic and clinical societies across the world. Consequently, 
the field of research on fracture risk is also changing direction towards use of 
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these measures. As one of the first studies in this field, we developed a model for 
prediction of 10-year absolute risk (or probability) of fracture using long-term 
follow-up data available in EPIC-Norfolk study. This method needs follow-up of 
more than 10 years for at least a subset of participants as it uses the semi-
parametric Cox proportional-hazards regression modelling. However, the method 
can be extended to parametric methods such as Poisson regression to use in 
cohorts with shorter follow-ups. I have also applied this method for comparison of 
two bone measurement modalities and for assessment of independent power of 
bone ultrasound measures for fracture risk prediction. Our method has already 
attracted large attention and I am collaborating now with a team of experts from 
the International Society for Clinical Densitometry to develop guidelines for 
inclusion of bone ultrasound into FRAX®. 
 
 
12.2. Strengths and limitations of the study  
Studies presented in this thesis have several strengths and advantages related to 
the design and methodological subtleties contemplated in EPIC-Norfolk study. 
The long follow-up and large number of participants from both sexes are the 
obvious strengths. Participants have been examined for a thorough list of health 
measures related to a variety of outcomes and this enabled me to consider a 
number of them in this thesis. Although the cohort was not originally designed for 
assessment of osteoporotic fractures, participants in the second health 
examination of EPIC-Norfolk underwent measurement of heel QUS that, as 
shown in this thesis also, is a powerful predictor of risk of fractures. Designing 
and validating a detailed questionnaire for assessment of physical activity in 
different domains of life is another strength point of EPIC-Norfolk study. In all 
chapters of this thesis, I have used robust statistical tests with consideration to sex 
differences and adjustment for known risk factors of fracture. Large number of 
participants enabled us to look at the non-linear associations between some of 
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the complex exposures and risk of fracture. Use of these methods alongside with 
longitudinal design of EPIC-Norfolk makes a distinction between our findings and 
other studies previously reported in this field. 
Our studies have also some limitations that have been mainly discussed in each 
chapter. EPIC-Norfolk was not originally designed for assessment of osteoporosis 
and bone fractures and this put some restraints for exploitation of its findings in 
the field of bone research. The main limitation pointed out by several reviewers 
of our papers is the lack of DXA assessment in our studies. Although we have 
shown in Chapter 10 that heel QUS can predict fracture as efficiently as DXA, 
most of the researchers in this field do trust in DXA measures in a much respected 
way. The reason usually mentioned is that the output of DXA, which is mineral 
content and density of the bones, is obvious and sensible, while the output of 
QUS measures, which is change in the characteristics of the sound waves passing 
the bone, is not clear. In this sense, not using DXA in EPIC-Norfolk might be 
considered as a weakness. However, the expense and applicability of 
measurement techniques should also be considered in running a large 
population-based prospective study. This also should be noted for risk assessment 
of fracture in clinical practice. Moreover, associations observed in this thesis for 
different risk identifiers, which are all independent of heel BUA measures, are 
unlikely to be dependent on bone density and use of DXA measures would not 
change most of our findings. 
The other limitation of EPIC-Norfolk with respect to fracture risk assessment is the 
age structure of participants. EPIC-Norfolk can be considered as a young 
population compared to most of other cohorts in the field of osteoporosis. Given 
the exponential increase in fracture rate with age, most cohorts include 
participants older than 70 years, which are a minority in EPIC-Norfolk. This is 
especially true for the male population. There is also a potential for `healthy 
participant’ bias in our study. However, characteristics of EPIC-Norfolk study 
population are shown to be comparable with the Health Survey of England and 
this population can be considered representative of the UK population [107]. The 
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method of assignment of fractures is another potential limitation of our study. 
Although we can be sure that we have captured all the fractures with high health 
impact that demanded hospitalisation, the shape of distribution of different 
fracture types indicates that we might have lost some minor fractures (for instance 
in distal forearm). Lack of radiological assessment for potential vertebral fractures 
is another constraint. Active follow-up of participants and asking directly and 
frequently about different health outcomes including fractures is not practical in 
the settings of a large population-based study like EPIC-Norfolk and we had to put 
up with this limitation. However, we can be sure that we have covered for almost 
all of the high-impact clinical consequences of osteoporosis in our study for a 
long period of follow-up. 
 
 
12.3. Future works 
The findings of studies carried out in this thesis may be applied in clinical settings 
and may serve as a basis for future research in related topics. Results of first part 
of the thesis, after validation in independent populations, can be used in clinical 
practice for better estimation of fracture risk in patients. Currently, I have started 
collaboration with two cohorts (Canadian Multi-centre Osteoporosis Study and 
TwinsUK study) to validate these findings. Both cohorts are long-term prospective 
studies and have baseline and follow-up data available on measured height, 
respiratory function and percentage body fat. Unfortunately the method of 
assessment of physical activity is different in other cohorts and needs specific 
methods for analysis in each cohort.  
An important research question that can be considered as an extension to the 
works of this thesis is concerning the role of muscle function in prediction of 
fracture risk. The term sarcopenia, or reduced muscle mass and strength, is 
suggested to be the starting point for physical frailty process among the elderly 
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[373]. While the biological mechanisms underlying sarcopenia remains elusive, 
there is growing evidence for the link between sarcopenia and osteoporosis 
[374]. Several factors that play a role in the origin of osteoporosis are thought to 
contribute in causing sarcopenia. These putative causal factors include a 
decreased level of physical activity, hormonal changes, a reduction in dietary 
protein, and catabolic stimuli from chronic inflammation [375]. Furthermore, a 
role of genetic factors in linking muscle and bone mass has been advocated 
[376]. Sarcopenia may also be a risk factor for fracture as it increases the hazard 
of falling [377]. However, there is a lack of large-scale epidemiological studies 
focussing on the predictors and functional consequences of sarcopenia and its 
connection with osteoporotic fractures. Several methods can be considered for 
assessment of sarcopenia including measurement of muscle mass (using DXA, CT 
scan, or bio-impedance), muscle strength tests (such as handgrip test and knee 
flexion/extension test), physical performance tests (such as Short Physical 
Performance Battery [SPPB], gait speed, and timed get-up-and-go test), and 
balance tests [375]. Most of these tests are being performed for participants of the 
3rd health examination of EPIC-Norfolk. 
Future works for finding new risk identifiers or determinants of osteoporotic 
fractures inside EPIC-Norfolk study can be more focused on the measures of 
muscle strength or physical performance. Unfortunately, the length of follow-up 
for these variables is short and prospective analysis with the fracture outcomes is 
unlikely to be fruitful at this stage. However, as we are aware of the link between 
these measures and risk of osteoporotic fractures, we may consider them (or 
sarcopenia as a clinical entity) as a separate outcome and try to find predictors 
and determinants of them in EPIC-Norfolk population. The other option is 
collaboration with long-term prospective studies with data available in this field. 
Currently, I am applying for funding to start a collaborative project for working on 
the determinants and markers of sarcopenia in older men and women. This 
project will be based on four prospective cohorts: EPIC-Norfolk study, TwinsUK 
study, Hertfordshire Cohort study, and Framingham Osteoporosis study. We aim 
to understand the contribution of lifestyle, biological, and genetic determinants of 
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muscle strength and performance and to examine the association between 
sarcopenia and the prospective risk of development of physical frailty and its 
adverse outcomes including falls, fractures, increased medication, hospitalisation, 
institutionalisation and death.  
Works done in the second part of this thesis may also be applied in different 
ways. Methods developed for comparison of different risk factors using estimated 
absolute risks of fracture may be applied to other clinical and radiological tests. 
The method of evaluation of independent `risk factors’ (such as heel QUS in 
Chapter 11) can also be applied to other risk identifiers. I have also used the 
method for calculation of 10-year probability of fracture in the Canadian Multi-
centre Osteoporosis study (CaMos) for about 7,500 men and women aged > 50 
years. The estimated 10-year probabilities are being compared with the newly 
developed FRAX® for Canada and the results will be published in collaboration 
with CaMos researchers.  
Another important point of application for our method of estimation of fracture 
probability is related to the length of follow-up required to achieve an accurate 
estimate of 10-year fracture risk. These estimates should ideally come from 
population-specific prospective studies that follow representative members of the 
community for a sufficiently long time. However, given practical and resource 
constraints, cohort studies usually follow their participants for a shorter interval 
(typically 4-7 years) and extrapolate their results to generate 10-year predictions. 
The most widely used statistical methods for extrapolation are based on 
exponential distribution of fracture risk and using Poisson regression. This is also 
true for the FRAX® estimates since they are based on modelling in 59,644 
individuals followed for 252,034 person-years in 9 cohorts (follow-up average of 
4.2 years in the development set) [24]. I extended the method described in 
Chapter 9 to compare fracture probabilities derived from models with different 
length of follow-up.  
For this purpose, I employed sex-specific Poisson regression models adjusting for 
age, history of fracture, height, body mass index, smoking and alcohol 
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consumption in the original cohort of EPIC-Norfolk. 10-year absolute fracture 
risks were calculated in 10 different sub-cohorts with one year added interval of 
follow-up (i.e., the original cohort was re-arranged to produce 10 cohorts with 
follow-up period of 1, 2, 3, …, and 10 years; incident fractures after the follow-up 
period were censored for each cohort). While 758 fractures were observed in the 
first 10 years of follow-up among EPIC-Norfolk participants, models with 5, 6, 7, 
8, 9, and 10 years of follow-up, respectively, predicted this number to be 423, 
491, 569, 638, 685, and 761 fractures. This shows a strong trend towards 
underestimation with more censoring in shorter studies. When compared to sex-
specific Cox model with 10 years of follow-up, estimates derived from Poisson 
models with follow-up of 7 years or less showed significantly lower area under 
the ROC curve (AUC for Cox model = 0.700; AUC for Poisson models ranging 
from 0.670 to 0.696; P values < 0.05). I have also used this method in the CaMos 
dataset and found quite similar results. This suggests that short-term studies 
systematically underestimate long-term risks of fracture and might not be suitable 
for this purpose.  
 
In summary, various projects of this thesis have contributed to the field of 
epidemiology and risk assessment of osteoporotic fractures. The findings of our 
studies need verification in independent cohorts and methods used for analysis 
can be applied to other settings and other variables. The perspective of works in 
EPIC-Norfolk are being extended to include risk of muscle wasting and strength as 
a potential contributor to osteoporotic fractures and collaborations are underway 
for application of our absolute risk estimation method in other cohorts. 
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